Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 Commission File Number 1-11758 (Exact name of Registrant as specified in its charter) Delaware 1585 Broadway 36-3145972 (212) 761-4000 (State or other jurisdiction of incorporation or organization) New York, NY 10036 (I.R.S. Employer Identification No.) (Registrant’s telephone number, including area code) (Address of principal executive offices, including zip code) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of exchange on which registered Common Stock, $0.01 par value MS New York Stock Exchange Depositary Shares, each representing 1/1,000th interest in a share of Floating Rate MS/PA New York Stock Exchange Non-Cumulative Preferred Stock, Series A, $0.01 par value Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate MS/PE New York Stock Exchange Non-Cumulative Preferred Stock, Series E, $0.01 par value Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate MS/PF New York Stock Exchange Non-Cumulative Preferred Stock, Series F, $0.01 par value Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate MS/PI New York Stock Exchange Non-Cumulative Preferred Stock, Series I, $0.01 par value Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate MS/PK New York Stock Exchange Non-Cumulative Preferred Stock, Series K, $0.01 par value Depository Shares, each representing 1/1000th interest in a share of 4.875% MS/PL New York Stock Exchange Non-Cumulative Preferred Stock, Series L, $0.01 par value Global Medium-Term Notes, Series A, Fixed Rate Step-Up Senior Notes Due 2026 MS/26C New York Stock Exchange of Morgan Stanley Finance LLC (and Registrant’s guarantee with respect thereto) Morgan Stanley Cushing® MLP High Income Index ETNs due March 21, 2031 MLPY NYSE Arca, Inc. Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No Indicate by check mark whether the Registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the Registrant was required to submit such files). Yes No Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one): Large accelerated filer Accelerated filer Non-accelerated filer Smaller reporting company Emerging growth company If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No As of April 30, 2020, there were 1,575,656,380 shares of the Registrant’s Common Stock, par value $0.01 per share, outstanding. -- 1 of 93 -- Table of Contents i QUARTERLY REPORT ON FORM 10-Q For the quarter ended March 31, 2020 Table of Contents Part Item Page Risk Factors II 1A Financial Information I Management’s Discussion and Analysis of Financial Condition and Results of Operations I 2 Introduction Executive Summary Business Segments Supplemental Financial Information Other Matters Accounting Development Updates Critical Accounting Policies Liquidity and Capital Resources Balance Sheet Regulatory Requirements Quantitative and Qualitative Disclosures about Risk I 3 Market Risk Credit Risk Country and Other Risks Report of Independent Registered Public Accounting Firm Consolidated Financial Statements and Notes I 1 Consolidated Income Statements (Unaudited) Consolidated Comprehensive Income Statements (Unaudited) Consolidated Balance Sheets (Unaudited at March 31, 2020) Consolidated Statements of Changes in Total Equity (Unaudited) Consolidated Cash Flow Statements (Unaudited) Notes to Consolidated Financial Statements (Unaudited) 1. Introduction and Basis of Presentation 2. Significant Accounting Policies 3. Cash and Cash Equivalents 4. Fair Values 5. Fair Value Option 6. Derivative Instruments and Hedging Activities 7. Investment Securities 8. Collateralized Transactions 9. Loans, Lending Commitments and Related Allowance for Credit Losses 10. Other Assets—Equity Method Investments 11. Deposits 12. Borrowings and Other Secured Financings 13. Commitments, Guarantees and Contingencies 14. Variable Interest Entities and Securitization Activities 15. Regulatory Requirements 16. Total Equity 17. Interest Income and Interest Expense 18. Income Taxes 19. Segment, Geographic and Revenue Information Financial Data Supplement (Unaudited) Glossary of Common Terms and Acronyms Other Information II Legal Proceedings II 1 Unregistered Sales of Equity Securities and Use of Proceeds II 2 Controls and Procedures I 4 Exhibits II 6 Signatures 1 2 2 2 3 7 15 15 15 16 16 16 21 28 28 30 35 38 39 39 40 41 42 43 44 44 45 47 47 54 55 59 62 63 67 67 67 68 71 73 76 78 78 78 81 82 84 84 84 84 84 S-1 -- 2 of 93 -- Table of Contents ii Available Information We file annual, quarterly and current reports, proxy statements and other information with the SEC. The SEC maintains a website, www.sec.gov, that contains annual, quarterly and current reports, proxy and information statements and other information that issuers file electronically with the SEC. Our electronic SEC filings are available to the public at the SEC’s website. Our website is www.morganstanley.com. You can access our Investor Relations webpage at www.morganstanley.com/about-us-ir. We make available free of charge, on or through our Investor Relations webpage, our proxy statements, annual reports on Form 10- K, quarterly reports on Form 10-Q, current reports on Form 8-K and any amendments to those reports filed or furnished pursuant to the Securities Exchange Act of 1934, as amended (“Exchange Act”), as soon as reasonably practicable after such material is electronically filed with, or furnished to, the SEC. We also make available, through our Investor Relations webpage, via a link to the SEC’s website, statements of beneficial ownership of our equity securities filed by our directors, officers, 10% or greater shareholders and others under Section 16 of the Exchange Act. You can access information about our corporate governance at www.morganstanley.com/about-us-governance and our sustainability initiatives at www.morganstanley.com/about-us/sustainability-at-morgan-stanley. Our webpages include: • Amended and Restated Certificate of Incorporation; • Amended and Restated Bylaws; • Charters for our Audit Committee, Compensation, Management Development and Succession Committee, Nominating and Governance Committee, Operations and Technology Committee, and Risk Committee; • Corporate Governance Policies; • Policy Regarding Corporate Political Activities; • Policy Regarding Shareholder Rights Plan; • Equity Ownership Commitment; • Code of Ethics and Business Conduct; • Code of Conduct; • Integrity Hotline Information; • Environmental and Social Policies; and • Sustainability Report. Our Code of Ethics and Business Conduct applies to all directors, officers and employees, including our Chief Executive Officer, Chief Financial Officer and Deputy Chief Financial Officer. We will post any amendments to the Code of Ethics and Business Conduct and any waivers that are required to be disclosed by the rules of either the SEC or the New York Stock Exchange LLC (“NYSE”) on our website. You can request a copy of these documents, excluding exhibits, at no cost, by contacting Investor Relations, 1585 Broadway, New York, NY 10036 (212-761-4000). The information on our website is not incorporated by reference into this report. -- 3 of 93 -- Table of Contents 1 March 2020 Form 10-Q Risk Factors In addition to “Risk Factors” in Part I, Item 1A of the 2019 Form 10-K, please refer to the risk factor under Item 8.01. “Other Matters,” in the Current Report on Form 8-K filed with the SEC on April 16, 2020 and the additional risk factors under “Risk Factors” in the Registration Statement on Form S-4 filed with the SEC on April 17, 2020. -- 4 of 93 -- Table of Contents March 2020 Form 10-Q 2 Management’s Discussion and Analysis of Financial Condition and Results of Operations Introduction Morgan Stanley is a global financial services firm that maintains significant market positions in each of its business segments— Institutional Securities, Wealth Management and Investment Management. Morgan Stanley, through its subsidiaries and affiliates, provides a wide variety of products and services to a large and diversified group of clients and customers, including corporations, governments, financial institutions and individuals. Unless the context otherwise requires, the terms “Morgan Stanley,” “Firm,” “us,” “we” or “our” mean Morgan Stanley (the “Parent Company”) together with its consolidated subsidiaries. See the “Glossary of Common Terms and Acronyms” for the definition of certain terms and acronyms used throughout this Form 10-Q. A description of the clients and principal products and services of each of our business segments is as follows: Institutional Securities provides investment banking, sales and trading, lending and other services to corporations, governments, financial institutions and high to ultra-high net worth clients. Investment banking services consist of capital raising and financial advisory services, including services relating to the underwriting of debt, equity and other securities, as well as advice on mergers and acquisitions, restructurings, real estate and project finance. Sales and trading services include sales, financing, prime brokerage and market-making activities in equity and fixed income products, including foreign exchange and commodities. Lending activities include originating corporate loans and commercial real estate loans, providing secured lending facilities, and extending financing to sales and trading customers. Other activities include Asia wealth management services, investments and research. Wealth Management provides a comprehensive array of financial services and solutions to individual investors and small to medium-sized businesses and institutions covering: brokerage and investment advisory services; financial and wealth planning services; stock plan administration services; annuity and insurance products; securities-based lending, residential real estate loans and other lending products; banking; and retirement plan services. Investment Management provides a broad range of investment strategies and products that span geographies, asset classes, and public and private markets to a diverse group of clients across institutional and intermediary channels. Strategies and products, which are offered through a variety of investment vehicles, include equity, fixed income, liquidity and alternative/other products. Institutional clients include defined benefit/defined contribution plans, foundations, endowments, government entities, sovereign wealth funds, insurance companies, third-party fund sponsors and corporations. Individual clients are generally served through intermediaries, including affiliated and non-affiliated distributors. Management’s Discussion and Analysis includes certain metrics which we believe to be useful to us, investors, analysts and other stakeholders by providing further transparency about, or an additional means of assessing, our financial condition and operating results. Such metrics, when used, are defined and may be different from or inconsistent with metrics used by other companies. The results of operations in the past have been, and in the future may continue to be, materially affected by: competition; risk factors; legislative, legal and regulatory developments; and other factors. These factors also may have an adverse impact on our ability to achieve our strategic objectives. Additionally, the discussion of our results of operations herein may contain forward-looking statements. These statements, which reflect management’s beliefs and expectations, are subject to risks and uncertainties that may cause actual results to differ materially. For a discussion of the risks and uncertainties that may affect our future results, see “Forward-Looking Statements,” “Business—Competition,” “Business—Supervision and Regulation,” and “Risk Factors” in the 2019 Form 10-K, and “Liquidity and Capital Resources—Regulatory Requirements” herein. In addition, see “Executive Summary” herein and “Risk Factors” for information on the current and possible future effects of the COVID-19 pandemic on our results. -- 5 of 93 -- Table of Contents Management’s Discussion and Analysis 3 March 2020 Form 10-Q Executive Summary Overview of Financial Results Consolidated Results Net Revenues ($ in millions) Net Income Applicable to Morgan Stanley ($ in millions) Earnings per Common Share1 1. For further information on basic and diluted EPS, see Note 16 to the financial statements. We reported net revenues of $9,487 million in the quarter ended March 31, 2020 (“current quarter,” or “1Q 2020”), compared with $10,286 million in the quarter ended March 31, 2019 (“prior year quarter,” or “1Q 2019”). For the current quarter, net income applicable to Morgan Stanley was $1,698 million, or $1.01 per diluted common share, compared with $2,429 million or $1.39 per diluted common share, in the prior year quarter. See “Coronavirus Disease (COVID-19) Pandemic” herein for information on the current and possible future effects of the COVID-19 pandemic on our results. Non-interest Expenses1 ($ in millions) 1. The percentages on the bars in the chart represent the contribution of compensation and benefits expenses and non-compensation expenses to the total. • Compensation and benefits expenses of $4,283 million in the current quarter decreased 8% from $4,651 million in the prior year quarter. The decrease was primarily due to decreases in the fair value of investments to which certain deferred compensation plans are referenced and compensation associated with carried interest, partially offset by increases in discretionary incentive compensation, and the formulaic payout to Wealth Management representatives driven by the mix of revenues. • Non-compensation expenses of $3,058 million in the current quarter increased 14% from $2,680 million in the prior year quarter. The increase was primarily due to higher volume- related expenses and an increase in the provision for credit losses for lending commitments. Income Taxes The prior year quarter included intermittent net discrete tax benefits of $101 million, primarily associated with remeasurement of reserves and related interest as a result of new information pertaining to the resolution of multi-jurisdiction tax examinations. For further information, see “Supplemental Financial Information—Income Tax Matters” herein. -- 6 of 93 -- Table of Contents Management’s Discussion and Analysis March 2020 Form 10-Q 4 Selected Financial Information and Other Statistical Data Three Months Ended March 31, $ in millions 2020 2019 Net income applicable to Morgan Stanley $ 1,698 $ 2,429 Preferred stock dividends 108 93 Earnings applicable to Morgan Stanley common shareholders $ 1,590 $ 2,336 Expense efficiency ratio1 77.4% 71.3% ROE2 8.5% 13.1% Adjusted ROE3 8.3% 12.5% ROTCE2,3 9.7% 14.9% Adjusted ROTCE3 9.5% 14.2% Pretax margin4 22.6% 28.7% Pre-tax margin by segment4 Institutional Securities 19% 31% Wealth Management 26% 27% Investment Management 21% 22% in millions, except per share and employee data At March 31, 2020 At December 31, 2019 Liquidity resources5 $ 255,134 $ 215,868 Loans6 $ 148,697 $ 130,637 Total assets $ 947,795 $ 895,429 Deposits $ 235,239 $ 190,356 Borrowings $ 194,856 $ 192,627 Common shares outstanding 1,576 1,594 Common shareholders' equity $ 77,340 $ 73,029 Tangible common shareholders’ equity3 $ 68,194 $ 63,780 Book value per common share7 $ 49.09 $ 45.82 Tangible book value per common share3,7 $ 43.28 $ 40.01 Worldwide employees 60,670 60,431 At March 31, 2020 At December 31, 2019 Capital ratios8 Common Equity Tier 1 capital 15.2% 16.4% Tier 1 capital 17.3% 18.6% Total capital 19.6% 21.0% Tier 1 leverage 8.1% 8.3% SLR 6.2% 6.4% 1. The expense efficiency ratio represents total non-interest expenses as a percentage of net revenues. 2. ROE and ROTCE represent annualized earnings applicable to Morgan Stanley common shareholders as a percentage of average common equity and average tangible common equity, respectively. 3. Represents a non-GAAP measure. See “Selected Non-GAAP Financial Information” herein. 4. Pre-tax margin represents income from continuing operations before income taxes as a percentage of net revenues. 5. For a discussion of Liquidity resources, see “Liquidity and Capital Resources— Liquidity Risk Management Framework—Liquidity Resources” herein. 6. Amounts include loans held for investment (net of allowance) and loans held for sale but exclude loans at fair value, which are included in Trading assets in the balance sheets (see Note 9 to the financial statements). 7. Book value per common share and tangible book value per common share equal common shareholders’ equity and tangible common shareholders’ equity, respectively, divided by common shares outstanding. 8. At March 31, 2020 and December 31, 2019, our risk-based capital ratios are based on the Advanced Approach and the Standardized Approach rules, respectively. For a discussion of our capital ratios, see “Liquidity and Capital Resources—Regulatory Requirements” herein. Business Segment Results Net Revenues by Segment1 ($ in millions) Net Income Applicable to Morgan Stanley by Segment1 ($ in millions) 1. The percentages on the bars in the charts represent the contribution of each business segment to the total of the applicable financial category and may not total to 100% due to intersegment eliminations. See Note 19 to the financial statements for details of intersegment eliminations. • Institutional Securities net revenues of $4,905 million in the current quarter decreased 6% from $5,196 million in the prior year quarter primarily reflecting losses on loans and lending commitments held for sale and an increase in the provision for credit losses on loans and lending commitments held for investment, as well as losses related to investments associated with certain employee deferred cash-based compensation plans, partially offset by increases in Fixed Income and Equity sales and trading revenues driven by increased volumes and volatility. • Wealth Management net revenues of $4,037 million in the current quarter decreased 8% from $4,389 million in the prior year quarter, primarily reflecting losses related to investments associated with certain employee deferred cash-based compensation plans, partially offset by higher Asset management revenues and higher commissions driven by market volatility. -- 7 of 93 -- Table of Contents Management’s Discussion and Analysis 5 March 2020 Form 10-Q • Investment Management net revenues of $692 million in the current quarter decreased 14% from $804 million in the prior year quarter, primarily reflecting lower Investments revenues, partially offset by higher Asset management revenues. Net Revenues by Region1, 2 ($ in millions) 1. The percentages on the bars in the charts represent the contribution of each region to the total. 2. For a discussion of how the geographic breakdown of net revenues is determined, see Note 19 to the financial statements. Both the 34% increase in revenues in Asia and the 33% decrease in revenues in EMEA were primarily attributable to Equity sales and trading within the Institutional Securities business segment. The Equity sales and trading revenues increase in Asia reflects higher client volumes, while in EMEA market volatility and reduced dividend expectations weighed on revenues in the derivatives and financing businesses. Additionally, EMEA results reflected markdowns of held-for-sale loans and lending commitments. Coronavirus Disease (COVID-19) Pandemic The coronavirus disease (“COVID-19”) pandemic and related government-imposed shelter-in-place restrictions have had, and will likely continue to have, a severe impact on global economic conditions and the environment in which we operate our businesses. In responding to this unprecedented situation, we have taken measures to prioritize the health of our employees and their families, and to be prepared operationally to serve our clients, leveraging our business continuity planning and historical investments in technology. More than 90% of our employees are currently working from home, and to date, we have not experienced any significant loss of operational capability, as we have implemented our pandemic-related responses. We believe we are prepared to continue to operate with the vast majority of our workforce working remotely for as long as health guidelines and prudence require, with limited impact to our operational capabilities. The coronavirus disease has impacted many people’s health around the world, including many of our employees. Our Chairman and CEO was diagnosed with the coronavirus in March, but has fully recovered. The rest of the Firm’s Operating Committee remain healthy and are sheltering in place. With the COVID-19 impacts on individuals, communities and organizations continuing to evolve, governments around the world have reacted to the health crisis caused by the pandemic, and central banks have taken steps to proactively address market disruptions by cutting interest rates and providing liquidity sources and other stimulus programs. See “Regulatory Developments in Response to COVID-19” herein for further details. We also have taken several direct steps to provide assistance. Our balance sheet has increased as we: support market and client activity; take in increased deposits from our Wealth Management clients; extend credit to our institutional and retail clients to provide them with additional liquidity; and provide financing to support COVID-19 impacted clients across multiple sectors. Along with the seven other U.S. Banks comprising the Financial Services Forum, we voluntarily ceased our Share Repurchase Program to keep this capital available to help clients and took action on the Federal Reserve's encouragement to use its discount window by borrowing from it. We have also taken steps to participate in other Federal Reserve programs, notably the Primary Dealer Credit Facility (“PDCF”). Our financial condition, balance sheet, capital and liquidity have remained strong. In March 2020, we saw deposit inflows of $38 billion as customers sought relative safety away from volatile markets, and we raised more than $5 billion in new long-term debt supplementing our liquidity position. As further discussed in “Business Segments” herein, towards the end of the current quarter, we observed the impact of the pandemic on our business. The decline of asset prices, reduction in interest rates, widening of credit spreads, borrower and counterparty credit deterioration, market volatility and reduced investment banking activity had the most immediate negative impacts on our current quarter performance. Related to these effects, the Firm experienced mark-to-market losses, net of economic hedges of $610 million on loans and lending commitments held for sale, provisions of $407 million for credit losses on loans and lending commitments held for investment, and losses of $384 million on fund and business-related investments, net of hedges. At the same time, high levels of client trading activity, related to market volatility, significantly increased revenues for global macro products and Commodities in Institutional Securities, and the transactional businesses in Wealth Management. Though we are unable to estimate the extent of the impact, the continuing pandemic and related global economic crisis will adversely impact our future operating results. Additionally, with the continuance of many of the same negative impacts, without the benefit of higher client trading activity experienced in the -- 8 of 93 -- Table of Contents Management’s Discussion and Analysis March 2020 Form 10-Q 6 current quarter, it is uncertain that our financial objectives will be attained within the originally stated two year time frame. We continue to use the elements of our Enterprise Risk Management framework manage the significant uncertainty in the present economic and market conditions. See “Quantitative and Qualitative Disclosures about Risk” in the 2019 Form 10- K for further information about our Enterprise Risk Management Framework. In addition, refer to “Risk Factors” herein and Forward Looking Statements in the 2019 Form 10-K. Selected Non-GAAP Financial Information We prepare our financial statements using U.S. GAAP. From time to time, we may disclose certain “non-GAAP financial measures” in this document or in the course of our earnings releases, earnings and other conference calls, financial presentations, definitive proxy statement and otherwise. A “non- GAAP financial measure” excludes, or includes, amounts from the most directly comparable measure calculated and presented in accordance with U.S. GAAP. We consider the non-GAAP financial measures we disclose to be useful to us, investors, analysts and other stakeholders by providing further transparency about, or an alternate means of assessing, our financial condition, operating results, prospective regulatory capital requirements or capital adequacy. These measures are not in accordance with, or a substitute for, U.S. GAAP and may be different from or inconsistent with non- GAAP financial measures used by other companies. Whenever we refer to a non-GAAP financial measure, we will also generally define it or present the most directly comparable financial measure calculated and presented in accordance with U.S. GAAP, along with a reconciliation of the differences between the U.S. GAAP financial measure and the non-GAAP financial measure. The principal non-GAAP financial measures presented in this document are set forth in the following tables. Reconciliations from U.S. GAAP to Non-GAAP Consolidated Financial Measures Three Months Ended March 31, $ in millions, except per share data 2020 2019 Net income applicable to Morgan Stanley $ 1,698 $ 2,429 Impact of adjustments (31) (101) Adjusted net income applicable to Morgan Stanley—non-GAAP1 $ 1,667 $ 2,328 Earnings per diluted common share $ 1.01 $ 1.39 Impact of adjustments (0.02) (0.06) Adjusted earnings per diluted common share—non-GAAP1 $ 0.99 $ 1.33 Effective income tax rate 17.1% 16.5% Impact of adjustments 1.4% 3.4% Adjusted effective income tax rate— non-GAAP1 18.5% 19.9% Average Monthly Balance Three Months Ended March 31, $ in millions 2020 2019 Tangible equity Morgan Stanley shareholders' equity $ 83,244 $ 80,115 Less: Goodwill and net intangible assets (9,200) (8,806) Tangible Morgan Stanley shareholders' equity—Non-GAAP $ 74,044 $ 71,309 Common shareholders' equity $ 74,724 $ 71,595 Less: Goodwill and net intangible assets (9,200) (8,806) Tangible common shareholders' equity— Non-GAAP $ 65,524 $ 62,789 Three Months Ended March 31, $ in billions 2020 2019 Average common equity Unadjusted—GAAP $ 74.7 $ 71.6 Adjusted1—Non-GAAP 74.7 71.5 ROE2 Unadjusted—GAAP 8.5% 13.1% Adjusted—Non-GAAP1, 3 8.3% 12.5% Average tangible common equity—Non-GAAP Unadjusted $ 65.5 $ 62.8 Adjusted1 65.5 62.7 ROTCE2—Non-GAAP Unadjusted 9.7% 14.9% Adjusted1, 3 9.5% 14.2% -- 9 of 93 -- Table of Contents Management’s Discussion and Analysis 7 March 2020 Form 10-Q Non-GAAP Financial Measures by Business Segment Three Months Ended March 31, $ in billions 2020 2019 Average common equity4, 5 Institutional Securities $ 42.8 $ 40.4 Wealth Management 18.2 18.2 Investment Management 2.6 2.5 Average tangible common equity4, 5 Institutional Securities $ 42.3 $ 39.9 Wealth Management 10.4 10.2 Investment Management 1.7 1.5 ROE6 Institutional Securities 6.3% 12.9% Wealth Management 18.5% 19.8% Investment Management 11.7% 21.9% ROTCE6 Institutional Securities 6.4% 13.0% Wealth Management 32.3% 35.6% Investment Management 18.1% 35.3% 1. Adjusted amounts exclude net discrete tax provisions (benefits) that are intermittent and include those that are recurring. Provisions (benefits) related to conversion of employee share-based awards are expected to occur every year and, as such, are considered recurring discrete tax items. For further information on the net discrete tax provisions (benefits), see “Supplemental Financial Information—Income Tax Matters” herein. 2. ROE and ROTCE represent annualized earnings applicable to Morgan Stanley common shareholders as a percentage of average common equity and average tangible common equity, respectively. When excluding intermittent net discrete tax provisions (benefits), both the numerator and average denominator are adjusted. 3. The calculations used in determining our “ROE and ROTCE Targets” referred to in the following section are the Adjusted ROE and Adjusted ROTCE amounts shown in this table. 4. Average common equity and average tangible common equity for each business segment is determined using our Required Capital framework (see "Liquidity and Capital Resources—Regulatory Requirements—Attribution of Average Common Equity According to the Required Capital Framework” herein). 5. The sums of the segments' Average common equity and Average tangible common equity do not equal the Consolidated measures due to Parent equity. 6. The calculation of ROE and ROTCE by segment uses annualized net income applicable to Morgan Stanley by segment less preferred dividends allocated to each segment as a percentage of average common equity and average tangible common equity, respectively, allocated to each segment. Return on Tangible Common Equity Target In January 2020, we established an ROTCE Target of 13% to 15% to be achieved over the next two years. Our ROTCE Target is a forward-looking statement that was based on a normal market environment and may be materially affected by many factors, including, among other things: macroeconomic and market conditions; legislative and regulatory developments; industry trading and investment banking volumes; equity market levels; interest rate environment; outsized legal expenses or penalties; the ability to maintain a reduced level of expenses; and capital levels. With the COVID–19 pandemic, and the current global economic crisis that includes negative impacts from many of the aforementioned factors, it is uncertain that the ROTCE Target will be met within the originally stated time frame. See “Coronavirus Disease (COVID–19) Pandemic” herein and “Risk Factors” for further information on market and economic conditions and their effects on our financial results. For further information on non-GAAP measures (ROTCE excluding intermittent net discrete tax items), see “Selected Non-GAAP Financial Information” herein. For information on the impact of intermittent net discrete tax items, see “Supplemental Financial Information—Income Tax Matters” herein. Business Segments Substantially all of our operating revenues and operating expenses are directly attributable to our business segments. Certain revenues and expenses have been allocated to each business segment, generally in proportion to its respective net revenues, non-interest expenses or other relevant measures. For an overview of the components of our business segments, net revenues, compensation expense and income taxes, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Business Segments” in the 2019 Form 10-K. -- 10 of 93 -- Table of Contents Management’s Discussion and Analysis March 2020 Form 10-Q 8 Institutional Securities Income Statement Information Three Months Ended March 31, $ in millions 2020 2019 % Change Revenues Investment banking $ 1,144 $ 1,151 (1)% Trading 3,416 3,130 9 % Investments (25) 81 (131)% Commissions and fees 874 621 41 % Asset management 113 107 6 % Other (1,079) 222 N/M Total non-interest revenues 4,443 5,312 (16)% Interest income 2,423 3,056 (21)% Interest expense 1,961 3,172 (38)% Net interest 462 (116) N/M Net revenues 4,905 5,196 (6)% Compensation and benefits 1,814 1,819 — % Non-compensation expenses 2,141 1,782 20 % Total non-interest expenses 3,955 3,601 10 % Income before provision for income taxes 950 1,595 (40)% Provision for income taxes 151 190 (21)% Net income 799 1,405 (43)% Net income applicable to noncontrolling interests 42 34 24 % Net income applicable to Morgan Stanley $ 757 $ 1,371 (45)% Results in the Institutional Securities business segment reflect constructive markets in January and February 2020 and the significant effects of COVID-19 on markets in March. In particular, in March: • Uncertainty, driven by market volatility and the overall environment, resulted in lower activity in Advisory and Equity underwriting. • Market volumes and volatility were significantly higher than in the prior year quarter resulting in increased client activity across the Sales and Trading businesses and widened bid-offer spreads. Valuations were negatively impacted, and client balances declined significantly in the Equity Financing business. • Credit deteriorated rapidly, the results of which are reflected in losses on held-for-sale loans and lending commitments recorded in Other revenues, partially offset by positive hedge results in Other Sales and Trading, aggregating to $610 million for the current quarter; provisions for loan losses recorded in Other revenues, and lending commitments shown in Non-compensation expenses, aggregating to $388 million for the current quarter; Trading losses in certain Credit products within Fixed Income; and losses on certain counterparties’ failure to meet margin requirements in Equity sales and trading. These effects, in the context of the full quarter’s results, are further discussed herein. Investment Banking Investment Banking Revenues Three Months Ended March 31, $ in millions 2020 2019 % Change Advisory $ 362 $ 406 (11)% Underwriting: Equity 336 339 (1)% Fixed income 446 406 10 % Total Underwriting 782 745 5 % Total Investment banking $ 1,144 $ 1,151 (1)% Investment Banking Volumes Three Months Ended March 31, $ in billions 2020 2019 Completed mergers and acquisitions1 $ 109 $ 195 Equity and equity-related offerings2, 3 13 14 Fixed income offerings2, 4 82 58 Source: Refinitiv data as of April 1, 2020. Transaction volumes may not be indicative of net revenues in a given period. In addition, transaction volumes for prior periods may vary from amounts previously reported due to the subsequent withdrawal, change in value or change in timing of certain transactions. 1. Includes transactions of $100 million or more. Based on full credit to each of the advisors in a transaction. 2. Based on full credit for single book managers and equal credit for joint book managers. 3. Includes Rule 144A issuances and registered public offerings of common stock, convertible securities and rights offerings. 4. Includes Rule 144A and publicly registered issuances, non-convertible preferred stock, mortgage-backed and asset-backed securities, and taxable municipal debt. Excludes leveraged loans and self-led issuances. Investment banking revenues of $1,144 million in the current quarter were relatively unchanged from the prior year quarter, reflecting lower results in our advisory business offset by higher results in our fixed income underwriting business. • Advisory revenues decreased in the current quarter primarily as a result of lower volumes of completed M&A activity, particularly large transactions. • Equity underwriting revenues were relatively unchanged compared with subdued results in the prior year quarter as lower revenues in secondary block share trades were offset by higher revenues in initial public offerings and follow-on offerings. -- 11 of 93 -- Table of Contents Management’s Discussion and Analysis 9 March 2020 Form 10-Q • Fixed income underwriting revenues increased in the current quarter primarily due to higher overall volumes compared to the prior year quarter, with higher revenues in investment grade bond and non-investment grade loan issuances, partially offset by lower revenues from investment grade loan issuances. See “Investment Banking Volumes” herein. Sales and Trading Net Revenues By Income Statement Line Item Three Months Ended March 31, $ in millions 2020 2019 % Change Trading $ 3,416 $ 3,130 9% Commissions and fees 874 621 41% Asset management 113 107 6% Net interest 462 (116) N/M Total $ 4,865 $ 3,742 30% By Business Three Months Ended March 31, $ in millions 2020 2019 % Change Equity $ 2,422 $ 2,015 20% Fixed Income 2,203 1,710 29% Other 240 17 N/M Total $ 4,865 $ 3,742 30% Sales and Trading Revenues—Equity and Fixed Income Three Months Ended March 31, 2020 Net $ in millions Trading Fees1 Interest2 Total Financing $ 1,034 $ 101 $ (37) $ 1,098 Execution services 579 783 (38) 1,324 Total Equity $ 1,613 $ 884 $ (75) $ 2,422 Total Fixed Income $ 1,773 $ 102 $ 328 $ 2,203 Three Months Ended March 31, 2019 Net $ in millions Trading Fees1 Interest2 Total Financing $ 1,115 $ 98 $ (258) $ 955 Execution services 551 553 (44) 1,060 Total Equity $ 1,666 $ 651 $ (302) $ 2,015 Total Fixed Income $ 1,727 $ 78 $ (95) $ 1,710 1. Includes Commissions and fees and Asset management revenues. 2. Includes funding costs, which are allocated to the businesses based on funding usage. Equity Equity sales and trading net revenues of $2,422 million in the current quarter increased 20% from the prior year quarter, reflecting higher results in both our financing and execution services businesses. • Financing increased from the prior year quarter, primarily due to higher average client balances, partially offset by the impact of reduced dividend expectations on the valuation of certain hedges. Net interest increased reflecting a reduction in funding costs. • Execution services increased from the prior year quarter, reflecting an increase in market volumes in cash equities resulting in higher Commissions and fees, and higher client trading activity in derivatives products, which was partially offset by the impact of losses on certain counterparties’ failure to meet margin requirements and the impact of reduced dividend expectations on derivative valuations. Fixed Income Fixed Income sales and trading net revenues of $2,203 million in the current quarter were 29% higher than the prior year quarter, primarily driven by higher results in global macro products, partially offset by lower results in credit products. • Global macro products Trading revenues increased primarily due to higher client activity in both foreign exchange and rates products, and the widening of bid-offer spreads from higher market volatility. Higher average balances and lower funding costs contributed to an increase in Net interest revenues. • Credit products Trading revenues decreased primarily due to the widening of credit spreads which resulted in losses in securitized products and municipal securities, partially offset by increased revenues from client activity in corporate credit products from higher volumes and widening bid-offer spreads. Net interest revenues increased, primarily driven by higher spreads on Agency products and higher average balances in secured lending facilities. • Trading revenues from Commodities products and Other decreased as a result of lower client structuring activity within derivatives counterparty credit risk management, partially offset by improved inventory management in commodities due to higher market volatility in energy and metals. Net interest revenues increased, reflecting lower funding costs. Other • Other sales and trading revenues of $240 million in the current quarter increased from the prior year quarter reflecting gains on hedges associated with loans and lending commitments compared with losses in the prior year quarter, partially offset by losses related to investments associated with certain employee deferred cash-based compensation plans. -- 12 of 93 -- Table of Contents Management’s Discussion and Analysis March 2020 Form 10-Q 10 Investments, Other Revenues, Non-interest Expenses, and Income Tax Items Investments • Net investment losses of $25 million in the current quarter compared to gains in the prior year quarter, were primarily driven by losses in the current quarter on an energy-related investment and lower revenues from fund-related distributions. Other Revenues • Other net losses of $1,079 million in the current quarter were primarily as a result of mark-to-market losses on loans and lending commitments held for sale due to the widening of credit spreads, compared with gains in the prior year quarter, as well as an increase in the provision for credit losses on loans held for investment. Non-interest Expenses Non-interest expenses of $3,955 million in the current quarter increased from the prior year quarter, primarily reflecting a 20% increase in Non-compensation expenses. • Compensation and benefits expenses remained relatively unchanged in the current quarter as the benefit from a decrease in the fair value of investments to which certain deferred compensation plans are referenced was offset by an increase in discretionary incentive compensation reflecting baseline annual compensation estimates, exclusive of the benefit noted. • Non-compensation expenses increased in the current quarter primarily due to higher volume-related expenses as well as an increase in the provision for credit losses for lending commitments held for investment. Income Tax Items Intermittent net discrete tax benefits of $101 million were recognized in Provision for income taxes in the prior year quarter. For further information, see “Supplemental Financial Information—Income Tax Matters” herein. -- 13 of 93 -- Table of Contents Management’s Discussion and Analysis 11 March 2020 Form 10-Q Wealth Management Income Statement Information Three Months Ended March 31, $ in millions 2020 2019 % Change Revenues Investment banking $ 158 $ 109 45 % Trading (347) 302 N/M Investments — 1 (100)% Commissions and fees 588 406 45 % Asset management 2,680 2,361 14 % Other 62 80 (23)% Total non-interest revenues 3,141 3,259 (4)% Interest income 1,193 1,413 (16)% Interest expense 297 283 5 % Net interest 896 1,130 (21)% Net revenues 4,037 4,389 (8)% Compensation and benefits 2,212 2,462 (10)% Non-compensation expenses 770 739 4 % Total non-interest expenses 2,982 3,201 (7)% Income before provision for income taxes $ 1,055 $ 1,188 (11)% Provision for income taxes 191 264 (28)% Net income applicable to Morgan Stanley $ 864 $ 924 (6)% Results in the Wealth Management business segment reflect the significant effects of COVID-19 on the economy and markets in March 2020. In particular, in March: • The decline in global asset prices contributed to losses on investments associated with certain employee deferred cash- based compensation plans of $426 million in the current quarter. • Already elevated market volumes and volatility compared to the prior year quarter increased further, resulting in increased commissions from client activity. These effects, in the context of the full quarter’s results, are further discussed herein. Financial Information and Statistical Data At March 31, 2020 At December 31, 2019 $ in billions, except employee data Client assets $ 2,397 $ 2,700 Fee-based client assets1 $ 1,134 $ 1,267 Fee-based client assets as a percentage of total client assets 47% 47% Client liabilities2 $ 92 $ 90 Investment securities portfolio $ 75.5 $ 67.2 Loans and lending commitments $ 95.9 $ 93.2 Wealth Management representatives 15,432 15,468 Three Months Ended March 31, 2020 2019 Per representative: Annualized revenues ($ in thousands)3 $ 1,045 $ 1,118 Client assets ($ in millions)4 $ 155 $ 158 Fee-based asset flows ($ in billions)5 $ 18.4 $ 14.8 1. Fee-based client assets represent the amount of assets in client accounts where the fee for services is calculated based on those assets. 2. Client liabilities include securities-based and tailored lending, residential real estate loans and margin lending. 3. Revenues per representative equal Wealth Management’s annualized net revenues divided by the average number of representatives. 4. Client assets per representative equal total period-end client assets divided by period-end number of representatives. 5. For a description of the Inflows and Outflows included within Fee-based asset flows, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Business Segments—Wealth Management—Fee-Based Client Assets” in the 2019 Form 10-K. Excludes institutional cash management-related activity. Transactional Revenues Three Months Ended March 31, $ in millions 2020 2019 % Change Investment banking $ 158 $ 109 45 % Trading (347) 302 N/M Commissions and fees 588 406 45 % Total $ 399 $ 817 (51)% Transactional revenues as a % of Net revenues 10% 19% -- 14 of 93 -- Table of Contents Management’s Discussion and Analysis March 2020 Form 10-Q 12 Net Revenues Transactional Revenues Transactional revenues of $399 million in the current quarter decreased 51% from the prior year quarter as negative Trading revenues were partially offset by higher Commissions and fees and Investment banking revenues. • Investment banking revenues increased in the current quarter primarily due to higher revenues from structured products and closed-end fund issuances. • Trading revenues decreased in the current quarter principally due to losses related to investments associated with certain employee deferred cash-based compensation plans, compared with gains in the prior year quarter. • Commissions and fees increased in the current quarter primarily due to increased client activity in equities. Asset Management Asset management revenues of $2,680 million in the current quarter increased 14% from the prior year quarter primarily due to higher fee-based assets levels at the beginning of the monthly billing cycles in 2020 due to market appreciation and positive net flows, partially offset by lower average fee rates. See “Fee-Based Client Assets—Rollforwards” herein. Other Other revenues of $62 million in the current quarter decreased 23% from the prior year quarter primarily due to an increase in the provision for credit losses. Net Interest Net interest of $896 million in the current quarter decreased 21% from the prior year quarter primarily due to lower interest rates on Loans and the investment portfolio, changes in our funding mix, and higher prepayment amortization expense related to mortgage-backed securities. These decreases were partially offset by the impact of lower rates paid on brokerage sweep deposits and higher Loan balances. Non-interest Expenses Non-interest expenses of $2,982 million in the current quarter decreased 7% from the prior year quarter primarily as a result of lower Compensation and benefits expenses, partially offset by higher Non-compensation expenses. • Compensation and benefits expenses decreased in the current quarter, primarily due to decreases in the fair value of investments to which certain deferred compensation plans are referenced, partially offset by an increase in the formulaic payout to Wealth Management representatives driven by the mix of revenues. • Non-compensation expenses increased in the current quarter primarily due to incremental expenses related to Solium Capital, Inc., which was acquired in the second quarter of 2019. Fee-Based Client Assets Rollforwards $ in billions At December 31, 2019 Inflows Outflows Market Impact At March 31, 2020 Separately managed1 $ 322 $ 12 $ (7) $ 2 $ 329 Unified managed 313 16 (13) (53) 263 Advisor 155 10 (9) (25) 131 Portfolio manager 435 27 (18) (65) 379 Subtotal $ 1,225 $ 65 $ (47) $ (141) $ 1,102 Cash management 42 4 (14) — 32 Total fee-based client assets $ 1,267 $ 69 $ (61) $ (141) $ 1,134 $ in billions At December 31, 2018 Inflows Outflows Market Impact At March 31, 2019 Separately managed1 $ 279 $ 14 $ (5) $ (12) $ 276 Unified managed 257 13 (11) 24 283 Advisor 137 8 (9) 11 147 Portfolio manager 353 19 (14) 33 391 Subtotal $ 1,026 $ 54 $ (39) $ 56 $ 1,097 Cash management 20 4 (5) — 19 Total fee-based client assets $ 1,046 $ 58 $ (44) $ 56 $ 1,116 Average Fee Rates Three Months Ended March 31, Fee rate in bps 2020 2019 Separately managed 14 14 Unified managed 99 101 Advisor 85 88 Portfolio manager 94 96 Subtotal 72 74 Cash management 5 6 Total fee-based client assets 71 73 1. Includes non-custody account values reflecting prior quarter-end balances due to a lag in the reporting of asset values by third-party custodians. For a description of fee-based client assets and rollforward items in the previous tables, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations— Business Segments—Wealth Management—Fee-Based Client Assets” in the 2019 Form 10-K. -- 15 of 93 -- Table of Contents Management’s Discussion and Analysis 13 March 2020 Form 10-Q Investment Management Income Statement Information Three Months Ended March 31, $ in millions 2020 2019 % Change Revenues Trading $ (37) $ (3) N/M Investments 63 191 (67)% Asset management 665 617 8 % Other 7 3 133 % Total non-interest revenues 698 808 (14)% Interest income 8 4 100 % Interest expense 14 8 75 % Net interest (6) (4) (50)% Net revenues 692 804 (14)% Compensation and benefits 257 370 (31)% Non-compensation expenses 292 260 12 % Total non-interest expenses 549 630 (13)% Income before provision for income taxes 143 174 (18)% Provision for income taxes 25 33 (24)% Net income 118 141 (16)% Net income applicable to noncontrolling interests 40 5 N/M Net income applicable to Morgan Stanley $ 78 $ 136 (43)% Results in the Investment Management business segment reflect the significant effects of COVID-19 on the economy and markets in March 2020. In particular, in March: • The decline in global asset prices led to losses of $326 million in the current quarter related to the reversal of accrued carried interest, and losses on investments in certain of our funds, net of economic hedges, and net losses in Trading revenues. These effects, in the context of the full quarter’s results, are further discussed herein. Net Revenues Investments Investments revenues of $63 million in the current quarter decreased 67% from the prior year quarter primarily as a result of the reversal of accrued carried interest and investment losses in certain private equity, real estate, and infrastructure funds and losses on seed investments in certain funds. Partially offsetting these decreases were higher carried interest and investment gains in an Asia private equity fund, principally driven by gains from an underlying investment, which is subject to certain sales restrictions. Asset Management Asset management revenues of $665 million in the current quarter increased 8% from the prior year quarter primarily as a result of higher average AUM. See “Assets Under Management or Supervision” herein. Non-interest Expenses Non-interest expenses of $549 million in the current quarter decreased 13% from the prior year quarter primarily as a result of lower compensation and benefits expenses, partially offset by higher non-compensation expenses. • Compensation and benefits expenses decreased in the current quarter primarily due to lower compensation associated with carried interest and a decrease in the fair value of investments to which certain deferred compensation plans are referenced. • Non-compensation expenses in the current quarter increased from the prior year quarter primarily as a result of higher fee sharing paid to intermediaries driven by higher average AUM. -- 16 of 93 -- Table of Contents Management’s Discussion and Analysis March 2020 Form 10-Q 14 Assets Under Management or Supervision Rollforwards $ in billions At December 31, 2019 Inflows Outflows Market Impact Other At March 31, 2020 Equity $ 138 $ 14 $ (12) $ (18) $ (1) $ 121 Fixed income 79 10 (9) (4) (1) 75 Alternative/ Other 139 8 (4) (7) 5 141 Long-term AUM subtotal 356 32 (25) (29) 3 337 Liquidity 196 446 (395) 1 (1) 247 Total AUM $ 552 $ 478 $ (420) $ (28) $ 2 $ 584 Shares of minority stake assets 6 6 $ in billions At December 31, 2018 Inflows Outflows Market Impact Other At March 31, 2019 Equity $ 103 $ 9 $ (8) $ 16 $ — $ 120 Fixed income 68 6 (7) 1 — 68 Alternative/ Other 128 5 (4) 5 (1) 133 Long-term AUM subtotal 299 20 (19) 22 (1) 321 Liquidity 164 343 (348) 1 (1) 159 Total AUM $ 463 $ 363 $ (367) $ 23 $ (2) $ 480 Shares of minority stake assets 7 6 Average AUM Three Months Ended March 31, $ in billions 2020 2019 Equity $ 133 $ 113 Fixed income 79 68 Alternative/Other 139 131 Long-term AUM subtotal 351 312 Liquidity 206 163 Total AUM $ 557 $ 475 Shares of minority stake assets 6 6 Average Fee Rates Three Months Ended March 31, Fee rate in bps 2020 2019 Equity 77 76 Fixed income 31 32 Alternative/Other 60 68 Long-term AUM 60 63 Liquidity 17 17 Total AUM 44 47 For a description of the asset classes and rollforward items in the previous tables, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations— Business Segments—Investment Management—Assets Under Management or Supervision” in the 2019 Form 10-K. -- 17 of 93 -- Table of Contents Management’s Discussion and Analysis 15 March 2020 Form 10-Q Supplemental Financial Information Income Tax Matters Effective Tax Rate from Continuing Operations Three Months Ended March 31, $ in millions 2020 2019 U.S. GAAP 17.1% 16.5% Adjusted effective income tax rate— non-GAAP1 18.5% 19.9% Net discrete tax provisions/(benefits) Recurring2 $ (99) $ (107) Intermittent3 $ (31) $ (101) 1. The adjusted effective income tax rate is a non-GAAP measure that excludes net discrete tax provisions (benefits) that are intermittent and includes those that are recurring. For further information on non-GAAP measures, see “Selected Non-GAAP Financial Information” herein. 2. Provisions (benefits) related to conversion of employee share-based awards are expected to occur every year and, as such, are considered recurring discrete tax items. 3. Includes all tax provisions (benefits) that have been determined to be discrete, other than Recurring items as defined above. The current quarter includes intermittent net discrete tax benefits associated with the remeasurement of prior years’ tax liabilities. The prior year quarter includes intermittent net discrete tax benefits primarily associated with remeasurement of reserves and related interest as a result of new information pertaining to the resolution of multi-jurisdiction tax examinations. See Note 18 to the financial statements for further information. U.S. Bank Subsidiaries Our U.S. bank subsidiaries, Morgan Stanley Bank N.A. (“MSBNA”) and Morgan Stanley Private Bank, National Association (“MSPBNA”) (collectively, “U.S. Bank Subsidiaries”) accept deposits; provide loans to a variety of customers, from large corporate and institutional clients to high net worth individuals; and invest in securities. Lending activity recorded in the U.S. Bank subsidiaries from the Institutional Securities business segment primarily includes loans and lending commitments to corporate clients. Lending activity recorded in the U.S. Bank subsidiaries from the Wealth Management business segment primarily includes securities- based lending, which allows clients to borrow money against the value of qualifying securities, and residential real estate loans. For a further discussion of our credit risks, see “Quantitative and Qualitative Disclosures about Risk—Credit Risk.” For a further discussion about loans and lending commitments, see Notes 9 and 13 to the financial statements. U.S. Bank Subsidiaries’ Supplemental Financial Information1 $ in billions At March 31, 2020 At December 31, 2019 Assets $ 265.4 $ 219.6 Investment securities portfolio: Investment securities—AFS 49.0 42.4 Investment securities—HTM 28.7 26.1 Total investment securities $ 77.7 $ 68.5 Deposits2 $ 234.1 $ 189.3 Wealth Management Loans Securities-based lending and other3 $ 51.4 $ 49.9 Residential real estate 31.1 30.2 Total $ 82.5 $ 80.1 Institutional Securities Loans Corporate4: Corporate relationship and event-driven lending $ 15.4 $ 5.6 Secured lending facilities 28.4 26.8 Securities-based lending and other 5.1 5.4 Commercial and residential real estate 10.3 12.0 Total $ 59.2 $ 49.8 1. Amounts exclude transactions between the bank subsidiaries, as well as deposits from the Parent Company and affiliates. 2. For further information on deposits, see “Liquidity and Capital Resources —Funding Management—Unsecured Financing” herein. 3. Other loans primarily include tailored lending. 4. For a further discussion of corporate loans in the Institutional Securities business segment, see “Credit Risk—Institutional Securities Corporate Loans” herein. Other Matters Planned Acquisition of E*TRADE On February 20, 2020, we entered into a definitive agreement under which we will acquire E*TRADE Financial Corporation (“E*TRADE”) in an all-stock transaction. In the current quarter, we filed our application with the Federal Reserve and in early April the Hart-Scott-Rodino Antitrust waiting period expired. The acquisition is subject to customary closing conditions, including regulatory approvals and approval by E*TRADE shareholders, and we continue to expect the acquisition to close in the fourth quarter of 2020. Accounting Development Updates The Financial Accounting Standards Board has issued certain accounting updates that apply to us. Accounting updates not listed below were assessed and either determined to be not applicable or are not expected to have a significant impact on our financial statements. -- 18 of 93 -- Table of Contents Management’s Discussion and Analysis March 2020 Form 10-Q 16 The following accounting update is currently being evaluated to determine the potential impact of adoption: • Reference Rate Reform. This accounting update provides optional accounting relief to entities with contracts, hedge accounting relationships or other transactions that reference LIBOR or other interest rate benchmarks for which the referenced rate is expected to be discontinued or replaced. This optional relief generally allows for contract modifications solely related to the replacement of the reference rate to be accounted for as a continuation of the existing contract instead of as an extinguishment of the contract, and would therefore not trigger certain accounting impacts that would otherwise be required. The relief also allows entities to change certain critical terms of existing hedge accounting relationships that are affected by reference rate reform, and these changes would not require de- designating the hedge accounting relationship. The optional relief can be applied beginning January 1, 2020, and ending December 31, 2022. We plan to apply the accounting relief as relevant contract and hedge accounting relationship modifications are made during the course of the reference rate reform transition period. Critical Accounting Policies Our financial statements are prepared in accordance with U.S. GAAP, which requires us to make estimates and assumptions (see Note 1 to the financial statements). We believe that of our significant accounting policies (see Note 2 to the financial statements in the 2019 Form 10-K and Note 2 to the financial statements), the fair value, goodwill and intangible assets, legal and regulatory contingencies and income taxes policies involve a higher degree of judgment and complexity. For a further discussion about our critical accounting policies, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Policies” in the 2019 Form 10-K. Liquidity and Capital Resources Senior management, with oversight by the Asset/Liability Management Committee and the Board of Directors (“Board”), establishes and maintains our liquidity and capital policies. Through various risk and control committees, senior management reviews business performance relative to these policies, monitors the availability of alternative sources of financing, and oversees the liquidity, interest rate and currency sensitivity of our asset and liability position. Our Treasury department, Firm Risk Committee, Asset/Liability Management Committee, and other committees and control groups assist in evaluating, monitoring and controlling the impact that our business activities have on our balance sheet, liquidity and capital structure. Liquidity and capital matters are reported regularly to the Board and the Risk Committee of the Board. Balance Sheet We monitor and evaluate the composition and size of our balance sheet on a regular basis. Our balance sheet management process includes quarterly planning, business-specific thresholds, monitoring of business-specific usage versus key performance metrics and new business impact assessments. We establish balance sheet thresholds at the consolidated and business segment levels. We monitor balance sheet utilization and review variances resulting from business activity and market fluctuations. On a regular basis, we review current performance versus established thresholds and assess the need to re-allocate our balance sheet based on business unit needs. We also monitor key metrics, including asset and liability size and capital usage. Total Assets by Business Segment At March 31, 2020 $ in millions IS WM IM Total Assets Cash and cash equivalents $ 101,615 $ 29,803 $ 91 $ 131,509 Trading assets at fair value 266,781 389 3,746 270,916 Investment securities 40,662 75,495 — 116,157 Securities purchased under agreements to resell 88,008 16,792 — 104,800 Securities borrowed 71,826 474 — 72,300 Customer and other receivables 58,523 15,216 685 74,424 Loans1 66,171 82,516 10 148,697 Other assets2 13,903 13,139 1,950 28,992 Total assets $ 707,489 $ 233,824 $ 6,482 $ 947,795 At December 31, 2019 $ in millions IS WM IM Total Assets Cash and cash equivalents $ 67,657 $ 14,247 $ 267 $ 82,171 Trading assets at fair value 293,477 47 3,586 297,110 Investment securities 38,524 67,201 — 105,725 Securities purchased under agreements to resell 80,744 7,480 — 88,224 Securities borrowed 106,199 350 — 106,549 Customer and other receivables 39,743 15,190 713 55,646 Loans1 50,557 80,075 5 130,637 Other assets2 14,300 13,092 1,975 29,367 Total assets $ 691,201 $ 197,682 $ 6,546 $ 895,429 IS—Institutional Securities WM—Wealth Management IM—Investment Management 1. Amounts include loans held for investment, net of allowance, and loans held for sale but exclude loans at fair value, which are included in Trading assets in the balance sheets (see Note 9 to the financial statements). 2. Other assets primarily includes Goodwill and Intangible assets, premises, equipment and software, ROU assets related to leases, other investments, and deferred tax assets. A substantial portion of total assets consists of liquid marketable securities and short-term receivables arising principally from sales and trading activities in the Institutional Securities -- 19 of 93 -- Table of Contents Management’s Discussion and Analysis 17 March 2020 Form 10-Q business segment. Total assets increased to $948 billion at March 31, 2020 from $895 billion at December 31, 2019. Within Wealth Management, assets increased in the investment portfolio comprising Cash and cash equivalents, Investment securities and Securities purchased under agreements to resell, as a result of significantly higher deposits in this segment, and loans continued to grow. Institutional Securities’ assets were also higher reflecting increases within Cash and cash equivalents, primarily due to higher initial margin related to derivatives; Customer and other receivables, resulting from higher volumes of unsettled transactions in line with market conditions; and loan growth in March in support of client needs. Additionally, within Institutional Securities, Trading assets and Securities borrowed decreased, predominantly driven by corporate equities as the markets declined. The decrease in Trading assets includes a partial offset related to increased derivative exposures related to market volatility. Liquidity Risk Management Framework The core components of our Liquidity Risk Management Framework are the Required Liquidity Framework, Liquidity Stress Tests and Liquidity Resources, which support our target liquidity profile. For a further discussion about the Firm’s Required Liquidity Framework and Liquidity Stress Tests, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources— Liquidity Risk Management Framework” in the 2019 Form 10- K. At March 31, 2020 and December 31, 2019, we maintained sufficient liquidity to meet current and contingent funding obligations as modeled in our Liquidity Stress Tests. Liquidity Resources We maintain sufficient liquidity resources, which are comprised of HQLA and cash deposits with banks (“Liquidity Resources”) to cover daily funding needs and to meet strategic liquidity targets sized by the Required Liquidity Framework and Liquidity Stress Tests. The total amount of Liquidity Resources is actively managed by us considering the following components: unsecured debt maturity profile; balance sheet size and composition; funding needs in a stressed environment, inclusive of contingent cash outflows; legal entity, regional and segment liquidity requirements; regulatory requirements; and collateral requirements. The amount of Liquidity Resources we hold is based on our risk tolerance and is subject to change depending on market and Firm-specific events. The Liquidity Resources are primarily held within the Parent Company and its major operating subsidiaries. The Total HQLA values in the tables immediately following are different from Eligible HQLA which, in accordance with the LCR rule, also takes into account certain regulatory weightings and other operational considerations. Liquidity Resources by Type of Investment1 $ in millions At March 31, 2020 At December 31, 2019 Cash deposits with central banks $ 60,719 $ 35,025 Unencumbered HQLA Securities2: U.S. government obligations 95,619 88,754 U.S. agency and agency mortgage-backed securities 58,342 50,732 Non-U.S. sovereign obligations3 30,255 29,909 Other investment grade securities 700 1,591 Total HQLA2 $ 245,635 $ 206,011 Cash deposits with banks (non-HQLA) 9,499 9,857 Total Liquidity Resources $ 255,134 $ 215,868 1. In the first quarter of 2020, we changed our internal measure of liquidity from the Global Liquidity Reserve to Liquidity Resources, which is more closely aligned with the regulatory definition of HQLA. Prior periods have been recast to conform to the current presentation. 2. HQLA is presented prior to applying weightings and includes all HQLA held in subsidiaries. 3. Primarily composed of unencumbered U.K., French, Japanese, and German government obligations. Liquidity Resources by Bank and Non-Bank Legal Entities1 $ in millions At March 31, 2020 At December 31, 2019 Average Daily Balance Three Months Ended March 31, 2020 Bank legal entities Domestic $ 112,126 $ 75,894 $ 83,117 Foreign 5,265 4,049 4,419 Total Bank legal entities 117,391 79,943 87,536 Non-Bank legal entities Domestic: Parent Company 53,548 53,128 49,284 Non-Parent Company 33,665 28,905 36,295 Total Domestic 87,213 82,033 85,579 Foreign 50,530 53,892 54,333 Total Non-Bank legal entities 137,743 135,925 139,912 Total Liquidity Resources $ 255,134 $ 215,868 $ 227,448 1. In the first quarter of 2020, we changed our internal measure of liquidity from the Global Liquidity Reserve to Liquidity Resources, which is more closely aligned with the regulatory definition of HQLA. Prior periods have been recast to conform to the current presentation. Liquidity Resources may fluctuate from period to period based on the overall size and composition of our balance sheet, the maturity profile of our unsecured debt and estimates of funding needs in a stressed environment, among other factors. During the current quarter, cash deposits at central banks have increased, largely driven by an increase in deposits received from customers. -- 20 of 93 -- Table of Contents Management’s Discussion and Analysis March 2020 Form 10-Q 18 Regulatory Liquidity Framework Liquidity Coverage Ratio We and our U.S. Bank Subsidiaries are subject to LCR requirements, including a requirement to calculate each entity’s LCR on each business day. The requirements are designed to ensure that banking organizations have sufficient Eligible HQLA to cover net cash outflows arising from significant stress over 30 calendar days, thus promoting the short-term resilience of the liquidity risk profile of banking organizations. The LCR calculation applies weightings (or asset haircuts) to HQLA and excludes certain HQLA held in subsidiaries. As of March 31, 2020, we and our U.S. Bank Subsidiaries are compliant with the minimum required LCR of 100%. For further information on regulatory developments that have impacted our LCR, see “Liquidity and Capital Resources—Regulatory Requirements—Regulatory Developments” herein. Liquidity Coverage Ratio Average Daily Balance Three Months Ended $ in millions March 31, 2020 December 31, 2019 Eligible HQLA1 Cash deposits with central banks $ 32,778 $ 29,597 Securities2 140,336 148,221 Total Eligible HQLA1 $ 173,114 $ 177,818 LCR 127% 134% 1. Under the LCR rule, Eligible HQLA is calculated using weightings and excluding certain HQLA held in subsidiaries. 2. Primarily includes U.S. Treasuries, U.S. agency mortgage-backed securities, sovereign bonds and investment grade corporate bonds. The reduction in the LCR was driven by lower average Eligible HQLA amounts, which included the removal from Eligible HQLA of certain securities used to secure intraday credit, following a recent regulatory rule clarification. Net Stable Funding Ratio The NSFR requires banking organizations to maintain sufficiently stable sources of funding over a one-year horizon. In 2016, the U.S. banking agencies issued a proposal to implement the NSFR in the U.S.; however, a final rule has not yet been issued. For an additional discussion of the NSFR, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources— Regulatory Liquidity Framework—Net Stable Funding Ratio” in the 2019 Form 10-K. Funding Management We manage our funding in a manner that reduces the risk of disruption to our operations. We pursue a strategy of diversification of secured and unsecured funding sources (by product, investor and region) and attempt to ensure that the tenor of our liabilities equals or exceeds the expected holding period of the assets being financed. We fund our balance sheet on a global basis through diverse sources. These sources include our equity capital, borrowings, securities sold under agreements to repurchase, securities lending, deposits, letters of credit and lines of credit. We have active financing programs for both standard and structured products targeting global investors and currencies. Secured Financing For a discussion of our secured financing activities, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources— Funding Management—Secured Financing” in the 2019 Form 10-K. Collateralized Financing Transactions $ in millions At March 31, 2020 At December 31, 2019 Securities purchased under agreements to resell and Securities borrowed $ 177,100 $ 194,773 Securities sold under agreements to repurchase and Securities loaned $ 57,447 $ 62,706 Securities received as collateral1 $ 4,711 $ 13,022 Average Daily Balance Three Months Ended $ in millions March 31, 2020 December 31, 2019 Securities purchased under agreements to resell and Securities borrowed $ 177,971 $ 210,257 Securities sold under agreements to repurchase and Securities loaned $ 61,143 $ 64,870 1. Included within Trading assets—Corporate equities in the balance sheets. See “Total Assets by Business Segment” herein for more details on the assets shown in the previous table, Note 2 to the financial statements in the 2019 Form 10-K and Note 8 to the financial statements for more details on collateralized financing transactions. In addition to the collateralized financing transactions shown in the previous table, we engage in financing transactions collateralized by customer-owned securities, which are segregated in accordance with regulatory requirements. Receivables under these financing transactions, primarily margin loans, are included in Customer and other receivables in the balance sheets, and payables under these financing transactions, primarily to prime brokerage customers, are included in Customer and other payables in the balance sheets. Our risk exposure on these transactions is mitigated by collateral maintenance policies. We also hold related liquidity reserves. Unsecured Financing For a discussion of our unsecured financing activities, see “Management’s Discussion and Analysis of Financial Condition -- 21 of 93 -- Table of Contents Management’s Discussion and Analysis 19 March 2020 Form 10-Q and Results of Operations—Liquidity and Capital Resources— Funding Management—Unsecured Financing” in the 2019 Form 10-K. Deposits $ in millions At March 31, 2020 At December 31, 2019 Savings and demand deposits: Brokerage sweep deposits1 $ 151,618 $ 121,077 Savings and other 36,886 28,388 Total Savings and demand deposits 188,504 149,465 Time deposits 46,735 40,891 Total $ 235,239 $ 190,356 1. Amounts represent balances swept from client brokerage accounts. Deposits are primarily sourced from our Wealth Management clients and are considered to have stable, low-cost funding characteristics. Total deposits at March 31, 2020 significantly increased compared with December 31, 2019, primarily driven by higher brokerage sweep and savings deposits as customers sought relative safety away from volatile markets in March. In addition, total deposits increased as a result of higher time deposits. See Management’s Discussion and Analysis of Financial Condition and Results of Operations—Executive Summary—Coronavirus Disease (COVID-19) Pandemic herein for further information on market and economic conditions. Borrowings by Remaining Maturity at March 31, 20201 $ in millions Parent Company Subsidiaries Total Original maturities of one year or less $ 8 $ 2,203 $ 2,211 Original maturities greater than one year 2020 $ 8,264 $ 2,692 $ 10,956 2021 19,575 4,099 23,674 2022 16,116 3,045 19,161 2023 15,155 2,938 18,093 2024 15,678 4,809 20,487 Thereafter 79,688 20,586 100,274 Total $ 154,476 $ 38,169 $ 192,645 Total Borrowings $ 154,484 $ 40,372 $ 194,856 Maturities over next 12 months2 $ 17,153 1. Original maturity in the table is generally based on contractual final maturity. For borrowings with put options, remaining maturity represents the earliest put date. 2. Includes only borrowings with original maturities greater than one year. Borrowings of $195 billion as of March 31, 2020 were relatively unchanged when compared with $193 billion at December 31, 2019. We believe that accessing debt investors through multiple distribution channels helps provide consistent access to the unsecured markets. In addition, the issuance of borrowings with original maturities greater than one year allows us to reduce reliance on short-term credit sensitive instruments. Borrowings with original maturities greater than one year are generally managed to achieve staggered maturities, thereby mitigating refinancing risk, and to maximize investor diversification through sales to global institutional and retail clients across regions, currencies and product types. The availability and cost of financing to us can vary depending on market conditions, the volume of certain trading and lending activities, our credit ratings and the overall availability of credit. We also engage in, and may continue to engage in, repurchases of our borrowings in the ordinary course of business. For further information on Borrowings, see Note 12 to the financial statements. Credit Ratings We rely on external sources to finance a significant portion of our daily operations. The cost and availability of financing generally are impacted by our credit ratings, among other things. In addition, our credit ratings can have an impact on certain trading revenues, particularly in those businesses where longer- term counterparty performance is a key consideration, such as certain OTC derivative transactions. When determining credit ratings, rating agencies consider both company-specific and industry-wide factors. These include regulatory or legislative changes, the macroeconomic environment and perceived levels of support, among other things. See also “Risk Factors— Liquidity Risk” in the 2019 Form 10-K. Parent Company and U.S. Bank Subsidiaries' Issuer Ratings at April 30, 2020 Parent Company Short-Term Debt Long-Term Debt Rating Outlook DBRS, Inc. R-1 (middle) A (high) Stable Fitch Ratings, Inc. F1 A Negative Moody’s Investors Service, Inc. P-2 A3 Ratings Under Review Rating and Investment Information, Inc. a-1 A Stable S&P Global Ratings A-2 BBB+ Stable MSBNA Short-Term Debt Long-Term Debt Rating Outlook Fitch Ratings, Inc. F1 A+ Negative Moody’s Investors Service, Inc. P-1 A1 Ratings Under Review S&P Global Ratings A-1 A+ Stable MSPBNA Short-Term Debt Long-Term Debt Rating Outlook Moody’s Investors Service, Inc. P-1 A1 Ratings Under Review S&P Global Ratings A-1 A+ Stable On February 21, 2020, Moody’s Investors Service, Inc. placed the Parent Company and U.S. Bank Subsidiaries on review for -- 22 of 93 -- Table of Contents Management’s Discussion and Analysis March 2020 Form 10-Q 20 possible upgrade, changing their outlooks from Positive to Ratings Under Review. On April 23, 2020, Fitch Ratings, Inc. placed the Parent Company and MSBNA ratings on Negative outlook, a change from Stable, related to their expectation of significant operating environment headwinds due to the disruption to economic activity and financial markets from the COVID-19 pandemic. Incremental Collateral or Terminating Payments In connection with certain OTC derivatives and certain other agreements where we are a liquidity provider to certain financing vehicles associated with the Institutional Securities business segment, we may be required to provide additional collateral, immediately settle any outstanding liability balances with certain counterparties or pledge additional collateral to certain clearing organizations in the event of a future credit rating downgrade irrespective of whether we are in a net asset or net liability position. See Note 6 to the financial statements for additional information on OTC derivatives that contain such contingent features. While certain aspects of a credit rating downgrade are quantifiable pursuant to contractual provisions, the impact it would have on our business and results of operations in future periods is inherently uncertain and would depend on a number of interrelated factors, including, among other things, the magnitude of the downgrade, the rating relative to peers, the rating assigned by the relevant agency pre-downgrade, individual client behavior and future mitigating actions we might take. The liquidity impact of additional collateral requirements is included in our Liquidity Stress Tests. Capital Management We view capital as an important source of financial strength and actively manage our consolidated capital position based upon, among other things, business opportunities, risks, capital availability and rates of return together with internal capital policies, regulatory requirements and rating agency guidelines. In the future, we may expand or contract our capital base to address the changing needs of our businesses. Common Stock Repurchases Three Months Ended March 31, in millions, except for per share data 2020 2019 Number of shares 29 28 Average price per share $ 46.01 $ 42.19 Total $ 1,347 $ 1,180 On March 15, 2020, the Financial Services Forum announced that its eight U.S. Bank members, including us, had voluntarily suspended their share repurchase programs. See “Executive Summary—Coronavirus Disease (COVID-19) Pandemic” herein for information on the current and possible future effects of the COVID-19 pandemic on our results. For further information on our common stock repurchases, see Note 16 to the financial statements. For a description of our capital plan, see “Liquidity and Capital Resources—Regulatory Requirements—Capital Plans and Stress Tests.” Common Stock Dividend Announcement Announcement date April 16, 2020 Amount per share $0.35 Date to be paid May 15, 2020 Shareholders of record as of April 30, 2020 Preferred Stock Dividend Announcement Announcement date March 16, 2020 Date paid April 15, 2020 Shareholders of record as of March 31, 2020 For additional information on common and preferred stock, see Note 16 to the financial statements. Off-Balance Sheet Arrangements and Contractual Obligations Off-Balance Sheet Arrangements We enter into various off-balance sheet arrangements, including through unconsolidated SPEs and lending-related financial instruments (e.g., guarantees and commitments), primarily in connection with the Institutional Securities and Investment Management business segments. We utilize SPEs primarily in connection with securitization activities. For information on our securitization activities, see Note 14 to the financial statements. For information on our commitments, obligations under certain guarantee arrangements and indemnities, see Note 13 to the financial statements. For a further discussion of our lending commitments, see “Quantitative and Qualitative Disclosures about Risk—Credit Risk—Loans and Lending Commitments.” Contractual Obligations For a discussion about our contractual obligations, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources— Contractual Obligations” in the 2019 Form 10-K. -- 23 of 93 -- Table of Contents Management’s Discussion and Analysis 21 March 2020 Form 10-Q Regulatory Requirements Regulatory Capital Framework We are an FHC under the Bank Holding Company Act of 1956, as amended (“BHC Act”), and are subject to the regulation and oversight of the Federal Reserve. The Federal Reserve establishes capital requirements for us, including “well- capitalized” standards, and evaluates our compliance with such capital requirements. Regulatory capital requirements established by the Federal Reserve are largely based on the Basel III capital standards established by the Basel Committee and also implement certain provisions of the Dodd-Frank Wall Street Reform and Consumer Protection Act (“Dodd-Frank Act”). The OCC establishes similar capital requirements and standards for our U.S. Bank Subsidiaries. For us to remain an FHC, we must remain well-capitalized in accordance with standards established by the Federal Reserve and our U.S. Bank Subsidiaries must remain well-capitalized in accordance with standards established by the OCC. For additional information on regulatory capital requirements for our U.S. Bank Subsidiaries, see Note 15 to the financial statements. Regulatory Capital Requirements We are required to maintain minimum risk-based and leverage- based capital, and TLAC ratios. For more information, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources— Regulatory Capital Requirements” in the 2019 Form 10-K. For additional information on TLAC, see “Total Loss-Absorbing Capacity, Long-Term Debt and Clean Holding Company Requirements” herein. Risk-Based Regulatory Capital. Minimum risk-based capital ratio requirements apply to Common Equity Tier 1 capital, Tier 1 capital and Total capital (which includes Tier 2 capital). Capital standards require certain adjustments to, and deductions from, capital for purposes of determining these ratios. In addition to the minimum risk-based capital ratio requirements, we are subject to the following Common Equity Tier 1 buffers: • A greater than 2.5% capital conservation buffer; • The G-SIB capital surcharge, currently at 3%; and • Up to a 2.5% CCyB, currently set by U.S. banking agencies at zero. For a further discussion of the G-SIB capital surcharge, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources— Regulatory Requirements—G-SIB Capital Surcharge” in the 2019 Form 10-K. Our risk-based capital ratios for purposes of determining regulatory compliance are the lower of the capital ratios computed under (i) the standardized approaches for calculating credit risk and market risk RWA (“Standardized Approach”) or (ii) the applicable advanced approaches for calculating credit risk, market risk and operational risk RWA (“Advanced Approach”). The credit risk RWA calculations between the two approaches differ in that the Standardized Approach requires calculation of RWA using prescribed risk weights, whereas the Advanced Approach utilizes models to calculate exposure amounts and risk weights. At March 31, 2020 and December 31, 2019, our ratios for determining regulatory compliance are based on the Advanced Approach and the Standardized Approach rules, respectively. Leverage-Based Regulatory Capital. Minimum leverage-based capital requirements include a Tier 1 leverage ratio and an SLR. We are required to maintain an SLR of 5%, inclusive of an enhanced SLR capital buffer of at least 2%. As of March 31, 2020, our risk-based and leverage-based capital amounts and ratios, as well as RWA, adjusted average assets and supplementary leverage exposure are calculated excluding the effect of the adoption of CECL based on our election to defer this effect over a five-year transition period. For further information, see “Liquidity and Capital Resources—Regulatory Requirements—Regulatory Developments” herein. -- 24 of 93 -- Table of Contents Management’s Discussion and Analysis March 2020 Form 10-Q 22 Regulatory Capital Ratios At March 31, 2020 $ in millions Required Ratio1 Standardized Advanced Risk-based capital Common Equity Tier 1 capital $ 65,195 $ 65,195 Tier 1 capital 73,896 73,896 Total capital 84,121 83,847 Total RWA 415,002 427,782 Common Equity Tier 1 capital ratio 10.0% 15.7% 15.2% Tier 1 capital ratio 11.5% 17.8% 17.3% Total capital ratio 13.5% 20.3% 19.6% $ in millions Required Ratio1 At March 31, 2020 Leverage-based capital Adjusted average assets2 $ 910,499 Tier 1 leverage ratio 4.0% 8.1% Supplementary leverage exposure3 $ 1,185,734 SLR 5.0% 6.2% At December 31, 2019 $ in millions Required Ratio1 Standardized Advanced Risk-based capital Common Equity Tier 1 capital $ 64,751 $ 64,751 Tier 1 capital 73,443 73,443 Total capital 82,708 82,423 Total RWA 394,177 382,496 Common Equity Tier 1 capital ratio 10.0% 16.4% 16.9% Tier 1 capital ratio 11.5% 18.6% 19.2% Total capital ratio 13.5% 21.0% 21.5% $ in millions Required Ratio1 At December 31, 2019 Leverage-based capital Adjusted average assets2 $ 889,195 Tier 1 leverage ratio 4.0% 8.3% Supplementary leverage exposure3 $ 1,155,177 SLR 5.0% 6.4% 1. Required ratios are inclusive of any buffers applicable as of the date presented. Failure to maintain the buffers would result in restrictions on our ability to make capital distributions, including the payment of dividends and the repurchase of stock, and to pay discretionary bonuses to executive officers. 2. Adjusted average assets represents the denominator of the Tier 1 leverage ratio and is composed of the average daily balance of consolidated on-balance sheet assets for the quarters ending on the respective balance sheet dates, reduced by disallowed goodwill, intangible assets, investments in covered funds, defined benefit pension plan assets, after-tax gain on sale from assets sold into securitizations, investments in our own capital instruments, certain deferred tax assets and other capital deductions. 3. Supplementary leverage exposure is the sum of Adjusted average assets used in the Tier 1 leverage ratio and other adjustments, primarily: (i) for derivatives, potential future exposure and the effective notional principal amount of sold credit protection offset by qualifying purchased credit protection; (ii) the counterparty credit risk for repo-style transactions; and (iii) the credit equivalent amount for off-balance sheet exposures. Regulatory Capital $ in millions At March 31, 2020 At December 31, 2019 Change Common Equity Tier 1 capital Common stock and surplus $ 3,727 $ 5,228 $ (1,501) Retained earnings 71,718 70,589 1,129 AOCI 2,095 (2,788) 4,883 Regulatory adjustments and deductions: Net goodwill (7,058) (7,081) 23 Net intangible assets (1,924) (2,012) 88 Other adjustments and deductions1 (3,363) 815 (4,178) Total Common Equity Tier 1 capital $ 65,195 $ 64,751 $ 444 Additional Tier 1 capital Preferred stock $ 8,520 $ 8,520 $ — Noncontrolling interests 536 607 (71) Additional Tier 1 capital $ 9,056 $ 9,127 $ (71) Deduction for investments in covered funds (355) (435) 80 Total Tier 1 capital $ 73,896 $ 73,443 $ 453 Standardized Tier 2 capital Subordinated debt $ 9,090 $ 8,538 $ 552 Noncontrolling interests 126 143 (17) Eligible allowance for credit losses 1,013 590 423 Other adjustments and deductions (4) (6) 2 Total Standardized Tier 2 capital $ 10,225 $ 9,265 $ 960 Total Standardized capital $ 84,121 $ 82,708 $ 1,413 Advanced Tier 2 capital Subordinated debt $ 9,090 $ 8,538 $ 552 Noncontrolling interests 126 143 (17) Eligible credit reserves 739 305 434 Other adjustments and deductions (4) (6) 2 Total Advanced Tier 2 capital $ 9,951 $ 8,980 $ 971 Total Advanced capital $ 83,847 $ 82,423 $ 1,424 1. Other adjustments and deductions used in the calculation of Common Equity Tier 1 capital primarily includes net after-tax DVA, the credit spread premium over risk-free rate for derivative liabilities, defined benefit pension plan assets, after-tax gain on sale from assets sold into securitizations, investments in our own capital instruments and certain deferred tax assets. -- 25 of 93 -- Table of Contents Management’s Discussion and Analysis 23 March 2020 Form 10-Q RWA Rollforward Three Months Ended March 31, 2020 $ in millions Standardized Advanced Credit risk RWA Balance at December 31, 2019 $ 342,684 $ 228,927 Change related to the following items: Derivatives 12,902 31,104 Securities financing transactions (13,755) 837 Securitizations (768) (600) Investment securities 1,626 2,559 Commitments, guarantees and loans 11,162 3,652 Cash 919 591 Equity investments 953 1,003 Other credit risk1 4,652 4,925 Total change in credit risk RWA $ 17,691 $ 44,071 Balance at March 31, 2020 $ 360,375 $ 272,998 Market risk RWA Balance at December 31, 2019 $ 51,493 $ 51,597 Change related to the following items: Regulatory VaR 1,971 1,971 Regulatory stressed VaR 287 287 Incremental risk charge 1,737 1,737 Comprehensive risk measure 216 112 Specific risk: Non-securitization 2,034 2,034 Securitization (3,111) (3,111) Total change in market risk RWA $ 3,134 $ 3,030 Balance at March 31, 2020 $ 54,627 $ 54,627 Operational risk RWA Balance at December 31, 2019 N/A $ 101,972 Change in operational risk RWA N/A (1,815) Balance at March 31, 2020 N/A $ 100,157 Total RWA $ 415,002 $ 427,782 Regulatory VaR—VaR for regulatory capital requirements 1. Amounts reflect assets not in a defined category, non-material portfolios of exposures and unsettled transactions, as applicable. Credit risk RWA increased in the current quarter under both the Standardized and Advanced Approaches primarily from an increase in: i) Derivatives exposure, driven by market volatility; ii) Commitments, guarantees and loans, driven by an increase in commitments funded during the current quarter in the Institutional Securities business segment; and iii) Other credit risk, driven by an increase in unsettled transactions. Under the Advanced Approach, the increased exposure in Derivatives and widening credit spreads led to an increase in RWA related to CVA. Partially offsetting the increase in Standardized RWA was a decrease in Securities financing transactions. Market risk RWA increased in the current quarter under the Standardized Approach and Advanced Approach primarily due to increases in Non-securitization specific risk charges and the Incremental risk charge, both driven by increased exposures in credit products, and an increase in Regulatory VaR mainly as a result of a higher market volatility, partially offset by a decrease in Securitization specific risk charges due to reduced exposures to mortgage-backed securities. The decrease in operational risk RWA under the Advanced Approach in the current quarter reflects a decline in the severity of execution-related losses. Total Loss-Absorbing Capacity, Long-Term Debt and Clean Holding Company Requirements The Federal Reserve has established external TLAC, long-term debt (“LTD”) and clean holding company requirements for top- tier BHCs of U.S. G-SIBs (“covered BHCs”), including the Parent Company. These requirements are designed to ensure that covered BHCs will have enough loss-absorbing resources at the point of failure to be recapitalized through the conversion of eligible LTD to equity or otherwise by imposing losses on eligible LTD or other forms of TLAC where an SPOE resolution strategy is used. The External TLAC amount and ratios as of March 31, 2020 are calculated excluding the effect of the adoption of CECL based on our election to defer this effect over a five-year transition period. Our External TLAC ratios that were calculated including the full effect of the adoption of CECL also exceeded each respective required ratio as of March 31, 2020. Required and Actual TLAC and Eligible LTD Ratios Actual Amount/Ratio $ in millions Regulatory Minimum Required Ratio1 At March 31, 2020 At December 31, 2019 External TLAC2 $ 201,486 $ 196,888 External TLAC as a % of RWA 18.0% 21.5% 47.1% 49.9% External TLAC as a % of leverage exposure 7.5% 9.5% 17.0% 17.0% Eligible LTD3 $ 118,778 $ 113,624 Eligible LTD as a % of RWA 9.0% 9.0% 27.8% 28.8% Eligible LTD as a % of leverage exposure 4.5% 4.5% 10.0% 9.8% 1. Required ratios are inclusive of applicable buffers.The final rule imposes TLAC buffer requirements on top of both the risk-based and leverage exposure-based external TLAC minimum requirements. The risk-based TLAC buffer is equal to the sum of 2.5%, the covered BHC's Method 1 G-SIB surcharge and the CCyB, if any, as a percentage of total RWA. The leverage exposure-based TLAC buffer is equal to 2% of the covered BHC's total leverage exposure. Failure to maintain the buffers would result in restrictions on our ability to make capital distributions, including the payment of dividends and the repurchase of stock, and to pay discretionary bonuses to executive officers. 2. External TLAC consists of Common Equity Tier 1 capital and Additional Tier 1 capital (each excluding any noncontrolling minority interests), as well as eligible LTD. 3. Consists of TLAC-eligible LTD reduced by 50% for amounts of unpaid principal due to be paid in more than one year but less than two years from each respective balance sheet date. We are in compliance with all relevant TLAC requirements as of March 31, 2020 and December 31, 2019. For a further discussion of TLAC and related requirements, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources— Regulatory Requirements—Regulatory Capital Requirements -- 26 of 93 -- Table of Contents Management’s Discussion and Analysis March 2020 Form 10-Q 24 —Total Loss-Absorbing Capacity, Long-Term Debt and Clean Holding Company Requirements” in the 2019 Form 10-K. Capital Plans and Stress Tests Pursuant to the Dodd-Frank Act, the Federal Reserve has adopted capital planning and stress test requirements for large BHCs, including us, which form part of the Federal Reserve’s annual CCAR framework. We submitted our 2020 Capital Plan (“Capital Plan”) and company-run stress test results to the Federal Reserve on April 6, 2020. We expect that the Federal Reserve will provide its response to our 2020 Capital Plan and publish summary results of the CCAR and Dodd-Frank Act supervisory stress tests of each large BHC, including us, no later than June 30, 2020. We are required to disclose a summary of the results of our company- run stress tests within 15 days of the date that the Federal Reserve discloses the results of the supervisory stress tests. We may be required to resubmit our Capital Plan under certain circumstances, including in the event of a material change in our risk profile, financial condition or corporate structure. See “Risk Factors” in the 2019 Form 10-K. For a further discussion of our capital plans and stress tests, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources— Regulatory Requirements—Capital Plans and Stress Tests” in the 2019 Form 10-K. Attribution of Average Common Equity According to the Required Capital Framework Our required capital (“Required Capital”) estimation is based on the Required Capital framework, an internal capital adequacy measure. Common equity attribution to the business segments is based on capital usage calculated under the Required Capital framework, as well as each business segment’s relative contribution to our total Required Capital. The Required Capital framework is a risk-based and leverage use-of-capital measure, which is compared with our regulatory capital to ensure that we maintain an amount of going concern capital after absorbing potential losses from stress events, where applicable, at a point in time. The amount of capital allocated to the business segments is generally set at the beginning of each year and remains fixed throughout the year until the next annual reset unless a significant business change occurs (e.g., acquisition or disposition). We define the difference between our total average common equity and the sum of the average common equity amounts allocated to our business segments as Parent common equity. We generally hold Parent common equity for prospective regulatory requirements, organic growth, acquisitions and other capital needs. The Required Capital framework is expected to evolve over time in response to changes in the business and regulatory environment, for example, to incorporate changes in stress testing or enhancements to modeling techniques. We will continue to evaluate the framework with respect to the impact of future regulatory requirements, as appropriate. Average Common Equity Attribution1 Three Months Ended March 31, $ in billions 2020 2019 Institutional Securities $ 42.8 $ 40.4 Wealth Management 18.2 18.2 Investment Management 2.6 2.5 Parent 11.1 10.5 Total $ 74.7 $ 71.6 1. The attribution of average common equity to the business segments is a non-GAAP financial measure. See “Selected Non-GAAP Financial Information” herein. Resolution and Recovery Planning Pursuant to the Dodd-Frank Act, we are required to periodically submit to the Federal Reserve and the FDIC a resolution plan that describes our strategy for a rapid and orderly resolution under the U.S. Bankruptcy Code in the event of our material financial distress or failure. Our next resolution plan submission is expected to be a targeted resolution plan in July 2021. As described in our 2019 resolution plan, which was submitted on June 28, 2019, our preferred resolution strategy is an SPOE strategy. In line with our SPOE strategy, the Parent Company has transferred, and has agreed to transfer on an ongoing basis, certain assets to its wholly owned, direct subsidiary Morgan Stanley Holdings LLC (the “Funding IHC”). In addition, the Parent Company has entered into an amended and restated support agreement with its material entities (including the Funding IHC) and certain other subsidiaries. In the event of a resolution scenario, the Parent Company would be obligated to contribute all of its Contributable Assets to our material entities and/or the Funding IHC. The Funding IHC would be obligated to provide capital and liquidity, as applicable, to our material entities. The combined implication of the SPOE resolution strategy and the requirement to maintain certain levels of TLAC is that losses in resolution would be imposed on the holders of eligible long-term debt and other forms of eligible TLAC issued by the Parent Company before any losses are imposed on the holders of the debt securities of our operating subsidiaries or before putting U.S. taxpayers at risk. For more information about resolution and recovery planning requirements and our activities in these areas, including the implications of such activities in a resolution scenario, see “Business—Supervision and Regulation—Financial Holding Company—Resolution and Recovery Planning,” “Risk Factors —Legal, Regulatory and Compliance Risk” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources— Regulatory Requirements—Resolution and Recovery Planning” in the 2019 Form 10-K. -- 27 of 93 -- Table of Contents Management’s Discussion and Analysis 25 March 2020 Form 10-Q Regulatory Developments Stress Capital Buffer Final Rule The Federal Reserve has adopted a final rule to integrate its annual capital planning and stress testing requirements with existing applicable regulatory capital requirements. The final rule, which applies to certain BHCs, including us, introduces a stress capital buffer (“SCB”) and related changes to the capital planning and stress testing processes. The SCB applies only with respect to Standardized Approach risk-based capital requirements and replaces the existing Common Equity Tier 1 capital conservation buffer, which is 2.5%. The SCB is the greater of (i) the maximum decline in our Common Equity Tier 1 capital ratio under the severely adverse scenario over the supervisory stress test measurement period plus the sum of the four quarters of planned common stock dividends divided by the projected RWAs from the quarter in which the Firm’s projected Common Equity Tier 1 capital ratio reaches its minimum in the supervisory stress test and (ii) 2.5%. Risk-based regulatory capital requirements under the Standardized Approach will include the SCB, as summarized above, as well as our Common Equity Tier 1 GSIB capital surcharge and any applicable Common Equity Tier 1 CCyB. The final rule makes related changes to capital planning and stress testing processes for BHCs subject to the SCB. In particular, the supervisory stress test will assume that BHCs generally maintain a constant level of assets and RWAs throughout the projection period. In addition, the supervisory stress test will no longer assume that BHCs make all planned capital distributions, although the SCB will incorporate the dollar amount of four quarters of planned common stock dividends, as summarized above. The final rule does not change regulatory capital requirements under the Advanced Approach, the Tier 1 leverage ratio or the SLR. The Firm’s initial SCB will be based on the results of the 2020 CCAR supervisory stress test which the Federal Reserve is expected to publish by June 30, 2020. The SCB will take effect on October 1, 2020 and will remain in effect until September 30, 2021, and will be updated annually thereafter based on the results of the annual CCAR supervisory stress test, with a revised SCB taking effect on October 1 each year. Upon receipt of the SCB, we will evaluate whether to update our Required Capital framework to take into account any changes in our risk-based capital requirements that result from the SCB. The SCB final rule also includes a transitional arrangement for the third quarter of 2020. Between July 1, 2020 and September 30, 2020, the Firm will be authorized to make capital distributions that do not exceed the four-quarter average of capital distributions for which the Federal Reserve indicated its non-objection in the 2019 capital plan cycle, unless otherwise determined by the Federal Reserve. Revisions to Definition of Eligible Retained Income The U.S. banking agencies have adopted an interim final rule amending the definition of eligible retained income in their respective capital rules. As amended, eligible retained income is defined by the Federal Reserve as the greater of (i) net income for the four preceding calendar quarters, net of any distributions and associated tax effects not already reflected in net income, and (ii) the average of net income over the preceding four quarters. This definition applies with respect to any payout restrictions applicable in the event of a breach of any regulatory capital buffers, including any applicable CCyB, G-SIB capital surcharge, capital conservation buffer, the enhanced SLR and, once effective, SCB, which replaces the capital conservation buffer under the Standardized Approach. The interim final rule became effective March 20, 2020. Separately, the Federal Reserve has adopted an interim final rule amending the definition of eligible retained income under its TLAC rule to be consistent with the revised definition of eligible retained income in the regulatory capital framework, as summarized above. The interim final rule became effective March 26, 2020. Regulatory Capital and Stress Testing Developments Related to Implementation of CECL The U.S. banking agencies have adopted an interim final rule altering, for purposes of the regulatory capital and TLAC requirements, the required adoption time period for CECL. Under the interim final rule, banking organizations that implement the new accounting standard before the end of 2020 may elect to follow the three-year transition available under a prior rule or a new five-year transition. This five-year transition involves a two-year delay in recognizing the effects on regulatory capital of the new accounting standard, followed by a three-year transition period during which the electing organization phases out the aggregate capital effects of the two- year delay. The interim final rule became effective March 27, 2020. We have elected to implement the five-year transition for recognizing the potentially adverse effects of the adoption of CECL. In addition, pursuant to the The Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”), banking organizations are not required to comply with CECL, for purposes of U.S. GAAP accounting, until the earlier of the end of the COVID-19 national emergency declared by the President of the United States on March 15, 2020 under the National Emergencies Act or December 31, 2020. We have not elected to delay our compliance with CECL for purposes of U.S. GAAP accounting. -- 28 of 93 -- Table of Contents Management’s Discussion and Analysis March 2020 Form 10-Q 26 Regulatory Developments in Response to COVID-19 In the United States, the Federal Reserve, the other U.S. state and federal financial regulatory agencies and Congress have taken actions to mitigate disruptions to economic activity and financial stability resulting from COVID-19. Federal Reserve Actions The Federal Reserve has established, or has taken steps to establish, a range of facilities and programs to support the U.S. economy and U.S. marketplace participants in response to economic disruptions associated with COVID-19. Through these facilities and programs, the Federal Reserve has taken steps to directly or indirectly purchase assets or debt instruments from, or make loans to, U.S. companies, financial institutions, municipalities and other market participants. In addition, the Federal Reserve has taken a range of other actions to support the flow of credit to households and businesses. For example, on March 15, 2020, the Federal Reserve reduced the target range for the federal funds rate to 0 to 0.25% and announced that it would increase its holdings of U.S. Treasury securities and agency mortgage-backed securities and begin purchasing agency commercial mortgage-backed securities. The Federal Reserve has also encouraged depository institutions to borrow from the discount window and has lowered the primary credit rate for such borrowings by 150 basis points to 0.25% while extending the term of such loans up to 90 days. In addition, effective March 26, 2020, reserve requirements have been reduced to zero. Acting in concert with the other U.S. banking agencies, the Federal Reserve has also issued statements encouraging banking organizations to use their capital and liquidity buffers as they lend to households and businesses affected by COVID-19. To facilitate banking organizations' use of their capital buffers, the Federal Reserve has revised the definition of eligible retained income applicable in the capital and TLAC frameworks. Additionally, the Federal Reserve has adopted an interim final rule that temporarily excludes U.S. Treasury securities and deposits at Federal Reserve Banks from the calculation of our supplementary leverage exposure used in the SLR. For a further discussion about the revised definition of eligible retained income and changes to the SLR calculation, see “Revisions to Definition of Eligible Retained Income” and “Supplementary Leverage Ratio Interim Final Rule,” respectively, herein. Further, the Federal Reserve along with the other U.S. banking agencies, issued guidance stating that granting certain concessions to borrowers that are current on existing loans, either individually or as part of a program for creditworthy borrowers who are experiencing short-term financial or operational problems as a result of the coronavirus pandemic, generally would not be considered TDRs under applicable U.S. GAAP. This guidance also clarifies that efforts to work with borrowers of one-to-four family residential mortgages impacted by the COVID-19 pandemic and meeting certain criteria will not result in such loans being deemed restructured or modified for purposes of U.S. Basel III, and will therefore not be subject to higher regulatory capital requirements. As of March 31, 2020, we have participated in the PDCF, which provides liquidity to primary dealers through a secured lending facility, and, following the Federal Reserve's statement encouraging banks to use its discount window, we have accessed the discount window. While we continue to assess, we may participate in other of these facilities and programs, including on behalf of clients. Non-U.S. Central Bank Actions In addition to actions taken by the Federal Reserve, many non- U.S. central banks have announced similar facilities and programs in response to the economic and market disruptions associated with COVID-19. Firm subsidiaries operating in non- U.S. markets may participate, or perform customer facilitation roles, in such non-U.S. facilities or programs. The CARES Act The CARES Act was signed into law on March 27, 2020. Pursuant to the CARES Act, the U.S. Treasury has the authority to provide loans, guarantees and other investments in support of eligible businesses, states and municipalities affected by the economic effects of COVID-19. Some of these funds may also be used to support the several Federal Reserve programs and facilities described in “Federal Reserve Actions” previously or additional programs or facilities that are established by the Federal Reserve under its Section 13(3) authority and meet certain criteria. Among other provisions, the CARES Act also includes funding for the Small Business Administration to expand lending, relief from certain U.S. GAAP requirements to allow COVID-19-related loan modifications to not be categorized as TDRs and a range of incentives to encourage deferment, forbearance or modification of consumer credit and mortgage contracts. The CARES Act also includes several measures that will temporarily adjust existing laws or regulations. These include providing the FDIC with additional authority to guarantee the deposits of solvent insured depository institutions held in non- interest-bearing business transaction accounts to a maximum amount specified by the FDIC, reinstating the FDIC’s Temporary Liquidity Guarantee Authority to guarantee debt obligations of solvent insured depository institutions or depository institution holding companies, temporarily allowing the U.S. Treasury to fully guarantee money market mutual funds and granting additional authority to the OCC to provide certain exemptions to the lending limits imposed on national banks. -- 29 of 93 -- Table of Contents Management’s Discussion and Analysis 27 March 2020 Form 10-Q Supplementary Leverage Ratio Interim Final Rule In response to the COVID-19 pandemic, the Federal Reserve has adopted an interim final rule that excludes, on a temporary basis, U.S. Treasury securities and deposits at Federal Reserve Banks from our SLR exposure measure from April 1, 2020 to March 31, 2021. This interim final rule does not amend our U.S. Bank Subsidiaries’ SLR requirements. Other Matters U.K. Withdrawal from the E.U. On January 31, 2020, the U.K. withdrew from the E.U. under the terms of a withdrawal agreement between the U.K. and the E.U. The withdrawal agreement provides for a transition period to the end of December 2020, during which time the U.K. will continue to apply E.U. law as if it were a member state, and U.K. firms’ rights to provide financial services in E.U. member states will continue. Access to the E.U. market after the transition period remains subject to negotiation. We have prepared the structure of our European operations for a range of potential outcomes, including for the possibility that U.K. financial firms’ access to E.U. markets after the transition period is limited, and we expect to be able to continue to serve our clients and customers under each of these potential outcomes. For more information on the U.K.’s withdrawal from the E.U., our related preparations and the potential impact on our operations, see “Risk Factors— International Risk” in the 2019 Form 10-K. For further information regarding our exposure to the U.K., see also “Quantitative and Qualitative Disclosures about Risk—Country and Other Risks." Planned Replacement of London Interbank Offered Rate and Replacement or Reform of Other Interest Rates Central banks around the world, including the Federal Reserve, have commissioned committees and working groups of market participants and official sector representatives to replace LIBOR and replace or reform other interest rate benchmarks (collectively, the “IBORs”). Accordingly, we have established and are undertaking a Firmwide IBOR transition plan to promote the transition to alternative reference rates, which takes into account the considerable uncertainty regarding the availability of LIBOR beyond 2021. For a further discussion of the expected replacement of the IBORs and/or reform of interest rate benchmarks, and the related risks and our transition plan, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations— Liquidity and Capital Resources—Regulatory Requirements— Other Matters” and “Risk Factors—Risk Management,” respectively, in the 2019 Form 10-K. -- 30 of 93 -- Table of Contents March 2020 Form 10-Q 28 Quantitative and Qualitative Disclosures about Risk Management believes effective risk management is vital to the success of our business activities. For a discussion of our Enterprise Risk Management framework and risk management functions, see “Quantitative and Qualitative Disclosures about Risk—Risk Management” in the 2019 Form 10-K. Market Risk Market risk refers to the risk that a change in the level of one or more market prices, rates, indices, volatilities, correlations or other market factors, such as market liquidity, will result in losses for a position or portfolio. Generally, we incur market risk as a result of trading, investing and client facilitation activities, principally within the Institutional Securities business segment where the substantial majority of our VaR for market risk exposures is generated. In addition, we incur non-trading market risk, principally within the Wealth Management and Investment Management business segments. The Wealth Management business segment primarily incurs non-trading market risk from lending and deposit-taking activities. The Investment Management business segment primarily incurs non-trading market risk from capital investments in alternative and other funds. For a further discussion of market risk, see “Quantitative and Qualitative Disclosures about Risk—Market Risk” in the 2019 Form 10-K. Trading Risks We are exposed to a wide range of risks related to interest rates, equity prices, foreign exchange rates and commodity prices, and the associated implied volatilities and spreads, related to the global markets in which we conduct our trading activities. The statistical technique known as VaR is one of the tools we use to measure, monitor and review the market risk exposures of our trading portfolios. For information regarding our primary risk exposures and market risk management, VaR methodology, assumptions and limitations, see “Quantitative and Qualitative Disclosures about Risk—Market Risk—Trading Risks” in the 2019 Form 10-K. 95%/One-Day Management VaR for the Trading Portfolio Three Months Ended March 31, 2020 $ in millions Period End Average High2 Low2 Interest rate and credit spread $ 62 $ 32 $ 62 $ 24 Equity price 22 15 23 12 Foreign exchange rate 11 8 14 5 Commodity price 12 13 19 10 Less: Diversification benefit1 (65) (33) N/A N/A Primary Risk Categories $ 42 $ 35 $ 52 $ 28 Credit Portfolio 25 15 25 12 Less: Diversification benefit1 (12) (10) N/A N/A Total Management VaR $ 55 $ 40 $ 58 $ 32 Three Months Ended December 31, 2019 $ in millions Period End Average High2 Low2 Interest rate and credit spread $ 26 $ 28 $ 31 $ 24 Equity price 11 14 18 11 Foreign exchange rate 10 9 13 6 Commodity price 10 17 22 10 Less: Diversification benefit1 (27) (33) N/A N/A Primary Risk Categories $ 30 $ 35 $ 40 $ 30 Credit Portfolio 15 15 17 13 Less: Diversification benefit1 (10) (11) N/A N/A Total Management VaR $ 35 $ 39 $ 43 $ 33 1. Diversification benefit equals the difference between the total Management VaR and the sum of the component VaRs. This benefit arises because the simulated one-day losses for each of the components occur on different days; similar diversification benefits also are taken into account within each component. 2. The high and low VaR values for the total Management VaR and each of the component VaRs might have occurred on different days during the quarter, and therefore, the diversification benefit is not an applicable measure. While Average total Management VaR and average Management VaR for the Primary Risk Categories were relatively unchanged from the three months ended December 31, 2019, the period-end balance increased. The increase in period-end VaR resulted primarily from the interest rate and credit spread and equity price risk categories, which were predominantly driven by increased market volatility related to COVID-19, and reflected increased exposures in the Fixed Income and Equity businesses related to client facilitation activity and market movements in March 2020. These increases were partially offset by an increased diversification benefit. For information on the impact of COVID-19 on market and economic conditions and their effect on our financial results, refer to “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Executive Summary— Coronavirus Disease (COVID-19) Pandemic” herein. -- 31 of 93 -- Table of Contents Risk Disclosures 29 March 2020 Form 10-Q Distribution of VaR Statistics and Net Revenues We evaluate the reasonableness of our VaR model by comparing the potential declines in portfolio values generated by the model with corresponding actual trading results for the Firm, as well as individual business units. For days where losses exceed the VaR statistic, we examine the drivers of trading losses to evaluate the VaR model’s accuracy relative to realized trading results. There were two days with trading losses in the current quarter, one of which exceeded the 95%/one-day Total Management VaR. Daily 95%/One-Day Total Management VaR for the Current Quarter ($ in millions) Daily Net Trading Revenues for the Current Quarter ($ in millions) The previous histogram shows the distribution of daily net trading revenues for the current quarter. Daily net trading revenues include profits and losses from Interest rate and credit spread, Equity price, Foreign exchange rate, Commodity price, and Credit Portfolio positions and intraday trading activities for our trading businesses. Certain items such as fees, commissions and net interest income are excluded from daily net trading revenues and the VaR model. Revenues required for Regulatory VaR backtesting further exclude intraday trading. Non-Trading Risks We believe that sensitivity analysis is an appropriate representation of our non-trading risks. The following sensitivity analyses cover substantially all of the non-trading risk in our portfolio. Credit Spread Risk Sensitivity1 $ in millions At March 31, 2020 At December 31, 2019 Derivatives $ 6 $ 6 Funding liabilities2 39 42 1. Amounts represent the potential gain for each 1 bps widening of our credit spread. 2. Relates to Borrowings carried at fair value. U.S. Bank Subsidiaries’ Net Interest Income Sensitivity Analysis $ in millions At March 31, 2020 At December 31, 2019 Basis point change +100 $ 850 $ 151 -100 (495) (642) The previous table presents an analysis of selected instantaneous upward and downward parallel interest rate shocks (subject to a floor of zero percent in the downward scenario) on net interest income over the next 12 months for our U.S. Bank Subsidiaries. These shocks are applied to our 12-month forecast for our U.S. Bank Subsidiaries, which incorporates market expectations of interest rates and our forecasted business activity. We do not manage to any single rate scenario but rather manage net interest income in our U.S. Bank Subsidiaries to optimize across a range of possible outcomes, including non-parallel rate change scenarios. The sensitivity analysis assumes that we take no action in response to these scenarios, assumes there are no changes in other macroeconomic variables normally correlated with changes in interest rates, and includes subjective assumptions regarding customer and market re-pricing behavior and other factors. The change in sensitivity to interest rates between March 31, 2020 and December 31, 2019 is primarily driven by lower market rates. Given the current rate environment, the correlation between market rate increases and deposit cost increases is low, and therefore provides an incremental benefit in the +100bps scenario. -- 32 of 93 -- Table of Contents Risk Disclosures March 2020 Form 10-Q 30 Investments Sensitivity, Including Related Carried Interest Loss from 10% Decline $ in millions At March 31, 2020 At December 31, 2019 Investments related to Investment Management activities $ 327 $ 367 Other investments: MUMSS 173 169 Other Firm investments 197 195 MUMSS—Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. We have exposure to public and private companies through direct investments, as well as through funds that invest in these assets. These investments are predominantly equity positions with long investment horizons, a portion of which is for business facilitation purposes. The market risk related to these investments is measured by estimating the potential reduction in net income associated with a 10% decline in investment values and related impact on performance-based fees, as applicable. The change in investments sensitivity related to Investment Management activities between March 31, 2020 and December 31, 2019 is primarily driven by lower valuations in private equity funds, related to the decline of global asset prices due to the effect of COVID-19 on economies and markets around the world. For information on the impact of COVID-19 on market and economic conditions and their effect on our financial results, refer to “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Executive Summary—Coronavirus Disease (COVID-19) Pandemic” herein. Equity Market Sensitivity In the Wealth Management and Investment Management business segments, certain fee-based revenue streams are driven by the value of clients’ equity holdings. The overall level of revenues for these streams also depends on multiple additional factors that include, but are not limited to, the level and duration of the equity market increase or decline, price volatility, the geographic and industry mix of client assets, the rate and magnitude of client investments and redemptions, and the impact of such market increase or decline and price volatility on client behavior. Therefore, overall revenues do not correlate completely with changes in the equity markets. For information on the impact of COVID-19 on market and economic conditions and their effect on our financial results, refer to “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Executive Summary—Coronavirus Disease (COVID-19) Pandemic” herein. Credit Risk Credit risk refers to the risk of loss arising when a borrower, counterparty or issuer does not meet its financial obligations to us. We are primarily exposed to credit risk from institutions and individuals through our Institutional Securities and Wealth Management business segments. For a further discussion of our credit risks, see “Quantitative and Qualitative Disclosures about Risk—Credit Risk” in the 2019 Form 10-K. The credit environment deteriorated rapidly towards the end of the current quarter, driven by the effect of COVID-19 on economic and market conditions. Within Institutional Securities the effects were notable, with mark-to-market losses on held- for-sale loans and lending commitments and increased allowances for credit losses related to held-for-investment loans and lending commitments, as discussed in Management’s Discussion and Analysis. The uncertain environment also caused an increase in client requests to draw down on lending commitments and market volatility led to increased counterparty credit exposures, both of which are further discussed herein. In addition, we have begun to have discussions with and receive requests from certain clients for forbearance, or deferral of their loan payments to us, driven or exacerbated by the economic environment and following in part from the U.S. government’s enactment of the CARES Act. These requests and discussions primarily relate to commercial and residential real estate loans. Certain clients have also requested modifications of covenant terms. The forbearance process is different based on loan and borrower type, among other factors. In general, qualifying requests for forbearance related to single family residential real estate loans are immediately granted, whereas commercial real estate loan forbearance requires negotiation and approval. Receiving or granting forbearance or modification requests does not necessarily mean that we will incur credit losses. As of April 30, 2020, the principal amount of loans for which forbearance requests are currently active related to near-term payments on commercial real estate loans and residential real estate loans approximated $2 billion and $800 million, respectively. These trends could continue in future periods given the present uncertain global economic and market conditions. See “Executive Summary—Coronavirus Disease (COVID-19) Pandemic,” and “Risk Factors” herein for further information. See also "Forward Looking Statements" in the 2019 10-K. -- 33 of 93 -- Table of Contents Risk Disclosures 31 March 2020 Form 10-Q Loans and Lending Commitments At March 31, 2020 $ in millions IS WM IM1 Total Loans held for investment, before allowance $ 49,358 $ 82,589 $ 5 $ 131,952 Allowance for credit losses (530) (87) — (617) Loans held for investment, net of allowance $ 48,828 $ 82,502 $ 5 $ 131,335 Loans held for sale 17,343 14 5 17,362 Loans held at fair value 9,573 — 489 10,062 Total loans $ 75,744 $ 82,516 $ 499 $ 158,759 Lending commitments2 92,911 13,366 — 106,277 Total loans and lending commitments2 $ 168,655 $ 95,882 $ 499 $ 265,036 Total loans, before allowance $ 76,274 $ 82,603 $ 499 $ 159,376 At December 31, 2019 $ in millions IS WM IM1 Total Loans held for investment, before allowance $ 38,290 $ 80,114 $ 5 $ 118,409 Allowance for credit losses (297) (52) — (349) Loans held for investment, net of allowance $ 37,993 $ 80,062 $ 5 $ 118,060 Loans held for sale 12,564 13 — 12,577 Loans held at fair value 11,075 — 251 11,326 Total loans $ 61,632 $ 80,075 $ 256 $ 141,963 Lending commitments2 106,886 13,161 21 120,068 Total loans and lending commitments2 $ 168,518 $ 93,236 $ 277 $ 262,031 Total loans, before allowance $ 61,929 $ 80,127 $ 256 $ 142,312 1. Investment Management business segment loans are related to certain of our activities as an investment advisor and manager. At March 31, 2020 and December 31, 2019, loans held at fair value are predominantly the result of the consolidation of CLO vehicles, managed by Investment Management, composed primarily of senior secured corporate loans. 2. Lending commitments represent the notional amount of legally binding obligations to provide funding to clients for lending transactions. Since commitments associated with these business activities may expire unused or may not be utilized to full capacity, they do not necessarily reflect the actual future cash funding requirements. We provide loans and lending commitments to a variety of customers, from large corporate and institutional clients to high net worth individuals. In addition, we purchase loans in the secondary market. Loans and lending commitments are either held for investment, held for sale or carried at fair value. For more information on these loan classifications, see Note 2 to the financial statements in the 2019 Form 10-K. Total loans and lending commitments increased by approximately $3 billion since December 31, 2019, primarily due to growth in tailored lending and Residential real estate loans within the Wealth Management business segment. In addition, within the Institutional Securities business segment, there was an increase in Corporate relationship and event-driven lending commitments funded during the current quarter. See Notes 4, 9 and 13 to the financial statements for further information. Allowance for Credit Losses Rollforward—Loans and Lending Commitments $ in millions December 31, 20191 $ 590 Effect of CECL adoption (41) Gross charge-offs (32) Provision 407 Other (3) March 31, 2020 $ 921 Allowance for credit losses—Loans $ 617 Allowance for credit losses—Lending commitments 304 1. At December 31, 2019, the total allowance for credit losses for Loans and Lending commitments was $349 million and $241 million, respectively. Credit exposure arising from our loans and lending commitments is measured in accordance with our internal risk management standards. Risk factors considered in determining the aggregate allowance for loan and commitment losses include the borrower’s financial strength, industry, facility structure, loan-to-value ratio, debt service ratio, collateral and covenants. Qualitative and environmental factors such as economic and business conditions, nature and volume of the portfolio and lending terms, and volume and severity of past due loans may also be considered. The aggregate allowance for loans and lending commitments increased in the current quarter, principally reflecting a provision for credit losses within the Institutional Securities business segment resulting from the economic impact of COVID-19. This provision was primarily the result of higher actual and expected future downgrades, an increase in funded balances, principally in Corporate relationship and event-driven loans, as well as revisions to our forecasts in light of current and expected future market and macroeconomic conditions. See Note 2 to the financial statements for a discussion of the Firm’s allowance for credit loss methodology under CECL. Status of Loans Held for Investment At March 31, 2020 At December 31, 2019 IS WM IS WM Current 99.5% 99.9% 99.0% 99.9% Nonaccrual1 0.5% 0.1% 1.0% 0.1% 1. These loans are on nonaccrual status because the loans were past due for a period of 90 days or more or payment of principal or interest was in doubt. -- 34 of 93 -- Table of Contents Risk Disclosures March 2020 Form 10-Q 32 Institutional Securities Loans and Lending Commitments1 At March 31, 2020 Contractual Years to Maturity $ in millions Less than 1 1-3 3-5 Over 5 Total Loans AA $ 59 $ 47 $ 14 $ 5 $ 125 A 931 1,456 554 589 3,530 BBB 3,619 5,872 6,867 574 16,932 BB 12,401 11,430 10,186 1,251 35,268 Other NIG 5,865 5,503 4,313 2,242 17,923 Unrated2 101 92 286 1,487 1,966 Total loans 22,976 24,400 22,220 6,148 75,744 Lending commitments AAA — 50 — — 50 AA 2,831 818 2,562 30 6,241 A 3,994 7,477 9,150 279 20,900 BBB 8,407 12,732 15,460 731 37,330 BB 3,635 3,986 7,219 1,067 15,907 Other NIG 2,064 2,754 6,604 1,056 12,478 Unrated2 3 — — 2 5 Total lending commitments 20,934 27,817 40,995 3,165 92,911 Total exposure $ 43,910 $ 52,217 $ 63,215 $ 9,313 $ 168,655 At December 31, 2019 Contractual Years to Maturity $ in millions Less than 1 1-3 3-5 Over 5 Total Loans AA $ 7 $ 50 $ — $ 5 $ 62 A 955 923 516 277 2,671 BBB 2,297 5,589 3,592 949 12,427 BB 9,031 11,189 9,452 1,449 31,121 Other NIG 4,020 5,635 2,595 1,143 13,393 Unrated2 117 82 131 1,628 1,958 Total loans 16,427 23,468 16,286 5,451 61,632 Lending commitments AAA — 50 — — 50 AA 2,838 908 2,509 — 6,255 A 6,461 7,287 9,371 298 23,417 BBB 7,548 13,780 20,560 753 42,641 BB 2,464 5,610 8,333 1,526 17,933 Other NIG 2,193 4,741 7,062 2,471 16,467 Unrated2 — 9 107 7 123 Total lending commitments 21,504 32,385 47,942 5,055 106,886 Total exposure $ 37,931 $ 55,853 $ 64,228 $10,506 $ 168,518 NIG–Non-investment grade 1. Counterparty credit ratings are internally determined by CRM. 2. Unrated loans and lending commitments are primarily trading positions that are measured at fair value and risk-managed as a component of market risk. For a further discussion of our market risk, see “Market Risk” herein. As a result of the economic impacts of COVID-19, there was an increase in lending commitments funded during the current quarter in the Institutional Securities business segment. The increase was primarily driven by clients with non-investment grade and BBB internal credit ratings, who sought liquidity in a period where, given the economic backdrop, capital markets alternatives to drawing on lines of credit were less available. Institutional Securities Loans and Lending Commitments by Industry $ in millions At March 31, 2020 At December 31, 2019 Industry Financials $ 40,142 $ 40,992 Real estate 27,190 28,348 Industrials 16,100 13,136 Healthcare 13,582 14,113 Communications services 10,839 12,165 Utilities 10,231 9,905 Information technology 10,019 9,201 Consumer discretionary 9,993 9,589 Energy 9,856 9,461 Consumer staples 9,415 9,724 Materials 5,469 5,577 Insurance 3,961 3,755 Other 1,858 2,552 Total $ 168,655 $ 168,518 The decline in economic activity, driven by the effects of COVID-19, and recent decline in oil prices, have currently impacted borrowers in many industries. The future developments of COVID-19 and its related effect on the economic environment are uncertain and may continue to impact certain sectors and industries, in which we have, or may in the future have, exposure in the form of loans or lending commitments. In addition, refer to “Risk Factors” herein. The Institutional Securities business segment lending activities include Corporate relationship and event-driven lending, Secured lending facilities, Commercial real estate lending and Securities-based lending and other. Corporate relationship and event-driven loans and lending commitments typically consist of revolving lines of credit, term loans and bridge loans; may have varying terms; may be senior or subordinated; may be secured or unsecured; are generally contingent upon representations, warranties and contractual conditions applicable to the borrower; and may be syndicated, traded or hedged. For additional information on event-driven loans, see “Institutional Securities Event-Driven Loans and Lending Commitments” herein. Secured lending facilities include loans provided to clients, which are primarily secured by loans on underlying real estate or other assets. The underlying loans are associated with various types of collateral, including residential real estate, commercial real estate, corporate and financial assets. These facilities generally provide for overcollateralization. Credit risk with respect to these loans and lending commitments arises from the failure of a borrower to perform according to the terms of the loan agreement and/or a decline in the underlying collateral -- 35 of 93 -- Table of Contents Risk Disclosures 33 March 2020 Form 10-Q value. The Firm monitors collateral levels against the requirements of lending agreements. Commercial real estate loans are primarily senior, secured by underlying real estate and typically in term loan form. Securities-based lending and other includes financing extended to sales and trading customers and corporate loans purchased in the secondary market. Institutional Securities Loans1 $ in millions At March 31, 2020 At December 31, 2019 Corporate relationship and event-driven lending $ 27,058 $ 11,638 Secured lending facilities 30,493 29,654 Commercial & residential real estate 11,604 13,198 Securities-based lending and other 7,119 7,439 Total Institutional Securities loans $ 76,274 $ 61,929 1. Amounts include loans held for investment, before the allowance for credit losses, loans held for sale and loans at fair value. Institutional Securities Event-Driven Loans and Lending Commitments1 At March 31, 2020 Contractual Years to Maturity $ in millions Less than 1 1-3 3-5 Over 5 Total Loans $ 3,284 $ 1,205 $ 1,527 $ 1,132 $ 7,148 Lending commitments 7,312 2,317 1,921 1,507 13,057 Total loans and lending commitments $ 10,596 $ 3,522 $ 3,448 $ 2,639 $20,205 At December 31, 2019 Contractual Years to Maturity $ in millions Less than 1 1-3 3-5 Over 5 Total Loans $ 1,194 $ 1,024 $ 839 $ 390 $ 3,447 Lending commitments 7,921 5,012 2,285 3,090 18,308 Total loans and lending commitments $ 9,115 $ 6,036 $ 3,124 $ 3,480 $21,755 1. Amounts include loans and lending commitments held for investment, before the allowance for credit losses, and held for sale. Event-driven loans and lending commitments are associated with a particular event or transaction, such as to support client merger, acquisition, recapitalization or project finance activities. Balances may fluctuate as such lending is related to transactions that vary in timing and size from period to period. In the current quarter, credit spreads in the market for these loans and commitments widened significantly, resulting in a substantial slowdown in the volume of sales and syndications, which is a trend that could continue in the future given the current uncertain economic and market conditions. See “Executive Summary—Coronavirus Disease (COVID-19) Pandemic” and “Risk Factors” herein, and Forward Looking Statements in the 2019 Form 10-K. Institutional Securities Loans and Lending Commitments Held for Investment At March 31, 2020 At December 31, 2019 $ in millions Loans Lending Commitments Loans Lending Commitments Corporate relationship and event-driven lending $ 15,457 $ 55,365 $ 5,426 $ 61,716 Secured lending facilities 25,805 5,987 24,502 6,105 Commercial & residential real estate1 7,430 730 7,859 425 Securities-based lending and other2 666 461 503 832 Total, before allowance for credit losses $ 49,358 $ 62,543 $ 38,290 $ 69,078 Allowance for credit losses (530) (298) (297) (236) 1. Amounts principally comprise Commercial real estate loans and lending commitments. 2. Amounts principally comprise Other loans and lending commitments. Institutional Securities Allowance for Credit Losses Rollforward—Loans $ in millions Corporate relationship and event- driven lending Secured lending facilities Commercial & residential real estate Securities- based lending and other Total December 31, 2019 $ 115 $ 101 $ 75 $ 6 $ 297 Effect of CECL adoption (2) (42) 34 3 (7) Gross charge-offs (32) — — — (32) Provision 177 29 66 1 273 Other — — (1) — (1) March 31, 2020 $ 258 $ 88 $ 174 $ 10 $ 530 Institutional Securities Allowance for Credit Losses Rollforward—Lending Commitments $ in millions Corporate relationship and event- driven lending Secured lending facilities Commercial & residential real estate Securities- based lending and other Total December 31, 2019 $ 201 $ 27 $ 7 $ 1 $ 236 Effect of CECL adoption (41) (11) 1 — (51) Provision 91 16 5 3 115 Other (2) — — — (2) March 31, 2020 $ 249 $ 32 $ 13 $ 4 $ 298 -- 36 of 93 -- Table of Contents Risk Disclosures March 2020 Form 10-Q 34 Institutional Securities HFI Loans—Ratios of Allowance for Credit Losses to Balance Before Allowance At March 31, 2020 At December 31, 2019 Corporate relationship and event-driven lending 1.7% 2.1% Secured lending facilities 0.3% 0.4% Commercial & residential real estate 2.3% 1.0% Securities-based lending and other 1.5% 1.2% Total Institutional Securities loans 1.1% 0.8% Wealth Management Loans and Lending Commitments At March 31, 2020 Contractual Years to Maturity $ in millions Less than 1 1-3 3-5 Over 5 Total Securities-based lending and other loans $ 43,158 $ 4,709 $ 2,141 $ 1,441 $51,449 Residential real estate loans 14 7 — 31,046 31,067 Total loans $ 43,172 $ 4,716 $ 2,141 $32,487 $82,516 Lending commitments 10,397 2,382 326 261 13,366 Total loans and lending commitments $ 53,569 $ 7,098 $ 2,467 $32,748 $95,882 At December 31, 2019 Contractual Years to Maturity $ in millions Less than 1 1-3 3-5 Over 5 Total Securities-based lending and other loans $ 41,863 $ 3,972 $ 2,783 $ 1,284 $49,902 Residential real estate loans 13 11 — 30,149 30,173 Total loans $ 41,876 $ 3,983 $ 2,783 $31,433 $80,075 Lending commitments 10,219 2,564 71 307 13,161 Total loans and lending commitments $ 52,095 $ 6,547 $ 2,854 $31,740 $93,236 The principal Wealth Management business segment lending activities include securities-based lending and residential real estate loans. Securities-based lending allows clients to borrow money against the value of qualifying securities, generally for any purpose other than purchasing, trading or carrying securities, or refinancing margin debt. For more information about our securities-based lending and residential real estate loans, see “Quantitative and Qualitative Disclosures about Risk—Credit Risk” in the 2019 Form 10-K. For the current quarter, Loans and Lending commitments associated with the Wealth Management business segment increased primarily due to growth in tailored lending and Residential real estate loans. Wealth Management Allowance for Credit Losses Rollforward —Loans and Lending Commitments $ in millions December 31, 20191 $ 57 Effect of CECL adoption 17 Provision 19 March 31, 2020 $ 93 Allowance for credit losses—Loans $ 87 Allowance for credit losses—Lending commitments 6 1. At December 31, 2019, the total Allowance for credit losses for Loans and Lending commitments was $52 million and $5 million, respectively. At March 31, 2020, approximately 75% of Wealth Management residential real estate loans were to borrowers with "Exceptional" or "Very Good" FICO scores (i.e., exceeding 740). Additionally, Wealth Management's securities-based lending portfolio remains well-collateralized and subject to daily client margining, which includes requiring customers to deposit additional collateral, or reduce debt positions, when necessary. Customer and Other Receivables Margin Loans At March 31, 2020 $ in millions IS WM Total Customer receivables representing margin loans $ 16,635 $ 9,546 $ 26,181 At December 31, 2019 $ in millions IS WM Total Customer receivables representing margin loans $ 22,216 $ 9,700 $ 31,916 The Institutional Securities and Wealth Management business segments provide margin lending arrangements, which allow customers to borrow against the value of qualifying securities, primarily for the purpose of purchasing additional securities, as well as to collateralize short positions. Margin lending activities generally have lower credit risk due to the value of collateral held and their short-term nature. Amounts may fluctuate from period to period as overall client balances change as a result of market levels, client positioning and leverage. Employee Loans $ in millions At March 31, 2020 At December 31, 2019 Currently employed by the Firm $ 2,867 N/A No longer employed by the Firm 150 N/A Balance $ 3,017 $ 2,980 Allowance for credit losses1 (180) (61) Balance, net $ 2,837 $ 2,919 Remaining repayment term, weighted average in years 5.0 4.8 1. The change in Allowance for credit losses includes a $124 million increase due to the adoption of CECL on January 1, 2020. -- 37 of 93 -- Table of Contents Risk Disclosures 35 March 2020 Form 10-Q Employee loans are granted in conjunction with a program established primarily to recruit certain Wealth Management representatives and are full recourse and generally require periodic repayments. The allowance for credit losses as of March 31, 2020 was calculated under CECL, while the allowance for credit losses at December 31, 2019 was calculated under the prior incurred loss model. The related provision is recorded in Compensation and benefits expense in the income statements. See Note 2 for a description of the CECL allowance methodology, including credit quality indicators, for employee loans. For additional information on employee loans, see Note 9. Derivatives Fair Value of OTC Derivative Assets Counterparty Credit Rating1 $ in millions AAA AA A BBB NIG Total At March 31, 2020 <1 year $ 2,046 $ 26,829 $ 55,668 $ 38,756 $ 19,369 $ 142,668 1-3 years 536 6,458 22,788 18,243 13,104 61,129 3-5 years 521 5,952 14,442 10,521 4,718 36,154 Over 5 years 4,257 32,785 93,165 68,387 17,506 216,100 Total, gross $ 7,360 $ 72,024 $ 186,063 $ 135,907 $ 54,697 $ 456,051 Counterparty netting (3,472) (55,991) (150,333) (104,343) (30,638) (344,777) Cash and securities collateral (3,336) (12,216) (29,345) (23,461) (16,979) (85,337) Total, net $ 552 $ 3,817 $ 6,385 $ 8,103 $ 7,080 $ 25,937 Counterparty Credit Rating1 $ in millions AAA AA A BBB NIG Total At December 31, 2019 <1 year $ 371 $ 9,195 $ 31,789 $ 22,757 $ 6,328 $ 70,440 1-3 years 378 5,150 17,707 11,495 9,016 43,746 3-5 years 502 4,448 9,903 6,881 3,421 25,155 Over 5 years 3,689 24,675 70,765 40,542 14,587 154,258 Total, gross $ 4,940 $ 43,468 $ 130,164 $ 81,675 $ 33,352 $ 293,599 Counterparty netting (2,172) (33,521) (103,452) (62,345) (19,514) (221,004) Cash and securities collateral (2,641) (8,134) (22,319) (14,570) (10,475) (58,139) Total, net $ 127 $ 1,813 $ 4,393 $ 4,760 $ 3,363 $ 14,456 $ in millions At March 31, 2020 At December 31, 2019 Industry Financials $ 8,343 $ 3,448 Utilities 5,226 4,275 Industrials 2,877 914 Healthcare 1,558 991 Regional governments 1,089 791 Not-for-profit organizations 936 657 Sovereign governments 900 403 Energy 891 524 Materials 826 325 Consumer staples 725 129 Information technology 686 659 Communications services 684 381 Consumer discretionary 463 370 Insurance 391 214 Real estate 215 315 Other 127 60 Total $ 25,937 $ 14,456 1. Counterparty credit ratings are determined internally by CRM. We are exposed to credit risk as a dealer in OTC derivatives. Credit risk with respect to derivative instruments arises from the possibility that a counterparty may fail to perform according to the terms of the contract. In the current quarter, our exposure to credit risk arising from OTC derivatives has increased, primarily as a function of the effect of market factors and volatility on the valuation of our positions. For more information on derivatives, see “Quantitative and Qualitative Disclosures about Risk— Credit Risk—Derivatives” in the 2019 Form 10-K and Note 6 to the financial statements. Country Risk Country risk exposure is the risk that events in, or that affect, a foreign country (any country other than the U.S.) might adversely affect us. We actively manage country risk exposure through a comprehensive risk management framework that combines credit and market fundamentals and allows us to effectively identify, monitor and limit country risk. For a further discussion of our country risk exposure see, “Quantitative and Qualitative Disclosures about Risk—Country and Other Risks” in the 2019 Form 10-K. Our sovereign exposures consist of financial contracts and obligations entered into with sovereign and local governments. Our non-sovereign exposures consist of financial contracts and obligations entered into primarily with corporations and financial institutions. Index credit derivatives are included in the following country risk exposure table. Each reference entity within an index is allocated to that reference entity’s country of risk. Index exposures are allocated to the underlying reference entities in proportion to the notional weighting of each reference entity in the index, adjusted for any fair value receivable or -- 38 of 93 -- Table of Contents Risk Disclosures March 2020 Form 10-Q 36 payable for that reference entity. Where credit risk crosses multiple jurisdictions, for example, a CDS purchased from an issuer in a specific country that references bonds issued by an entity in a different country, the fair value of the CDS is reflected in the Net Counterparty Exposure row based on the country of the CDS issuer. Further, the notional amount of the CDS adjusted for the fair value of the receivable or payable is reflected in the Net Inventory row based on the country of the underlying reference entity. Top 10 Non-U.S. Country Exposures at March 31, 2020 United Kingdom $ in millions Sovereigns Non-sovereigns Total Net inventory1 $ (238) $ 1,327 $ 1,089 Net counterparty exposure2 88 13,314 13,402 Loans — 2,822 2,822 Lending commitments — 6,547 6,547 Exposure before hedges (150) 24,010 23,860 Hedges3 (311) (1,266) (1,577) Net exposure $ (461) $ 22,744 $ 22,283 Germany $ in millions Sovereigns Non-sovereigns Total Net inventory1 $ 1,080 $ 281 $ 1,361 Net counterparty exposure2 127 5,539 5,666 Loans — 1,649 1,649 Lending commitments — 3,492 3,492 Exposure before hedges 1,207 10,961 12,168 Hedges3 (285) (874) (1,159) Net exposure $ 922 $ 10,087 $ 11,009 Japan $ in millions Sovereigns Non-sovereigns Total Net inventory1 $ 1,501 $ 431 $ 1,932 Net counterparty exposure2 78 4,559 4,637 Loans — 714 714 Lending commitments — 3 3 Exposure before hedges 1,579 5,707 7,286 Hedges3 (92) (130) (222) Net exposure $ 1,487 $ 5,577 $ 7,064 France $ in millions Sovereigns Non-sovereigns Total Net inventory1 $ (427) $ (476) $ (903) Net counterparty exposure2 14 3,734 3,748 Loans — 935 935 Lending commitments — 2,919 2,919 Exposure before hedges (413) 7,112 6,699 Hedges3 (6) (712) (718) Net exposure $ (419) $ 6,400 $ 5,981 Canada $ in millions Sovereigns Non-sovereigns Total Net inventory1 $ 587 $ 369 $ 956 Net counterparty exposure2 57 3,221 3,278 Loans — 629 629 Lending commitments — 985 985 Exposure before hedges 644 5,204 5,848 Hedges3 — (97) (97) Net exposure $ 644 $ 5,107 $ 5,751 Spain $ in millions Sovereigns Non-sovereigns Total Net inventory1 $ 360 $ (139) $ 221 Net counterparty exposure2 3 383 386 Loans — 3,623 3,623 Lending commitments — 713 713 Exposure before hedges 363 4,580 4,943 Hedges3 — (132) (132) Net exposure $ 363 $ 4,448 $ 4,811 China $ in millions Sovereigns Non-sovereigns Total Net inventory1 $ (432) $ 1,487 $ 1,055 Net counterparty exposure2 135 460 595 Loans — 1,965 1,965 Lending commitments — 770 770 Exposure before hedges (297) 4,682 4,385 Hedges3 (82) (82) (164) Net exposure $ (379) $ 4,600 $ 4,221 Australia $ in millions Sovereigns Non-sovereigns Total Net inventory1 $ 1,464 $ 359 $ 1,823 Net counterparty exposure2 16 1,346 1,362 Loans — 355 355 Lending commitments — 647 647 Exposure before hedges 1,480 2,707 4,187 Hedges3 — (107) (107) Net exposure $ 1,480 $ 2,600 $ 4,080 Brazil $ in millions Sovereigns Non-sovereigns Total Net inventory1 $ 2,384 $ 79 $ 2,463 Net counterparty exposure2 — 924 924 Loans — 237 237 Lending commitments — 64 64 Exposure before hedges 2,384 1,304 3,688 Hedges3 (12) (16) (28) Net exposure $ 2,372 $ 1,288 $ 3,660 -- 39 of 93 -- Table of Contents Risk Disclosures 37 March 2020 Form 10-Q India $ in millions Sovereigns Non-sovereigns Total Net inventory1 $ 1,571 $ 680 $ 2,251 Net counterparty exposure2 — 612 612 Loans — 235 235 Exposure before hedges 1,571 1,527 3,098 Net exposure $ 1,571 $ 1,527 $ 3,098 1. Net inventory represents exposure to both long and short single-name and index positions (i.e., bonds and equities at fair value and CDS based on a notional amount assuming zero recovery adjusted for the fair value of any receivable or payable). 2. Net counterparty exposure (e.g., repurchase transactions, securities lending and OTC derivatives) is net of the benefit of collateral received and also is net by counterparty when legally enforceable master netting agreements are in place. For more information, see “Additional Information—Top 10 Non-U.S. Country Exposures” herein. 3. Amounts represent net CDS hedges (purchased and sold) on net counterparty exposure and lending executed by trading desks responsible for hedging counterparty and lending credit risk exposures. Amounts are based on the CDS notional amount assuming zero recovery adjusted for any fair value receivable or payable. For further description of the contractual terms for purchased credit protection and whether they may limit the effectiveness of our hedges, see “Quantitative and Qualitative Disclosures about Risk—Credit Risk—Derivatives” in the 2019 Form 10-K. Additional Information—Top 10 Non-U.S. Country Exposures Collateral Held against Net Counterparty Exposure1 $ in millions At March 31, 2020 Counterparty credit exposure Collateral2 United Kingdom U.K., U.S. and Spain $ 14,985 Germany Italy and Germany 13,356 Other Japan, U.S. and Canada 27,025 1. The benefit of collateral received is reflected in the Top 10 Non-U.S. Country Exposures at March 31, 2020. 2. Collateral primarily consists of cash and government obligations. Country Risk Exposures Related to the U.K. At March 31, 2020, our country risk exposures in the U.K. included net exposures of $22,283 million (as shown in the Top 10 Non-U.S. Country Exposures table) and overnight deposits of $5,163 million. The $22,744 million of exposures to non- sovereigns were diversified across both names and sectors and include $7,253 million to U.K.-focused counterparties that generate more than one-third of their revenues in the U.K., $5,845 million to geographically diversified counterparties, and $8,361 million to exchanges and clearinghouses. Operational Risk Operational risk refers to the risk of loss, or of damage to our reputation, resulting from inadequate or failed processes or systems, from human factors or from external events (e.g., fraud, theft, legal and compliance risks, cyber attacks or damage to physical assets). We may incur operational risk across the full scope of our business activities, including revenue-generating activities (e.g., sales and trading) and support and control groups (e.g., information technology and trade processing). For a further discussion about our operational risk, see “Quantitative and Qualitative Disclosures about Risk—Operational Risk” in the 2019 Form 10-K. In addition, for further information on market and economic conditions and their effects on risk in general, see "Management’s Discussion and Analysis of Financial Condition and Results of Operations—Executive Summary—Coronavirus Disease (COVID-19) Pandemic" and “Risk Factors” herein. Model Risk Model risk refers to the potential for adverse consequences from decisions based on incorrect or misused model outputs. Model risk can lead to financial loss, poor business and strategic decision making or damage to our reputation. The risk inherent in a model is a function of the materiality, complexity and uncertainty around inputs and assumptions. Model risk is generated from the use of models impacting financial statements, regulatory filings, capital adequacy assessments and the formulation of strategy. For a further discussion about our model risk, see “Quantitative and Qualitative Disclosures about Risk—Model Risk” in the 2019 Form 10-K. Liquidity Risk Liquidity risk refers to the risk that we will be unable to finance our operations due to a loss of access to the capital markets or difficulty in liquidating our assets. Liquidity risk also encompasses our ability (or perceived ability) to meet our financial obligations without experiencing significant business disruption or reputational damage that may threaten our viability as a going concern. For a further discussion about our liquidity risk, see “Quantitative and Qualitative Disclosures about Risk —Liquidity Risk” in the 2019 Form 10-K and “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Liquidity and Capital Resources” herein. In addition, for further information on market and economic conditions and their effects on risk in general, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Executive Summary—Coronavirus Disease (COVID-19) Pandemic” and “Risk Factors” herein. Legal and Compliance Risk Legal and compliance risk includes the risk of legal or regulatory sanctions, material financial loss, including fines, penalties, judgments, damages and/or settlements, or loss to reputation that we may suffer as a result of failure to comply with laws, regulations, rules, related self-regulatory organization standards and codes of conduct applicable to our business activities. This risk also includes contractual and commercial risk, such as the risk that a counterparty’s performance obligations will be unenforceable. It also includes compliance with AML, terrorist financing, and anti-corruption rules and regulations. For a further discussion about our legal and compliance risk, see “Quantitative and Qualitative Disclosures about Risk—Legal and Compliance Risk” in the 2019 Form 10-K. -- 40 of 93 -- Table of Contents March 2020 Form 10-Q 38 Report of Independent Registered Public Accounting Firm To the Board of Directors and Shareholders of Morgan Stanley: Results of Review of Interim Financial Information We have reviewed the accompanying condensed consolidated balance sheet of Morgan Stanley and subsidiaries (the “Firm”) as of March 31, 2020, and the related condensed consolidated income statements, comprehensive income statements, cash flow statements and statements of changes in total equity for the three-month periods ended March 31, 2020 and 2019, and the related notes (collectively referred to as the “interim financial information”). Based on our reviews, we are not aware of any material modifications that should be made to the accompanying interim financial information for it to be in conformity with accounting principles generally accepted in the United States of America. We have previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheet of the Firm as of December 31, 2019, and the related consolidated income statement, comprehensive income statement, cash flow statement and statement of changes in total equity for the year then ended (not presented herein) included in the Firm’s Annual Report on Form 10-K; and in our report dated February 27, 2020, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying condensed consolidated balance sheet as of December 31, 2019 is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived. Basis for Review Results This interim financial information is the responsibility of the Firm’s management. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Firm in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. We conducted our reviews in accordance with the standards of the PCAOB. A review of interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the PCAOB, the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion. /s/ Deloitte & Touche LLP New York, New York May 5, 2020 -- 41 of 93 -- Table of Contents Consolidated Income Statements (Unaudited) See Notes to Consolidated Financial Statements 39 March 2020 Form 10-Q Three Months Ended March 31, in millions, except per share data 2020 2019 Revenues Investment banking $ 1,271 $ 1,242 Trading 3,056 3,441 Investments 38 273 Commissions and fees 1,360 966 Asset management 3,417 3,049 Other (1,011) 301 Total non-interest revenues 8,131 9,272 Interest income 3,503 4,290 Interest expense 2,147 3,276 Net interest 1,356 1,014 Net revenues 9,487 10,286 Non-interest expenses Compensation and benefits 4,283 4,651 Brokerage, clearing and exchange fees 740 593 Information processing and communications 563 532 Professional services 449 514 Occupancy and equipment 365 347 Marketing and business development 132 141 Other 809 553 Total non-interest expenses 7,341 7,331 Income before provision for income taxes 2,146 2,955 Provision for income taxes 366 487 Net income $ 1,780 $ 2,468 Net income applicable to noncontrolling interests 82 39 Net income applicable to Morgan Stanley $ 1,698 $ 2,429 Preferred stock dividends 108 93 Earnings applicable to Morgan Stanley common shareholders $ 1,590 $ 2,336 Earnings per common share Basic $ 1.02 $ 1.41 Diluted $ 1.01 $ 1.39 Average common shares outstanding Basic 1,555 1,658 Diluted 1,573 1,677 -- 42 of 93 -- Table of Contents Consolidated Comprehensive Income Statements (Unaudited) March 2020 Form 10-Q 40 See Notes to Consolidated Financial Statements Three Months Ended March 31, $ in millions 2020 2019 Net income $ 1,780 $ 2,468 Other comprehensive income (loss), net of tax: Foreign currency translation adjustments (132) (22) Change in net unrealized gains (losses) on available-for-sale securities 1,325 429 Pension, postretirement and other 25 1 Change in net debt valuation adjustment 3,803 (620) Total other comprehensive income (loss) $ 5,021 $ (212) Comprehensive income $ 6,801 $ 2,256 Net income applicable to noncontrolling interests 82 39 Other comprehensive income (loss) applicable to noncontrolling interests 138 (31) Comprehensive income applicable to Morgan Stanley $ 6,581 $ 2,248 -- 43 of 93 -- Table of Contents Consolidated Balance Sheets See Notes to Consolidated Financial Statements 41 March 2020 Form 10-Q $ in millions, except share data (Unaudited) At March 31, 2020 At December 31, 2019 Assets Cash and cash equivalents $ 131,509 $ 82,171 Trading assets at fair value ($103,637 and $128,386 were pledged to various parties) 270,916 297,110 Investment securities (includes $68,871 and $62,223 at fair value) 116,157 105,725 Securities purchased under agreements to resell (includes $5 and $4 at fair value) 104,800 88,224 Securities borrowed 72,300 106,549 Customer and other receivables 74,424 55,646 Loans: Held for investment (net of allowance of $617 and $349) 131,335 118,060 Held for sale 17,362 12,577 Goodwill 7,125 7,143 Intangible assets (net of accumulated amortization of $3,281 and $3,204) 2,021 2,107 Other assets 19,846 20,117 Total assets $ 947,795 $ 895,429 Liabilities Deposits (includes $4,052 and $2,099 at fair value) $ 235,239 $ 190,356 Trading liabilities at fair value 142,076 133,356 Securities sold under agreements to repurchase (includes $775 and $733 at fair value) 45,816 54,200 Securities loaned 11,631 8,506 Other secured financings (includes $6,897 and $7,809 at fair value) 13,058 14,698 Customer and other payables 198,074 197,834 Other liabilities and accrued expenses 19,817 21,155 Borrowings (includes $57,162 and $64,461 at fair value) 194,856 192,627 Total liabilities 860,567 812,732 Commitments and contingent liabilities (see Note 13) Equity Morgan Stanley shareholders’ equity: Preferred stock 8,520 8,520 Common stock, $0.01 par value: Shares authorized: 3,500,000,000; Shares issued: 2,038,893,979; Shares outstanding: 1,575,500,507 and 1,593,973,680 20 20 Additional paid-in capital 23,428 23,935 Retained earnings 71,518 70,589 Employee stock trusts 3,088 2,918 Accumulated other comprehensive income (loss) 2,095 (2,788) Common stock held in treasury at cost, $0.01 par value (463,393,472 and 444,920,299 shares) (19,721) (18,727) Common stock issued to employee stock trusts (3,088) (2,918) Total Morgan Stanley shareholders’ equity 85,860 81,549 Noncontrolling interests 1,368 1,148 Total equity 87,228 82,697 Total liabilities and equity $ 947,795 $ 895,429 -- 44 of 93 -- Table of Contents Consolidated Statements of Changes in Total Equity (Unaudited) See Notes to Consolidated Financial Statements 42 March 2020 Form 10-Q Three Months Ended March 31, $ in millions 2020 2019 Preferred Stock Beginning and ending balance $ 8,520 $ 8,520 Common Stock Beginning and ending balance 20 20 Additional Paid-in Capital Beginning balance 23,935 23,794 Share-based award activity (507) (618) Other net increases — 2 Ending balance 23,428 23,178 Retained Earnings Beginning balance 70,589 64,175 Cumulative adjustments for accounting changes1 (100) 63 Net income applicable to Morgan Stanley 1,698 2,429 Preferred stock dividends2 (108) (93) Common stock dividends2 (561) (513) Ending balance 71,518 66,061 Employee Stock Trusts Beginning balance 2,918 2,836 Share-based award activity 170 164 Ending balance 3,088 3,000 Accumulated Other Comprehensive Income (Loss) Beginning balance (2,788) (2,292) Net change in Accumulated other comprehensive income (loss) 4,883 (181) Ending balance 2,095 (2,473) Common Stock Held In Treasury at Cost Beginning balance (18,727) (13,971) Share-based award activity 788 1,034 Repurchases of common stock and employee tax withholdings (1,782) (1,645) Ending balance (19,721) (14,582) Common Stock Issued to Employee Stock Trusts Beginning balance (2,918) (2,836) Share-based award activity (170) (164) Ending balance (3,088) (3,000) Non-Controlling Interests Beginning balance 1,148 1,160 Net income applicable to non-controlling interests 82 39 Net change in Accumulated other comprehensive income (loss) 138 (31) Ending balance 1,368 1,168 Total Equity $ 87,228 $ 81,892 1. See Notes 2 and 16 for further information regarding cumulative adjustments for accounting changes. 2. See Note 16 for information regarding dividends per share for each class of stock. -- 45 of 93 -- Table of Contents Consolidated Cash Flow Statements (Unaudited) See Notes to Consolidated Financial Statements 43 March 2020 Form 10-Q Three Months Ended March 31, $ in millions 2020 2019 Cash flows from operating activities Net income $ 1,780 $ 2,468 Adjustments to reconcile net income to net cash provided by (used for) operating activities: Stock-based compensation expense 154 293 Depreciation and amortization 824 658 Provision for (Release of) credit losses on lending activities 407 36 Other operating adjustments 1,044 (92) Changes in assets and liabilities: Trading assets, net of Trading liabilities 35,079 23,977 Securities borrowed 34,249 (22,578) Securities loaned 3,125 600 Customer and other receivables and other assets (23,619) 1,567 Customer and other payables and other liabilities (4,247) 9,971 Securities purchased under agreements to resell (16,576) 1,952 Securities sold under agreements to repurchase (8,384) (1,811) Net cash provided by (used for) operating activities 23,836 17,041 Cash flows from investing activities Proceeds from (payments for): Other assets—Premises, equipment and software, net (354) (529) Changes in loans, net (13,243) (1,329) Investment securities: Purchases (12,924) (15,895) Proceeds from sales 3,128 7,875 Proceeds from paydowns and maturities 2,378 2,663 Other investing activities (93) (12) Net cash provided by (used for) investing activities (21,108) (7,227) Cash flows from financing activities Net proceeds from (payments for): Other secured financings 259 (1,575) Deposits 44,694 (8,089) Proceeds from issuance of Borrowings 20,601 8,091 Payments for: Borrowings (14,967) (11,927) Repurchases of common stock and employee tax withholdings (1,782) (1,645) Cash dividends (688) (663) Other financing activities (163) (56) Net cash provided by (used for) financing activities 47,954 (15,864) Effect of exchange rate changes on cash and cash equivalents (1,344) (464) Net increase (decrease) in cash and cash equivalents 49,338 (6,514) Cash and cash equivalents, at beginning of period 82,171 87,196 Cash and cash equivalents, at end of period $ 131,509 $ 80,682 Supplemental Disclosure of Cash Flow Information Cash payments for: Interest $ 2,123 $ 2,896 Income taxes, net of refunds 342 245 -- 46 of 93 -- Table of Contents Notes to Consolidated Financial Statements (Unaudited) March 2020 Form 10-Q 44 1. Introduction and Basis of Presentation The Firm Morgan Stanley is a global financial services firm that maintains significant market positions in each of its business segments— Institutional Securities, Wealth Management and Investment Management. Morgan Stanley, through its subsidiaries and affiliates, provides a wide variety of products and services to a large and diversified group of clients and customers, including corporations, governments, financial institutions and individuals. Unless the context otherwise requires, the terms “Morgan Stanley” or the “Firm” mean Morgan Stanley (the “Parent Company”) together with its consolidated subsidiaries. See the “Glossary of Common Terms and Acronyms” for the definition of certain terms and acronyms used throughout this Form 10-Q. A description of the clients and principal products and services of each of the Firm’s business segments is as follows: Institutional Securities provides investment banking, sales and trading, lending and other services to corporations, governments, financial institutions and high to ultra-high net worth clients. Investment banking services consist of capital raising and financial advisory services, including services relating to the underwriting of debt, equity and other securities, as well as advice on mergers and acquisitions, restructurings, real estate and project finance. Sales and trading services include sales, financing, prime brokerage and market-making activities in equity and fixed income products, including foreign exchange and commodities. Lending activities include originating corporate loans and commercial real estate loans, providing secured lending facilities, and extending financing to sales and trading customers. Other activities include Asia wealth management services, investments and research. Wealth Management provides a comprehensive array of financial services and solutions to individual investors and small to medium-sized businesses and institutions covering: brokerage and investment advisory services; financial and wealth planning services; stock plan administration services; annuity and insurance products; securities-based lending, residential real estate loans and other lending products; banking; and retirement plan services. Investment Management provides a broad range of investment strategies and products that span geographies, asset classes, and public and private markets to a diverse group of clients across institutional and intermediary channels. Strategies and products, which are offered through a variety of investment vehicles, include equity, fixed income, liquidity and alternative/other products. Institutional clients include defined benefit/defined contribution plans, foundations, endowments, government entities, sovereign wealth funds, insurance companies, third-party fund sponsors and corporations. Individual clients are generally served through intermediaries, including affiliated and non-affiliated distributors. Basis of Financial Information The financial statements are prepared in accordance with U.S. GAAP, which requires the Firm to make estimates and assumptions regarding the valuations of certain financial instruments, the valuations of goodwill and intangible assets, the outcome of legal and tax matters, deferred tax assets, allowance for credit losses, and other matters that affect its financial statements and related disclosures. The Firm believes that the estimates utilized in the preparation of its financial statements are prudent and reasonable. Actual results could differ materially from these estimates. Certain reclassifications have been made to prior periods to conform to the current presentation. The Notes are an integral part of the Firm's financial statements. The Firm has evaluated subsequent events for adjustment to or disclosure in these financial statements through the date of this report and has not identified any recordable or disclosable events not otherwise reported in these financial statements or the notes thereto. The accompanying financial statements should be read in conjunction with the Firm’s financial statements and notes thereto included in the 2019 Form 10-K. Certain footnote disclosures included in the 2019 Form 10-K have been condensed or omitted from these financial statements as they are not required for interim reporting under U.S. GAAP. The financial statements reflect all adjustments of a normal, recurring nature that are, in the opinion of management, necessary for the fair presentation of the results for the interim period. The results of operations for interim periods are not necessarily indicative of results for the entire year. Consolidation The financial statements include the accounts of the Firm, its wholly owned subsidiaries and other entities in which the Firm has a controlling financial interest, including certain VIEs (see Note 14). Intercompany balances and transactions have been eliminated. For consolidated subsidiaries that are not wholly owned, the third-party holdings of equity interests are referred to as noncontrolling interests. The net income attributable to noncontrolling interests for such subsidiaries is presented as Net income applicable to noncontrolling interests in the income statements. The portion of shareholders’ equity that is attributable to noncontrolling interests for such subsidiaries is presented as noncontrolling interests, a component of Total equity, in the balance sheets. For a discussion of the Firm’s significant regulated U.S. and international subsidiaries and its involvement with VIEs, see Note 1 to the financial statements in the 2019 Form 10-K. -- 47 of 93 -- Table of Contents Notes to Consolidated Financial Statements (Unaudited) 45 March 2020 Form 10-Q 2. Significant Accounting Policies For a detailed discussion about the Firm’s significant accounting policies and for further information on accounting updates adopted in the prior year, see Note 2 to the financial statements in the 2019 Form 10-K. During the three months ended March 31, 2020 (“current quarter”), there were no significant revisions to the Firm’s significant accounting policies, other than for the accounting updates adopted. Accounting Updates Adopted in 2020 See Note 16 for a summary of the Retained earnings impact of this adoption. Financial Instruments — Credit Losses The Firm adopted the Financial Instruments - Credit Losses accounting update on January 1, 2020. This accounting update impacted the impairment model for certain financial assets measured at amortized cost by requiring a CECL methodology to estimate expected credit losses over the entire life of the financial asset, recorded at inception or purchase. CECL replaced the loss model currently applicable to loans held for investment, HTM securities and other receivables carried at amortized cost, such as employee loans. The update also eliminated the concept of other-than-temporary impairment for AFS securities and instead requires impairments on AFS securities to be recognized in earnings through an allowance when the fair value is less than amortized cost and a credit loss exists, and through a permanent reduction of the amortized cost basis when the securities are expected to be sold before recovery of amortized cost. For certain portfolios, we determined that there are de minimus or zero expected credit losses; for example, for lending and financing transactions, such as Securities borrowed, Securities purchased under agreements to resell and certain other portfolios where collateral arrangements are being followed. Also, we have zero expected credit losses for certain financial assets based on the credit quality of the borrower or issuer, such as U.S. government and agency securities. At transition on January 1, 2020, the adoption of this accounting standard resulted in an increase in the allowance for credit losses of $131 million with a corresponding reduction in Retained earnings of $100 million, net of tax. The adoption impact was primarily attributable to a $124 million increase in the allowance for credit losses on employee loans. The following discussion highlights changes to the Firm’s accounting policies as a result of this adoption. Instruments Measured at Amortized Cost and Certain Off- Balance Sheet Credit Exposures Allowance for Credit Losses (“ACL”) The ACL for financial instruments measured at amortized cost and certain off-balance sheet exposures (e.g., HFI loans and lending commitments, HTM securities, customer and other receivables and certain guarantees) represents an estimate of expected credit losses over the entire life of the financial instrument. Factors considered by management when determining the ACL include payment status, fair value of collateral, expected payments of principal and interest, as well as internal or external information relating to past events, current conditions and reasonable and supportable forecasts. The Firm’s forecasts include assumptions about certain macroeconomic variables including, but not limited to, U.S. gross domestic product, equity market indices, unemployment rates, as well as commercial real estate and home price indices. At the conclusion of the Firm’s reasonable and supportable forecast period of three years, there is a gradual reversion back to historical averages. The ACL is measured on a collective basis when similar risk characteristics exist for multiple instruments considering all available information relevant to assessing the collectability of cash flows. Generally, the Firm applies a probability of default (“PD”)/loss given default (“LGD”) model (“PD/LGD model”) for instruments that are collectively assessed, under which the ACL is calculated as the product of PD, LGD and exposure at default (“EAD”). These parameters are forecast for each collective group of loans using a scenario-based statistical model and at the conclusion of the Firm’s reasonable and supportable forecast period, the parameters gradually revert back to historical averages. If the instrument does not share similar risk characteristics with other instruments, including when it is probable that the Firm will be unable to collect the full payment of principal and interest on the instrument when due, the ACL is measured on an individual basis. The Firm typically applies a discounted cash flow (“DCF”) method for instruments that are individually assessed. The Firm may also elect to use an approach that considers the fair value of the collateral when measuring the ACL if the loan is collateral dependent (i.e.,repayment of the loan is expected to be provided substantially by the sale or operation of the underlying collateral and the borrower is experiencing financial difficulty). Additionally, the Firm can elect to use an approach to measure the ACL using the fair value of collateral where the borrower is required to, and reasonably expected to, continually adjust and replenish the amount of collateral securing the instrument to reflect changes in the fair value of such collateral. The Firm has -- 48 of 93 -- Table of Contents Notes to Consolidated Financial Statements (Unaudited) March 2020 Form 10-Q 46 elected to use this approach for certain securities-based loans, customer receivables representing margin loans, Securities purchased under agreements to resell and Securities borrowed. Credit quality indicators considered in developing the ACL include: • Corporate loans and Commercial real estate loans and securities: Internal risk ratings developed by CRM which are refreshed at least annually, and more frequently as necessary. These ratings generally correspond to external ratings published by S&P. The Firm also considers transaction structure, including type of collateral, collateral terms, and position of the obligation within the capital structure. In addition, for Commercial real estate, the Firm considers property type and location, net operating income, LTV ratios, among others, as well as commercial real estate price and credit spread indices and capitalization rates. • Residential real estate loans: Loan origination Fair Isaac Corporation (“FICO”) credit scores as determined by independent credit agencies in the United States and loan- to-value (“LTV”) ratios. • Employee loans: Employment status, which includes those currently employed by the Firm and for which the Firm can deduct any unpaid amounts due to it through certain compensation arrangements; and those no longer employed by the Firm where such compensation arrangements are no longer applicable. Consumer loans primarily comprise securities-based loans and therefore the Firm generally measures the ACL on such loans based on the fair value of collateral. Qualitative and environmental factors such as economic and business conditions, the nature and volume of the portfolio, and lending terms and the volume and severity of past due loans are also considered in the ACL calculations. Recognition. The Firm recognizes its ACL and provision for credit losses in its balance sheets and income statements, respectively, for on– and off–balance sheet instruments as follows. ACL Provision for credit losses Instruments measured at amortized cost (e.g., HFI loans, HTM securities and customer and other receivables) Contra asset Other revenue Employee loans Contra asset Compensation and benefits expense Off-balance sheet instruments (e.g., HFI lending commitments and certain guarantees) Other liabilities and accrued expenses Other expense Troubled Debt Restructurings (“TDRs”) The Firm may modify the terms of certain loans for economic or legal reasons related to a borrower’s financial difficulties by granting one or more concessions that the Firm would not otherwise consider. Such modifications are accounted for and reported as a TDR, except for certain modifications related to the Coronavirus Disease (“COVID-19”) as noted in “Modifications and Nonaccrual Status for Borrowers Impacted by COVID-19” herein. A loan that has been modified in a TDR is generally considered to be impaired and is evaluated individually. TDRs are also generally classified as nonaccrual and may be returned to accrual status only after the Firm expects repayment of the remaining contractual principal and interest and there is sustained repayment performance for a reasonable period. Nonaccrual The Firm places financial instruments on nonaccrual status if principal or interest is past due for a period of 90 days or more or payment of principal or interest is in doubt unless the obligation is well-secured and in the process of collection, or in certain cases when related to the Coronavirus Disease (“COVID-19”) as noted in “Modifications and Nonaccrual Status for Borrowers Impacted by COVID-19” herein. For any instrument placed on nonaccrual status, the Firm reverses any unpaid interest accrued with an offsetting reduction to Interest income. Principal and interest payments received on nonaccrual instruments are applied to principal if there is doubt regarding the ultimate collectability of principal. If collection of the principal is not in doubt, interest income is realized on a cash basis. If neither principal nor interest collection is in doubt and the instruments are brought current, instruments are generally placed on accrual status and interest income is recognized using the effective interest method. Modifications and Nonaccrual Status for Borrowers Impacted by COVID-19 In the first quarter of 2020, the Firm elected to apply the guidance issued by Congress in the Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) as well as by the U.S. banking agencies stating that certain concessions granted to borrowers that are current on existing loans, either individually or as part of a program for creditworthy borrowers who are experiencing short-term financial or operational problems as a result of the coronavirus pandemic, generally would not be considered TDRs or nonaccrual. ACL Write-offs The Firm writes-off a financial instrument in the period that it is deemed uncollectible and records a reduction in the ACL and the balance of the financial instrument in the balance sheet. However, for accrued interest receivable balances that are separately recorded from the related financial instruments, the Firm's nonaccrual policy requires that accrued interest receivable be written off against Interest income when the related financial instrument is placed in nonaccrual status. Accordingly, the Firm elected not to measure an ACL for accrued interest receivables. -- 49 of 93 -- Table of Contents Notes to Consolidated Financial Statements (Unaudited) 47 March 2020 Form 10-Q Available-for-Sale (“AFS”) Investment Securities Unrealized Losses on AFS Securities AFS securities are analyzed as part of the Firm's periodic assessment of credit losses at the individual security level. When considering if a credit loss exists, the Firm considers relevant information as discussed in Note 2 of the 2019 Form 10-K. Upon the adoption of Financial Instruments—Credit Losses, the Firm no longer considers the length of time the fair value has been less than the amortized cost basis in determining whether a credit loss exists. Recognition. The Firm recognizes its ACL and provision for credit losses for AFS securities in its balance sheets and income statements, respectively, as follows. ACL Provision for credit losses AFS securities Contra asset Other revenue The Firm recognizes the non-credit loss component of the unrealized loss as an adjustment to the security’s asset balance with an offsetting entry to AOCI in the balance sheets. For AFS securities in an unrealized loss position as of the balance sheet date that the Firm either has the intent to sell or that the Firm is likely to be required to sell before recovery of its amortized cost basis, any allowance for credit losses previously established is written off and the amortized cost basis is written down to the security’s fair value with any incremental unrealized losses reported in Other revenues. Nonaccrual & ACL Write-Offs on AFS Securities AFS securities follow the same nonaccrual and write-off guidance as discussed in “Instruments Measured at Amortized Cost and Certain Off-Balance Sheet Credit Exposures” herein. 3. Cash and Cash Equivalents Cash and cash equivalents consist of Cash and due from banks and Interest bearing deposits with banks. Cash equivalents are highly liquid investments with remaining maturities of three months or less from the acquisition date that are readily convertible to cash and are not held for trading purposes. $ in millions At March 31, 2020 At December 31, 2019 Cash and due from banks $ 11,570 $ 6,763 Interest bearing deposits with banks 119,939 75,408 Total Cash and cash equivalents $ 131,509 $ 82,171 Restricted cash $ 56,064 $ 32,512 Cash and cash equivalents also include Restricted cash such as cash in banks subject to withdrawal restrictions, restricted deposits held as compensating balances and cash segregated in compliance with federal or other regulations, including the minimum reserve requirement set by the Federal Reserve Bank and other central banks. 4. Fair Values Recurring Fair Value Measurements Assets and Liabilities Measured at Fair Value on a Recurring Basis At March 31, 2020 $ in millions Level 1 Level 2 Level 3 Netting1 Total Assets at fair value Trading assets: U.S. Treasury and agency securities $ 42,231 $ 29,105 $ 99 $ — $ 71,435 Other sovereign government obligations 29,493 5,017 17 — 34,527 State and municipal securities — 2,226 1 — 2,227 MABS — 838 483 — 1,321 Loans and lending commitments2 — 4,082 5,980 — 10,062 Corporate and other debt — 23,448 1,708 — 25,156 Corporate equities3 66,409 582 146 — 67,137 Derivative and other contracts: Interest rate 14,025 253,646 1,367 — 269,038 Credit — 12,605 753 — 13,358 Foreign exchange 26 112,711 76 — 112,813 Equity 1,041 93,175 1,560 — 95,776 Commodity and other 1,070 17,813 3,384 — 22,267 Netting1 (12,720) (376,568) (1,301) (69,653) (460,242) Total derivative and other contracts 3,442 113,382 5,839 (69,653) 53,010 Investments4 562 204 725 — 1,491 Physical commodities — 960 — — 960 Total trading assets4 142,137 179,844 14,998 (69,653) 267,326 Investment securities—AFS 35,899 32,972 — — 68,871 Securities purchased under agreements to resell — 5 — — 5 Total assets at fair value $ 178,036 $ 212,821 $ 14,998 $ (69,653) $ 336,202 -- 50 of 93 -- Table of Contents Notes to Consolidated Financial Statements (Unaudited) March 2020 Form 10-Q 48 At March 31, 2020 $ in millions Level 1 Level 2 Level 3 Netting1 Total Liabilities at fair value Deposits $ — $ 3,935 $ 117 $ — $ 4,052 Trading liabilities: U.S. Treasury and agency securities 13,273 201 16 — 13,490 Other sovereign government obligations 20,273 836 2 — 21,111 Corporate and other debt — 9,341 6 — 9,347 Corporate equities3 57,134 85 40 — 57,259 Derivative and other contracts: Interest rate 14,655 242,840 494 — 257,989 Credit — 12,631 555 — 13,186 Foreign exchange 20 112,552 226 — 112,798 Equity 1,090 89,344 2,936 — 93,370 Commodity and other 1,438 15,280 1,535 — 18,253 Netting1 (12,720) (376,568) (1,301) (64,138) (454,727) Total derivative and other contracts 4,483 96,079 4,445 (64,138) 40,869 Total trading liabilities 95,163 106,542 4,509 (64,138) 142,076 Securities sold under agreements to repurchase — 775 — — 775 Other secured financings — 6,508 389 — 6,897 Borrowings — 53,164 3,998 — 57,162 Total liabilities at fair value $ 95,163 $ 170,924 $ 9,013 $ (64,138) $ 210,962 At December 31, 2019 $ in millions Level 1 Level 2 Level 3 Netting1 Total Assets at fair value Trading assets: U.S. Treasury and agency securities $ 36,866 $ 28,992 $ 22 $ — $ 65,880 Other sovereign government obligations 23,402 4,347 5 — 27,754 State and municipal securities — 2,790 1 — 2,791 MABS — 1,690 438 — 2,128 Loans and lending commitments2 — 6,253 5,073 — 11,326 Corporate and other debt — 22,124 1,396 — 23,520 Corporate equities3 123,942 652 97 — 124,691 Derivative and other contracts: Interest rate 1,265 182,977 1,239 — 185,481 Credit — 6,658 654 — 7,312 Foreign exchange 15 64,260 145 — 64,420 Equity 1,219 48,927 922 — 51,068 Commodity and other 1,079 7,255 2,924 — 11,258 Netting1 (2,794) (235,947) (993) (47,804) (287,538) Total derivative and other contracts 784 74,130 4,891 (47,804) 32,001 Investments4 481 252 858 — 1,591 Physical commodities — 1,907 — — 1,907 Total trading assets4 185,475 143,137 12,781 (47,804) 293,589 Investment securities—AFS 32,902 29,321 — — 62,223 Securities purchased under agreements to resell — 4 — — 4 Total assets at fair value $ 218,377 $ 172,462 $ 12,781 $ (47,804) $ 355,816 At December 31, 2019 $ in millions Level 1 Level 2 Level 3 Netting1 Total Liabilities at fair value Deposits $ — $ 1,920 $ 179 $ — $ 2,099 Trading liabilities: U.S. Treasury and agency securities 11,191 34 — — 11,225 Other sovereign government obligations 21,837 1,332 1 — 23,170 Corporate and other debt — 7,410 — — 7,410 Corporate equities3 63,002 79 36 — 63,117 Derivative and other contracts: Interest rate 1,144 171,025 462 — 172,631 Credit — 7,391 530 — 7,921 Foreign exchange 6 67,473 176 — 67,655 Equity 1,200 49,062 2,606 — 52,868 Commodity and other 1,194 7,118 1,312 — 9,624 Netting1 (2,794) (235,947) (993) (42,531) (282,265) Total derivative and other contracts 750 66,122 4,093 (42,531) 28,434 Total trading liabilities 96,780 74,977 4,130 (42,531) 133,356 Securities sold under agreements to repurchase — 733 — — 733 Other secured financings — 7,700 109 — 7,809 Borrowings — 60,373 4,088 — 64,461 Total liabilities at fair value $ 96,780 $ 145,703 $ 8,506 $ (42,531) $ 208,458 MABS—Mortgage- and asset-backed securities 1. For positions with the same counterparty that cross over the levels of the fair value hierarchy, both counterparty netting and cash collateral netting are included in the column titled “Netting.” Positions classified within the same level that are with the same counterparty are netted within that level. For further information on derivative instruments and hedging activities, see Note 6. 2. For a further breakdown by type, see the following Detail of Loans and Lending Commitments at Fair Value table. 3. For trading purposes, the Firm holds or sells short equity securities issued by entities in diverse industries and of varying sizes. 4. Amounts exclude certain investments that are measured based on NAV per share, which are not classified in the fair value hierarchy. For additional disclosure about such investments, see “Net Asset Value Measurements” herein. Detail of Loans and Lending Commitments at Fair Value $ in millions At March 31, 2020 At December 31, 2019 Corporate $ 7,711 $ 8,036 Residential real estate 1,154 1,192 Commercial real estate 1,197 2,098 Total $ 10,062 $ 11,326 Unsettled Fair Value of Futures Contracts1 $ in millions At March 31, 2020 At December 31, 2019 Customer and other receivables, net $ 935 $ 365 1. These contracts are primarily Level 1, actively traded, valued based on quoted prices from the exchange and are excluded from the previous recurring fair value tables. For a description of the valuation techniques applied to the Firm’s major categories of assets and liabilities measured at fair value on a recurring basis, see Note 3 to the financial statements in the 2019 Form 10-K. During the current quarter, there were no significant revisions made to the Firm’s valuation techniques. -- 51 of 93 -- Table of Contents Notes to Consolidated Financial Statements (Unaudited) 49 March 2020 Form 10-Q Rollforward of Level 3 Assets and Liabilities Measured at Fair Value on a Recurring Basis Three Months Ended March 31, $ in millions 2020 2019 U.S. Treasury and agency securities Beginning balance $ 22 $ 54 Realized and unrealized gains (losses) 5 — Purchases 85 — Sales (21) (50) Net transfers 8 3 Ending balance $ 99 $ 7 Unrealized gains (losses) $ 5 $ — Other sovereign government obligations Beginning balance $ 5 $ 17 Realized and unrealized gains (losses) 1 — Purchases 10 2 Sales — (2) Net transfers 1 (12) Ending balance $ 17 $ 5 Unrealized gains (losses) $ 1 $ — State and municipal securities Beginning balance $ 1 $ 148 Realized and unrealized gains (losses) — 1 Purchases — 10 Sales — (44) Net transfers — (103) Ending balance $ 1 $ 12 Unrealized gains (losses) $ — $ 1 MABS Beginning balance $ 438 $ 354 Realized and unrealized gains (losses) (89) (7) Purchases 158 19 Sales (140) (83) Settlements — (3) Net transfers 116 21 Ending balance $ 483 $ 301 Unrealized gains (losses) $ (92) $ (14) Loans and lending commitments Beginning balance $ 5,073 $ 6,870 Realized and unrealized gains (losses) (102) — Purchases and originations 1,952 1,255 Sales (529) (108) Settlements (1,387) (820) Net transfers1 973 (854) Ending balance $ 5,980 $ 6,343 Unrealized gains (losses) $ (101) $ (7) Three Months Ended March 31, $ in millions 2020 2019 Corporate and other debt Beginning balance $ 1,396 $ 1,076 Realized and unrealized gains (losses) (92) 43 Purchases 585 204 Sales (177) (127) Settlements — (3) Net transfers (4) (132) Ending balance $ 1,708 $ 1,061 Unrealized gains (losses) $ (90) $ 41 Corporate equities Beginning balance $ 97 $ 95 Realized and unrealized gains (losses) (60) 6 Purchases 22 51 Sales (40) (9) Net transfers 127 9 Ending balance $ 146 $ 152 Unrealized gains (losses) $ (54) $ 7 Investments Beginning balance $ 858 $ 757 Realized and unrealized gains (losses) (63) 10 Purchases 15 10 Sales (8) (4) Net transfers (77) 201 Ending balance $ 725 $ 974 Unrealized gains (losses) $ (64) $ 14 Net derivatives: Interest rate Beginning balance $ 777 $ 618 Realized and unrealized gains (losses) 156 (48) Purchases 61 24 Issuances (7) (19) Settlements (42) (12) Net transfers (72) (12) Ending balance $ 873 $ 551 Unrealized gains (losses) $ 111 $ (43) Net derivatives: Credit Beginning balance $ 124 $ 40 Realized and unrealized gains (losses) 131 162 Purchases 26 26 Issuances (21) (442) Settlements (24) (33) Net transfers (38) (14) Ending balance $ 198 $ (261) Unrealized gains (losses) $ 123 $ 167 -- 52 of 93 -- Table of Contents Notes to Consolidated Financial Statements (Unaudited) March 2020 Form 10-Q 50 Three Months Ended March 31, $ in millions 2020 2019 Net derivatives: Foreign exchange Beginning balance $ (31) $ 75 Realized and unrealized gains (losses) (62) (113) Purchases 3 1 Issuances (8) — Settlements (8) 8 Net transfers (44) 34 Ending balance $ (150) $ 5 Unrealized gains (losses) $ (164) $ 3 Net derivatives: Equity Beginning balance $ (1,684) $ (1,485) Realized and unrealized gains (losses) 635 (191) Purchases 97 34 Issuances (144) (193) Settlements (167) 139 Net transfers (113) (64) Ending balance $ (1,376) $ (1,760) Unrealized gains (losses) $ 566 $ (203) Net derivatives: Commodity and other Beginning balance $ 1,612 $ 2,052 Realized and unrealized gains (losses) 75 43 Purchases 3 5 Issuances (3) (1) Settlements 157 (81) Net transfers 5 88 Ending balance $ 1,849 $ 2,106 Unrealized gains (losses) $ 22 $ (25) Deposits Beginning balance $ 179 $ 27 Realized and unrealized losses (gains) (6) 6 Issuances 12 24 Settlements (5) (1) Net transfers (63) 43 Ending balance $ 117 $ 99 Unrealized losses (gains) $ (6) $ 6 Nonderivative trading liabilities Beginning balance $ 37 $ 16 Realized and unrealized losses (gains) (43) (1) Purchases (82) (6) Sales 52 23 Net transfers 100 11 Ending balance $ 64 $ 43 Unrealized losses (gains) $ (43) $ (1) Other secured financings Beginning balance $ 109 $ 208 Realized and unrealized losses (gains) (12) 4 Issuances 2 — Settlements (115) (7) Net transfers 405 (52) Ending balance $ 389 $ 153 Unrealized losses (gains) $ (12) $ 4 Three Months Ended March 31, $ in millions 2020 2019 Borrowings Beginning balance $ 4,088 $ 3,806 Realized and unrealized losses (gains) (897) 287 Issuances 701 264 Settlements (234) (115) Net transfers 340 (467) Ending balance $ 3,998 $ 3,775 Unrealized losses (gains) $ (895) $ 276 Portion of Unrealized losses (gains) recorded in OCI—Change in net DVA (398) 59 1. Net transfers in the current quarter include the transfer of $857 million of equity margin loans from Level 2 to Level 3 as the unobservable input became significant. Level 3 instruments may be hedged with instruments classified in Level 1 and Level 2. The realized and unrealized gains (losses) for assets and liabilities within the Level 3 category presented in the previous tables do not reflect the related realized and unrealized gains (losses) on hedging instruments that have been classified by the Firm within the Level 1 and/or Level 2 categories. The unrealized gains (losses) during the period for assets and liabilities within the Level 3 category may include changes in fair value during the period that were attributable to both observable and unobservable inputs. Total realized and unrealized gains (losses) are primarily included in Trading revenues in the income statements. Additionally, in the previous tables, consolidations of VIEs are included in Purchases and deconsolidations of VIEs are included in Settlements. -- 53 of 93 -- Table of Contents Notes to Consolidated Financial Statements (Unaudited) 51 March 2020 Form 10-Q Significant Unobservable Inputs Used in Recurring and Nonrecurring Level 3 Fair Value Measurements Valuation Techniques and Unobservable Inputs Balance / Range (Average)1 $ in millions, except inputs At March 31, 2020 At December 31, 2019 Assets Measured at Fair Value on a Recurring Basis U.S. Treasury and agency securities $ 99 $ 22 Comparable pricing: Bond price 18 to 117 points (86 points) N/M MABS $ 483 $ 438 Comparable pricing: Bond price 0 to 87 points (43 points) 0 to 96 points (47 points) Loans and lending commitments $ 5,980 $ 5,073 Margin loan model: Discount rate 1% to 10% (2%) 1% to 9% (2%) Volatility skew 13% to 89% (58%) 15% to 80% (28%) Credit Spread 12 to 109 bps (41 bps) 9 to 39 bps (19 bps) Comparable pricing: Loan price 71 to 100 points (92 points) 69 to 100 points (93 points) Corporate and other debt $ 1,708 $ 1,396 Comparable pricing: Bond price 10 to 108 points (85 points) 11 to 108 points (84 points) Discounted cash flow: Recovery rate 51% to 62% (54% / 51%) 35% Option model: At the money volatility 21% 21% Corporate equities $ 146 $ 97 Comparable pricing: Equity price 100% 100% Investments $ 725 $ 858 Discounted cash flow: WACC 11% to 16% (14%) 8% to 17% (15%) Exit multiple 7 to 17 times (12 times) 7 to 16 times (11 times) Market approach: EBITDA multiple 7 to 22 times (9 times) 7 to 24 times (11 times) Comparable pricing: Equity price 50% to 100% (99%) 75% to 100% (99%) Net derivative and other contracts: Interest rate $ 873 $ 777 Option model: IR volatility skew 2% to 183% (68% / 70%) 24% to 156% (63% / 59%) IR curve correlation 46% to 88% (71% / 73%) 47% to 90% (72% / 72%) Bond volatility 6% to 35% (25% / 25%) 4% to 15% (13% / 14%) Inflation volatility 24% to 63% (44% / 41%) 24% to 63% (44% / 41%) IR curve 0% 1% Balance / Range (Average)1 $ in millions, except inputs At March 31, 2020 At December 31, 2019 Credit $ 198 $ 124 Credit default swap model: Cash-synthetic basis 6 points 6 points Bond price 0 to 98 points (52 points) 0 to 104 points (45 points) Credit spread 20 to 488 bps (114 bps) 9 to 469 bps (81 bps) Funding spread 204 to 278 bps (267 bps) 47 to 117 bps (84 bps) Correlation model: Credit correlation 40% to 78% (50%) 29% to 62% (36%) Foreign exchange2 $ (150) $ (31) Option model: IR - FX correlation 21% to 58% (38% / 38%) 32% to 56% (46% / 46%) IR volatility skew 2% to 183% (68% / 70%) 24% to 156% (63% / 59%) IR curve 10% 10% to 11% (10% / 10%) Contingency probability 95% 85% to 95% (94% / 95%) Equity2 $ (1,376) $ (1,684) Option model: At the money volatility 17% to 78% (45%) 9% to 90% (36%) Volatility skew -4% to 0% (-1%) -2% to 0% (-1%) Equity correlation 5% to 96% (76%) 5% to 98% (70%) FX correlation -79% to 55% (-39%) -79% to 60% (-37%) IR correlation -7% to 44% (19% / 18%) -11% to 44% (18% / 16%) Commodity and other $ 1,849 $ 1,612 Option model: Forward power price $1 to $137 ($26) per MWh $3 to $182 ($28) per MWh Commodity volatility 8% to 145% (18%) 7% to 183% (18%) Cross-commodity correlation 5% to 99% (93%) 43% to 99% (93%) Liabilities Measured at Fair Value on a Recurring Basis Deposits $ 117 $ 179 Option Model: At the money volatility 7% to 24% (7%) 16% to 37% (20%) Other secured financings $ 389 $ 109 Discounted cash flow: Funding spread 106 to 161 bps (121 bps) 111 to 124 bps (117 bps) Comparable pricing: Loan price 30 to 101 points (86 points) N/M Borrowings $ 3,998 $ 4,088 Option model: At the money volatility 5% to 55% (31%) 5% to 44% (21%) Volatility skew -2% to 0% (0%) -2% to 0% (0%) Equity correlation 39% to 98% (81%) 38% to 94% (78%) Equity - FX correlation -75% to 17% (-32%) -75% to 26% (-25%) IR - FX Correlation -27% to 7% (-5% / -5%) -26% to 10% (-7% / -7%) -- 54 of 93 -- Table of Contents Notes to Consolidated Financial Statements (Unaudited) March 2020 Form 10-Q 52 Balance / Range (Average)1 $ in millions, except inputs At March 31, 2020 At December 31, 2019 Nonrecurring Fair Value Measurement Loans $ 3,901 $ 1,500 Corporate loan model: Credit spread 44 to 600 bps (367 bps) 69 to 446 bps (225 bps) Warehouse model: Credit spread 159 to 743 bps (313 bps) 287 to 318 bps (297 bps) Points—Percentage of par IR—Interest rate FX—Foreign exchange 1. A single amount is disclosed for range and average when there is no significant difference between the minimum, maximum and average. Amounts represent weighted averages except where simple averages and the median of the inputs are more relevant. 2. Includes derivative contracts with multiple risks (i.e., hybrid products). The previous tables provide information on the valuation techniques, significant unobservable inputs, and the ranges and averages for each major category of assets and liabilities measured at fair value on a recurring and nonrecurring basis with a significant Level 3 balance. The level of aggregation and breadth of products cause the range of inputs to be wide and not evenly distributed across the inventory of financial instruments. Further, the range of unobservable inputs may differ across firms in the financial services industry because of diversity in the types of products included in each firm’s inventory. There are no predictable relationships between multiple significant unobservable inputs attributable to a given valuation technique. For a description of the Firm’s significant unobservable inputs and qualitative information about the effect of hypothetical changes in the values of those inputs, see Note 3 to the financial statements in the 2019 Form 10-K. During the current quarter, there were no significant revisions made to the descriptions of the Firm’s significant unobservable inputs. Net Asset Value Measurements Fund Interests At March 31, 2020 At December 31, 2019 $ in millions Carrying Value Commitment Carrying Value Commitment Private equity $ 2,219 $ 557 $ 2,078 $ 450 Real estate 1,280 147 1,349 150 Hedge1 91 — 94 4 Total $ 3,590 $ 704 $ 3,521 $ 604 1. Investments in hedge funds may be subject to initial period lock-up or gate provisions, which restrict an investor from withdrawing from the fund during a certain initial period or restrict the redemption amount on any redemption date, respectively. Amounts in the previous table represent the Firm’s carrying value of general and limited partnership interests in fund investments, as well as any related performance-based fees in the form of carried interest. The carrying amounts are measured based on the NAV of the fund taking into account the distribution terms applicable to the interest held. This same measurement applies whether the fund investments are accounted for under the equity method or fair value. For a description of the Firm’s investments in private equity funds, real estate funds and hedge funds, which are measured based on NAV, see Note 3 to the financial statements in the 2019 Form 10-K. See Note 13 for information regarding general partner guarantees, which include potential obligations to return performance fee distributions previously received. See Note 19 for information regarding unrealized carried interest at risk of reversal. Nonredeemable Funds by Contractual Maturity Carrying Value at March 31, 2020 $ in millions Private Equity Real Estate Less than 5 years $ 1,409 $ 431 5-10 years 759 173 Over 10 years 51 676 Total $ 2,219 $ 1,280 Nonrecurring Fair Value Measurements Carrying and Fair Values At March 31, 2020 Fair Value $ in millions Level 2 Level 31 Total Assets Loans $ 5,823 $ 3,901 $ 9,724 Liabilities Other liabilities and accrued expenses— Lending commitments $ 321 $ 247 $ 568 At December 31, 2019 Fair Value $ in millions Level 2 Level 31 Total Assets Loans $ 1,543 $ 1,500 $ 3,043 Other assets—Other investments $ — $ 113 $ 113 Total $ 1,543 $ 1,613 $ 3,156 Liabilities Other liabilities and accrued expenses— Lending commitments $ 132 $ 69 $ 201 Total $ 132 $ 69 $ 201 1. For significant Level 3 balances, refer to “Significant Unobservable Inputs Used in Recurring and Nonrecurring Level 3 Fair Value Measurements” section herein for details of the significant unobservable inputs used for nonrecurring fair value measurement. -- 55 of 93 -- Table of Contents Notes to Consolidated Financial Statements (Unaudited) 53 March 2020 Form 10-Q Gains (Losses) from Fair Value Remeasurements1 Three Months Ended March 31, $ in millions 2020 2019 Assets Loans2 $ (713) $ 36 Other assets—Other investments3 — (5) Other assets—Premises, equipment and software4 (3) (2) Total $ (716) $ 29 Liabilities Other liabilities and accrued expenses— Lending commitments2 $ (316) $ 67 Total $ (316) $ 67 1. Gains and losses for Loans and Other assets—Other investments are classified in Other revenues. For other items, gains and losses are recorded in Other revenues if the item is held for sale; otherwise, they are recorded in Other expenses. 2. Nonrecurring changes in the fair value of loans and lending commitments were calculated as follows: for the held-for-investment category, based on the value of the underlying collateral; and for the held-for-sale category, based on recently executed transactions, market price quotations, valuation models that incorporate market observable inputs where possible, such as comparable loan or debt prices and CDS spread levels adjusted for any basis difference between cash and derivative instruments, or default recovery analysis where such transactions and quotations are unobservable. 3. Losses related to Other assets—Other investments were determined using techniques that included discounted cash flow models, methodologies that incorporate multiples of certain comparable companies and recently executed transactions. 4. Losses related to Other assets—Premises, equipment and software generally include write-offs related to the disposal of certain assets. Financial Instruments Not Measured at Fair Value At March 31, 2020 Carrying Value Fair Value $ in millions Level 1 Level 2 Level 3 Total Financial assets Cash and cash equivalents $ 131,509 $ 131,509 $ — $ — $ 131,509 Investment securities—HTM 47,286 32,207 17,149 777 50,133 Securities purchased under agreements to resell 104,795 — 103,451 1,426 104,877 Securities borrowed 72,300 — 72,303 — 72,303 Customer and other receivables1 69,923 — 67,086 2,852 69,938 Loans2 148,697 — 32,529 114,841 147,370 Other assets 461 — 461 — 461 Financial liabilities Deposits $ 231,187 $ — $231,555 $ — $ 231,555 Securities sold under agreements to repurchase 45,041 — 45,077 — 45,077 Securities loaned 11,631 — 11,633 — 11,633 Other secured financings 6,161 — 6,167 — 6,167 Customer and other payables1 195,211 — 195,211 — 195,211 Borrowings 137,694 — 135,148 10 135,158 Commitment Amount Lending commitments3 $ 105,466 $ — $ 1,668 $ 1,089 $ 2,757 At December 31, 2019 Carrying Value Fair Value $ in millions Level 1 Level 2 Level 3 Total Financial assets Cash and cash equivalents $ 82,171 $ 82,171 $ — $ — $ 82,171 Investment securities— HTM 43,502 30,661 12,683 789 44,133 Securities purchased under agreements to resell 88,220 — 86,794 1,442 88,236 Securities borrowed 106,549 — 106,551 — 106,551 Customer and other receivables1 51,134 — 48,215 2,872 51,087 Loans2 130,637 — 22,293 108,059 130,352 Other assets 495 — 495 — 495 Financial liabilities Deposits $ 188,257 $ — $ 188,639 $ — $ 188,639 Securities sold under agreements to repurchase 53,467 — 53,486 — 53,486 Securities loaned 8,506 — 8,506 — 8,506 Other secured financings 6,889 — 6,800 92 6,892 Customer and other payables1 195,035 — 195,035 — 195,035 Borrowings 128,166 — 133,563 10 133,573 Commitment Amount Lending commitments3 $ 119,004 $ — $ 748 $ 338 $ 1,086 1. Accrued interest and dividend receivables and payables have been excluded. Carrying value approximates fair value for these receivables and payables. As of March 31, 2020 and December 31, 2019, accrued interest receivable was $2.4 billion and $1.7 billion, respectively. 2. Amounts include loans measured at fair value on a nonrecurring basis. 3. Represents Lending commitments accounted for as Held for Investment and Held for Sale. For a further discussion on lending commitments, see Note 13. The previous tables exclude certain financial instruments such as equity method investments and all non-financial assets and liabilities such as the value of the long-term relationships with the Firm’s deposit customers. -- 56 of 93 -- Table of Contents Notes to Consolidated Financial Statements (Unaudited) March 2020 Form 10-Q 54 5. Fair Value Option The Firm has elected the fair value option for certain eligible instruments that are risk managed on a fair value basis to mitigate income statement volatility caused by measurement basis differences between the elected instruments and their associated risk management transactions or to eliminate complexities of applying certain accounting models. Borrowings Measured at Fair Value on a Recurring Basis $ in millions At March 31, 2020 At December 31, 2019 Business Unit Responsible for Risk Management Equity $ 25,089 $ 30,214 Interest rates 25,195 27,298 Commodities 4,681 4,501 Credit 1,179 1,246 Foreign exchange 1,018 1,202 Total $ 57,162 $ 64,461 Net Revenues from Borrowings under the Fair Value Option Three Months Ended March 31, $ in millions 2020 2019 Trading revenues $ 3,447 $ (2,903) Interest expense 83 93 Net revenues1 $ 3,364 $ (2,996) 1. Amounts do not reflect any gains or losses from related economic hedges. Gains (losses) from changes in fair value are recorded in Trading revenues and are mainly attributable to movements in the reference price or index, interest rates or foreign exchange rates. Gains (Losses) Due to Changes in Instrument-Specific Credit Risk Three Months Ended March 31, 2020 2019 $ in millions Trading Revenues OCI Trading Revenues OCI Borrowings $ (5) $ 4,948 $ (4) $ (816) Loans and other debt1 (281) — 93 — Lending commitments 2 — (1) — Deposits — 72 — (4) $ in millions At March 31, 2020 At December 31, 2019 Cumulative pre-tax DVA gain (loss) recognized in AOCI $ 3,022 $ (1,998) 1. Loans and other debt instrument-specific credit gains (losses) were determined by excluding the non-credit components of gains and losses. Difference Between Contractual Principal and Fair Value1 $ in millions At March 31, 2020 At December 31, 2019 Loans and other debt2 $ 13,654 $ 13,037 Nonaccrual loans2 11,014 10,849 Borrowings3 798 (1,665) 1. Amounts indicate contractual principal greater than or (less than) fair value. 2. The majority of the difference between principal and fair value amounts for loans and other debt relates to distressed debt positions purchased at amounts well below par. 3. Excludes borrowings where the repayment of the initial principal amount fluctuates based on changes in a reference price or index. The previous tables exclude non-recourse debt from consolidated VIEs, liabilities related to transfers of financial assets treated as collateralized financings, pledged commodities and other liabilities that have specified assets attributable to them. Fair Value Loans on Nonaccrual Status $ in millions At March 31, 2020 At December 31, 2019 Nonaccrual loans $ 1,150 $ 1,100 Nonaccrual loans 90 or more days past due $ 262 $ 330 -- 57 of 93 -- Table of Contents Notes to Consolidated Financial Statements (Unaudited) 55 March 2020 Form 10-Q 6. Derivative Instruments and Hedging Activities Fair Values of Derivative Contracts At March 31, 2020 Assets $ in millions Bilateral OTC Cleared OTC Exchange- Traded Total Designated as accounting hedges Interest rate $ 1,295 $ 7 $ — $ 1,302 Foreign exchange 152 83 — 235 Total 1,447 90 — 1,537 Not designated as accounting hedges Interest rate 252,956 13,730 1,050 267,736 Credit 10,204 3,154 — 13,358 Foreign exchange 109,212 3,191 175 112,578 Equity 44,289 — 51,487 95,776 Commodity and other 17,778 — 4,489 22,267 Total 434,439 20,075 57,201 511,715 Total gross derivatives $ 435,886 $ 20,165 $ 57,201 $ 513,252 Amounts offset Counterparty netting (328,104) (16,673) (54,079) (398,856) Cash collateral netting (59,531) (1,855) — (61,386) Total in Trading assets $ 48,251 $ 1,637 $ 3,122 $ 53,010 Amounts not offset1 Financial instruments collateral (23,868) — — (23,868) Other cash collateral (83) — — (83) Net amounts $ 24,300 $ 1,637 $ 3,122 $ 29,059 Net amounts for which master netting or collateral agreements are not in place or may not be legally enforceable $ 3,984 Liabilities $ in millions Bilateral OTC Cleared OTC Exchange- Traded Total Designated as accounting hedges Interest rate $ — $ — $ — $ — Foreign exchange 54 2 — 56 Total 54 2 — 56 Not designated as accounting hedges Interest rate 245,978 10,698 1,313 257,989 Credit 9,556 3,630 — 13,186 Foreign exchange 109,225 3,336 181 112,742 Equity 39,606 — 53,764 93,370 Commodity and other 13,661 — 4,592 18,253 Total 418,026 17,664 59,850 495,540 Total gross derivatives $ 418,080 $ 17,666 $ 59,850 $ 495,596 Amounts offset Counterparty netting (328,104) (16,673) (54,079) (398,856) Cash collateral netting (55,307) (564) — (55,871) Total in Trading liabilities $ 34,669 $ 429 $ 5,771 $ 40,869 Amounts not offset1 Financial instruments collateral (8,357) — (3,825) (12,182) Other cash collateral (34) (37) — (71) Net amounts $ 26,278 $ 392 $ 1,946 $ 28,616 Net amounts for which master netting or collateral agreements are not in place or may not be legally enforceable 5,601 At December 31, 2019 Assets $ in millions Bilateral OTC Cleared OTC Exchange- Traded Total Designated as accounting hedges Interest rate $ 673 $ — $ — $ 673 Foreign exchange 41 1 — 42 Total 714 1 — 715 Not designated as accounting hedges Interest rate 179,450 4,839 519 184,808 Credit 4,895 2,417 — 7,312 Foreign exchange 62,957 1,399 22 64,378 Equity 27,621 — 23,447 51,068 Commodity and other 9,306 — 1,952 11,258 Total 284,229 8,655 25,940 318,824 Total gross derivatives $ 284,943 $ 8,656 $ 25,940 $ 319,539 Amounts offset Counterparty netting (213,710) (7,294) (24,037) (245,041) Cash collateral netting (41,222) (1,275) — (42,497) Total in Trading assets $ 30,011 $ 87 $ 1,903 $ 32,001 Amounts not offset1 Financial instruments collateral (15,596) — — (15,596) Other cash collateral (46) — — (46) Net amounts $ 14,369 $ 87 $ 1,903 $ 16,359 Net amounts for which master netting or collateral agreements are not in place or may not be legally enforceable $ 1,900 Liabilities $ in millions Bilateral OTC Cleared OTC Exchange- Traded Total Designated as accounting hedges Interest rate $ 1 $ — $ — $ 1 Foreign exchange 121 38 — 159 Total 122 38 — 160 Not designated as accounting hedges Interest rate 168,597 3,597 436 172,630 Credit 4,798 3,123 — 7,921 Foreign exchange 65,965 1,492 39 67,496 Equity 30,135 — 22,733 52,868 Commodity and other 7,713 — 1,911 9,624 Total 277,208 8,212 25,119 310,539 Total gross derivatives $ 277,330 $ 8,250 $ 25,119 $ 310,699 Amounts offset Counterparty netting (213,710) (7,294) (24,037) (245,041) Cash collateral netting (36,392) (832) — (37,224) Total in Trading liabilities $ 27,228 $ 124 $ 1,082 $ 28,434 Amounts not offset1 Financial instruments collateral (7,747) — (287) (8,034) Other cash collateral (14) — — (14) Net amounts $ 19,467 $ 124 $ 795 $ 20,386 Net amounts for which master netting or collateral agreements are not in place or may not be legally enforceable $ 3,680 1. Amounts relate to master netting agreements and collateral agreements that have been determined by the Firm to be legally enforceable in the event of default but where certain other criteria are not met in accordance with applicable offsetting accounting guidance. See Note 4 for information related to the unsettled fair value of futures contracts not designated as accounting hedges, which are excluded from the previous tables. -- 58 of 93 -- Table of Contents Notes to Consolidated Financial Statements (Unaudited) March 2020 Form 10-Q 56 Notionals of Derivative Contracts At March 31, 2020 Assets $ in billions Bilateral OTC Cleared OTC Exchange- Traded Total Designated as accounting hedges Interest rate $ 10 $ 144 $ — $ 154 Foreign exchange 5 2 — 7 Total 15 146 — 161 Not designated as accounting hedges Interest rate 4,261 8,028 615 12,904 Credit 173 111 — 284 Foreign exchange 3,054 104 10 3,168 Equity 426 — 453 879 Commodity and other 111 — 72 183 Total 8,025 8,243 1,150 17,418 Total gross derivatives $ 8,040 $ 8,389 $ 1,150 $ 17,579 Liabilities $ in billions Bilateral OTC Cleared OTC Exchange- Traded Total Designated as accounting hedges Interest rate $ — $ 43 $ — $ 43 Foreign exchange 6 — — 6 Total 6 43 — 49 Not designated as accounting hedges Interest rate 5,085 8,023 545 13,653 Credit 164 124 — 288 Foreign exchange 2,981 104 9 3,094 Equity 352 — 541 893 Commodity and other 89 — 69 158 Total 8,671 8,251 1,164 18,086 Total gross derivatives $ 8,677 $ 8,294 $ 1,164 $ 18,135 At December 31, 2019 Assets $ in billions Bilateral OTC Cleared OTC Exchange- Traded Total Designated as accounting hedges Interest rate $ 14 $ 94 $ — $ 108 Foreign exchange 2 — — 2 Total 16 94 — 110 Not designated as accounting hedges Interest rate 4,230 7,398 732 12,360 Credit 136 79 — 215 Foreign exchange 2,667 91 10 2,768 Equity 429 — 419 848 Commodity and other 99 — 61 160 Total 7,561 7,568 1,222 16,351 Total gross derivatives $ 7,577 $ 7,662 $ 1,222 $ 16,461 Liabilities $ in billions Bilateral OTC Cleared OTC Exchange- Traded Total Designated as accounting hedges Interest rate $ — $ 71 $ — $ 71 Foreign exchange 9 2 — 11 Total 9 73 — 82 Not designated as accounting hedges Interest rate 4,185 6,866 666 11,717 Credit 153 84 — 237 Foreign exchange 2,841 91 14 2,946 Equity 455 — 515 970 Commodity and other 85 — 61 146 Total 7,719 7,041 1,256 16,016 Total gross derivatives $ 7,728 $ 7,114 $ 1,256 $ 16,098 The Firm believes that the notional amounts of derivative contracts generally overstate its exposure. In most circumstances, notional amounts are used only as a reference point from which to calculate amounts owed between the parties to the contract. Furthermore, notional amounts do not reflect the benefit of legally enforceable netting arrangements or risk mitigating transactions. For a discussion of the Firm's derivative instruments and hedging activities, see Note 5 to the financial statements in the 2019 Form 10-K. -- 59 of 93 -- Table of Contents Notes to Consolidated Financial Statements (Unaudited) 57 March 2020 Form 10-Q Gains (Losses) on Accounting Hedges Three Months Ended March 31, $ in millions 2020 2019 Fair value hedges—Recognized in Interest income Interest rate contracts $ (64) $ (5) Investment Securities—AFS 65 5 Fair value hedges—Recognized in Interest expense Interest rate contracts $ 6,667 $ 1,577 Deposits1 (261) — Borrowings (6,432) (1,621) Net investment hedges—Foreign exchange contracts Recognized in OCI $ 410 $ 64 Forward points excluded from hedge effectiveness testing—Recognized in Interest income 33 35 Fair Value Hedges—Hedged Items $ in millions At March 31, 2020 At December 31, 2019 Investment Securities—AFS Carrying amount2 currently or previously hedged $ 1,969 $ 917 Basis adjustments included in carrying amount3 $ 77 $ 14 Deposits1 Carrying amount currently or previously hedged 18,335 5,435 Basis adjustments included in carrying amount3 254 (7) Borrowings Carrying amount currently or previously hedged $ 109,810 $ 102,456 Basis adjustments included in carrying amount3 $ 9,007 $ 2,593 1. The Firm began designating interest rate swaps as fair value hedges of certain Deposits in the fourth quarter of 2019. 2. Carrying amount represents amortized cost basis for AFS securities. 3. Hedge accounting basis adjustments are primarily related to outstanding hedges. Net Derivative Liabilities and Collateral Posted $ in millions At March 31, 2020 At December 31, 2019 Net derivative liabilities with credit risk- related contingent features $ 33,064 $ 21,620 Collateral posted 28,502 17,392 The previous table presents the aggregate fair value of certain derivative contracts that contain credit risk-related contingent features that are in a net liability position for which the Firm has posted collateral in the normal course of business. Incremental Collateral and Termination Payments upon Potential Future Ratings Downgrade $ in millions At March 31, 2020 One-notch downgrade $ 325 Two-notch downgrade 377 Bilateral downgrade agreements included in the amounts above1 $ 614 1. Amount represents arrangements between the Firm and other parties where upon the downgrade of one party, the downgraded party must deliver collateral to the other party. These bilateral downgrade arrangements are used by the Firm to manage the risk of counterparty downgrades. The additional collateral or termination payments that may be called in the event of a future credit rating downgrade vary by contract and can be based on ratings by either or both of Moody’s Investors Service, Inc. (“Moody’s”) and S&P Global Ratings. The previous table shows the future potential collateral amounts and termination payments that could be called or required by counterparties or exchange and clearing organizations in the event of one-notch or two-notch downgrade scenarios based on the relevant contractual downgrade triggers. Maximum Potential Payout/Notional of Credit Protection Sold1 Years to Maturity at March 31, 2020 $ in billions < 1 1-3 3-5 Over 5 Total Single-name CDS Investment grade $ 13 $ 17 $ 34 $ 13 $ 77 Non-investment grade 9 9 16 5 39 Total $ 22 $ 26 $ 50 $ 18 $ 116 Index and basket CDS Investment grade $ 5 $ 8 $ 65 $ 34 $ 112 Non-investment grade 7 5 21 17 50 Total $ 12 $ 13 $ 86 $ 51 $ 162 Total CDS sold $ 34 $ 39 $ 136 $ 69 $ 278 Other credit contracts — — — — — Total credit protection sold $ 34 $ 39 $ 136 $ 69 $ 278 CDS protection sold with identical protection purchased $ 242 Years to Maturity at December 31, 2019 $ in billions < 1 1-3 3-5 Over 5 Total Single-name CDS Investment grade $ 16 $ 17 $ 33 $ 9 $ 75 Non-investment grade 9 9 16 1 35 Total $ 25 $ 26 $ 49 $ 10 $ 110 Index and basket CDS Investment grade $ 4 $ 7 $ 46 $ 11 $ 68 Non-investment grade 7 4 17 10 38 Total $ 11 $ 11 $ 63 $ 21 $ 106 Total CDS sold $ 36 $ 37 $ 112 $ 31 $ 216 Other credit contracts — — — — — Total credit protection sold $ 36 $ 37 $ 112 $ 31 $ 216 CDS protection sold with identical protection purchased $ 187 -- 60 of 93 -- Table of Contents Notes to Consolidated Financial Statements (Unaudited) March 2020 Form 10-Q 58 Fair Value Asset (Liability) of Credit Protection Sold1 $ in millions At March 31, 2020 At December 31, 2019 Single-name CDS Investment grade $ (963) $ 1,057 Non-investment grade (3,350) (540) Total $ (4,313) $ 517 Index and basket CDS Investment grade $ (693) $ 1,052 Non-investment grade (4,849) 134 Total $ (5,542) $ 1,186 Total CDS sold $ (9,855) $ 1,703 Other credit contracts (4) (17) Total credit protection sold $ (9,859) $ 1,686 1. Investment grade/non-investment grade determination is based on the internal credit rating of the reference obligation. Internal credit ratings serve as the Credit Risk Management Department’s assessment of credit risk and the basis for a comprehensive credit limits framework used to control credit risk. The Firm uses quantitative models and judgment to estimate the various risk parameters related to each obligor. Protection Purchased with CDS Notional $ in billions At March 31, 2020 At December 31, 2019 Single name $ 123 $ 118 Index and basket 153 103 Tranched index and basket 18 15 Total $ 294 $ 236 Fair Value Asset (Liability) $ in millions At March 31, 2020 At December 31, 2019 Single name $ 4,152 $ (723) Index and basket 5,176 (1,139) Tranched index and basket 699 (450) Total $ 10,027 $ (2,312) The Firm enters into credit derivatives, principally CDS, under which it receives or provides protection against the risk of default on a set of debt obligations issued by a specified reference entity or entities. A majority of the Firm’s counterparties for these derivatives are banks, broker-dealers, and insurance and other financial institutions. The fair value amounts as shown in the previous tables are prior to cash collateral or counterparty netting. For further information on credit derivatives and other contracts, see Note 5 to the financial statements in the 2019 Form 10-K. -- 61 of 93 -- Table of Contents Notes to Consolidated Financial Statements (Unaudited) 59 March 2020 Form 10-Q 7. Investment Securities AFS and HTM Securities At March 31, 2020 $ in millions Amortized Cost1 Gross Unrealized Gains Gross Unrealized Losses Fair Value AFS securities U.S. government and agency securities: U.S. Treasury securities $ 34,600 $ 1,298 $ — $ 35,898 U.S. agency securities2 22,687 717 82 23,322 Total U.S. government and agency securities 57,287 2,015 82 59,220 Corporate and other debt: Agency CMBS 4,765 244 8 5,001 Corporate bonds 1,828 16 35 1,809 State and municipal securities 1,453 48 48 1,453 FFELP student loan ABS3 1,535 — 147 1,388 Total corporate and other debt 9,581 308 238 9,651 Total AFS securities 66,868 2,323 320 68,871 HTM securities U.S. government and agency securities: U.S. Treasury securities 29,951 2,256 — 32,207 U.S. agency securities2 16,542 607 — 17,149 Total U.S. government and agency securities 46,493 2,863 — 49,356 Corporate and other debt: Non-agency CMBS 793 4 20 777 Total HTM securities 47,286 2,867 20 50,133 Total investment securities $ 114,154 $ 5,190 $ 340 $ 119,004 At December 31, 2019 $ in millions Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Value AFS securities U.S. government and agency securities: U.S. Treasury securities $ 32,465 $ 224 $ 111 $ 32,578 U.S. agency securities2 20,725 249 100 20,874 Total U.S. government and agency securities 53,190 473 211 53,452 Corporate and other debt: Agency CMBS 4,810 55 57 4,808 Corporate bonds 1,891 17 1 1,907 State and municipal securities 481 22 — 503 FFELP student loan ABS3 1,580 1 28 1,553 Total corporate and other debt 8,762 95 86 8,771 Total AFS securities 61,952 568 297 62,223 HTM securities U.S. government and agency securities: U.S. Treasury securities 30,145 568 52 30,661 U.S. agency securities2 12,589 151 57 12,683 Total U.S. government and agency securities 42,734 719 109 43,344 Corporate and other debt: Non-agency CMBS 768 22 1 789 Total HTM securities 43,502 741 110 44,133 Total investment securities $ 105,454 $ 1,309 $ 407 $ 106,356 1. Amounts are net of any allowance for credit losses. 2. U.S. agency securities consist mainly of agency-issued debt, agency mortgage pass- through pool securities and CMOs. 3. Underlying loans are backed by a guarantee, ultimately from the U.S. Department of Education, of at least 95% of the principal balance and interest outstanding. In the current quarter, the Firm transferred certain municipal securities from Trading assets into AFS securities as a result of a change in intent due to the severe deterioration in liquidity for these instruments. At March 31, 2020, these securities had a fair value of $441 million. -- 62 of 93 -- Table of Contents Notes to Consolidated Financial Statements (Unaudited) March 2020 Form 10-Q 60 Investment Securities in an Unrealized Loss Position At March 31, 2020 Less than 12 Months 12 Months or Longer Total $ in millions Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses AFS securities U.S. agency securities $ 931 $ 7 $ 3,892 $ 75 $ 4,823 $ 82 Corporate and other debt: Agency CMBS 30 — 670 8 700 8 Corporate bonds 747 24 58 11 805 35 State and municipal securities 678 48 — — 678 48 FFELP student loan ABS 349 29 1,038 118 1,387 147 Total corporate and other debt 1,804 101 1,766 137 3,570 238 Total AFS securities $ 2,735 $ 108 $ 5,658 $ 212 $ 8,393 $ 320 At December 31, 2019 Less than 12 Months 12 Months or Longer Total $ in millions Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses Fair Value Gross Unrealized Losses AFS securities U.S. government and agency securities: U.S. Treasury securities $ 4,793 $ 28 $ 7,904 $ 83 $ 12,697 $ 111 U.S. agency securities 2,641 20 7,697 80 10,338 100 Total U.S. government and agency securities 7,434 48 15,601 163 23,035 211 Corporate and other debt: Agency CMBS 2,294 26 681 31 2,975 57 Corporate bonds 194 1 44 — 238 1 FFELP student loan ABS 91 — 1,165 28 1,256 28 Total corporate and other debt 2,579 27 1,890 59 4,469 86 Total AFS securities 10,013 75 17,491 222 27,504 297 HTM securities U.S. government and agency securities: U.S. Treasury securities 6,042 52 651 — 6,693 52 U.S. agency securities 2,524 18 2,420 39 4,944 57 Total U.S. government and agency securities 8,566 70 3,071 39 11,637 109 Corporate and other debt: Non-agency CMBS 167 1 65 — 232 1 Total HTM securities 8,733 71 3,136 39 11,869 110 Total investment securities $ 18,746 $ 146 $ 20,627 $ 261 $ 39,373 $ 407 For AFS securities, the Firm believes there are no securities in an unrealized loss position that have credit losses after performing the analysis described in Note 2. Additionally, the Firm does not intend to sell the securities and is not likely to be required to sell the securities prior to recovery of the amortized cost basis. Furthermore, the securities have not experienced credit losses as they are predominantly investment-grade and the Firm expects to recover the amortized cost basis. As of March 31, 2020, the HTM securities net carrying amount reflects an amortized cost of $47,312 million less an allowance for credit losses of $26 million related to Non-agency CMBS. See Note 2 for a description of the ACL methodology used beginning in 2020 following the Firm's adoption of CECL and see Note 2 to the financial statements in the 2019 Form 10-K for prior period credit loss considerations. There were no securities in an unrealized loss position as of December 31, 2019 that had credit losses. As of March 31, 2020, and December 31, 2019, Non-Agency CMBS HTM securities were all on accrual status and were predominantly investment-grade. See Note 14 for additional information on securities issued by VIEs, including U.S. agency mortgage-backed securities, non- agency CMBS and FFELP student loan ABS. -- 63 of 93 -- Table of Contents Notes to Consolidated Financial Statements (Unaudited) 61 March 2020 Form 10-Q Investment Securities by Contractual Maturity At March 31, 2020 $ in millions Amortized Cost1 Fair Value Annualized Average Yield AFS securities U.S. government and agency securities: U.S. Treasury securities: Due within 1 year $ 3,728 $ 3,770 2.0% After 1 year through 5 years 27,748 28,791 1.7% After 5 years through 10 years 3,124 3,337 1.6% Total 34,600 35,898 U.S. agency securities: Due within 1 year 235 236 0.8% After 1 year through 5 years 78 78 1.4% After 5 years through 10 years 1,293 1,322 1.8% After 10 years 21,081 21,686 2.3% Total 22,687 23,322 Total U.S. government and agency securities 57,287 59,220 1.9% Corporate and other debt: Agency CMBS: After 1 year through 5 years 599 605 1.8% After 5 years through 10 years 3,273 3,488 2.5% After 10 years 893 908 2.0% Total 4,765 5,001 Corporate bonds: Due within 1 year 44 44 2.3% After 1 year through 5 years 1,439 1,439 2.6% After 5 years through 10 years 345 326 2.9% Total 1,828 1,809 State and municipal securities: After 1 year through 5 years 2 2 3.4% After 5 years through 10 years 139 142 3.1% After 10 Years 1,312 1,309 2.8% Total 1,453 1,453 FFELP student loan ABS: After 1 year through 5 years 98 87 0.8% After 5 years through 10 years 307 270 0.9% After 10 years 1,130 1,031 1.2% Total 1,535 1,388 Total corporate and other debt 9,581 9,651 2.3% Total AFS securities 66,868 68,871 2.0% At March 31, 2020 $ in millions Amortized Cost1 Fair Value Annualized Average Yield HTM securities U.S. government and agency securities: U.S. Treasury securities: Due within 1 year 3,282 3,332 2.6% After 1 year through 5 years 17,769 18,733 2.0% After 5 years through 10 years 7,818 8,777 2.2% After 10 years 1,082 1,365 2.5% Total 29,951 32,207 U.S. agency securities: After 5 years through 10 years 50 51 1.8% After 10 years 16,492 17,098 2.4% Total 16,542 17,149 Total U.S. government and agency securities 46,493 49,356 2.2% Corporate and other debt: Non-agency CMBS: Due within 1 year 100 99 4.8% After 1 year through 5 years 107 104 3.7% After 5 years through 10 years 549 536 3.9% After 10 years 37 38 4.4% Total corporate and other debt 793 777 4.0% Total HTM securities 47,286 50,133 2.3% Total investment securities $ 114,154 $ 119,004 2.1% 1. Amounts are net of any allowance for credit losses. Gross Realized Gains (Losses) on Sales of AFS Securities Three Months Ended March 31, $ in millions 2020 2019 Gross realized gains $ 49 $ 19 Gross realized (losses) (8) (9) Total1 $ 41 $ 10 1. Realized gains and losses are recognized in Other revenues in the income statements. -- 64 of 93 -- Table of Contents Notes to Consolidated Financial Statements (Unaudited) March 2020 Form 10-Q 62 8. Collateralized Transactions Offsetting of Certain Collateralized Transactions At March 31, 2020 $ in millions Gross Amounts Amounts Offset Net Amounts Presented Amounts Not Offset1 Net Amounts Assets Securities purchased under agreements to resell $249,124 $ (144,324) $ 104,800 $ (98,800) $ 6,000 Securities borrowed 76,276 (3,976) 72,300 (67,384) 4,916 Liabilities Securities sold under agreements to repurchase $189,937 $ (144,121) $ 45,816 $ (39,114) $ 6,702 Securities loaned 15,810 (4,179) 11,631 (11,241) 390 Net amounts for which master netting agreements are not in place or may not be legally enforceable Securities purchased under agreements to resell $ 5,403 Securities borrowed 1,010 Securities sold under agreements to repurchase 5,325 Securities loaned 134 At December 31, 2019 $ in millions Gross Amounts Amounts Offset Net Amounts Presented Amounts Not Offset1 Net Amounts Assets Securities purchased under agreements to resell $247,545 $ (159,321) $ 88,224 $ (85,200) $ 3,024 Securities borrowed 109,528 (2,979) 106,549 (101,850) 4,699 Liabilities Securities sold under agreements to repurchase $213,519 $ (159,319) $ 54,200 $ (44,549) $ 9,651 Securities loaned 11,487 (2,981) 8,506 (8,324) 182 Net amounts for which master netting agreements are not in place or may not be legally enforceable Securities purchased under agreements to resell $ 2,255 Securities borrowed 1,181 Securities sold under agreements to repurchase 8,033 Securities loaned 101 1. Amounts relate to master netting agreements that have been determined by the Firm to be legally enforceable in the event of default but where certain other criteria are not met in accordance with applicable offsetting accounting guidance. For further discussion of the Firm’s collateralized transactions, see Note 7 to the financial statements in the 2019 Form 10-K. For information related to offsetting of derivatives, see Note 6. Gross Secured Financing Balances by Remaining Contractual Maturity At March 31, 2020 $ in millions Overnight and Open Less than 30 Days 30-90 Days Over 90 Days Total Securities sold under agreements to repurchase $ 65,591 $ 60,940 $25,746 $ 37,660 $189,937 Securities loaned 6,824 214 2,034 6,738 15,810 Total included in the offsetting disclosure $ 72,415 $ 61,154 $27,780 $ 44,398 $205,747 Trading liabilities— Obligation to return securities received as collateral 15,270 — — — 15,270 Total $ 87,685 $ 61,154 $27,780 $ 44,398 $221,017 At December 31, 2019 $ in millions Overnight and Open Less than 30 Days 30-90 Days Over 90 Days Total Securities sold under agreements to repurchase $ 67,158 $ 81,300 $26,904 $ 38,157 $213,519 Securities loaned 2,378 3,286 516 5,307 11,487 Total included in the offsetting disclosure $ 69,536 $ 84,586 $27,420 $ 43,464 $225,006 Trading liabilities— Obligation to return securities received as collateral 23,877 — — — 23,877 Total $ 93,413 $ 84,586 $27,420 $ 43,464 $248,883 Gross Secured Financing Balances by Class of Collateral Pledged $ in millions At March 31, 2020 At December 31, 2019 Securities sold under agreements to repurchase U.S. Treasury and agency securities $ 77,557 $ 68,895 State and municipal securities 689 905 Other sovereign government obligations 88,871 109,414 ABS 2,278 2,218 Corporate and other debt 7,369 6,066 Corporate equities 12,710 25,563 Other 463 458 Total $ 189,937 $ 213,519 Securities loaned Other sovereign government obligations $ 4,876 $ 3,026 Corporate equities 10,277 8,422 Other 657 39 Total $ 15,810 $ 11,487 Total included in the offsetting disclosure $ 205,747 $ 225,006 Trading liabilities—Obligation to return securities received as collateral Corporate equities $ 15,263 $ 23,873 Other 7 4 Total $ 15,270 $ 23,877 Total $ 221,017 $ 248,883 -- 65 of 93 -- Table of Contents Notes to Consolidated Financial Statements (Unaudited) 63 March 2020 Form 10-Q Carrying Value of Assets Loaned or Pledged without Counterparty Right to Sell or Repledge $ in millions At March 31, 2020 At December 31, 2019 Trading assets $ 40,345 $ 41,201 Loans (before allowance for credit losses) 1,158 750 Total $ 41,503 $ 41,951 The Firm pledges certain of its trading assets and loans to collateralize securities sold under agreements to repurchase, securities loaned, other secured financings and derivatives and to cover customer short sales. Counterparties may or may not have the right to sell or repledge the collateral. Pledged financial instruments that can be sold or repledged by the secured party are identified as Trading assets (pledged to various parties) in the balance sheets. Fair Value of Collateral Received with Right to Sell or Repledge $ in millions At March 31, 2020 At December 31, 2019 Collateral received with right to sell or repledge $ 604,450 $ 679,280 Collateral that was sold or repledged1 483,708 539,412 1. Does not include securities used to meet federal regulations for the Firm’s U.S. broker- dealers. Segregated Securities $ in millions At March 31, 2020 At December 31, 2019 Segregated securities1 35,491 25,061 1. Securities segregated under federal regulations for the Firm’s U.S. broker-dealers are sourced from Securities purchased under agreements to resell and Trading assets in the balance sheets. The Firm receives collateral in the form of securities in connection with securities purchased under agreements to resell, securities borrowed, securities-for-securities transactions, derivative transactions, customer margin loans and securities- based lending. In many cases, the Firm is permitted to sell or repledge this collateral to secure securities sold under agreements to repurchase, to enter into securities lending and derivative transactions or for delivery to counterparties to cover short positions. Customer Margin Lending $ in millions At March 31, 2020 At December 31, 2019 Customer receivables representing margin loans $ 26,181 $ 31,916 The Firm provides margin lending arrangements which allow customers to borrow against the value of qualifying securities. Receivables under margin lending arrangements are included within Customer and other receivables in the balance sheets. Under these agreements and transactions, the Firm receives collateral, which includes U.S. government and agency securities, other sovereign government obligations, corporate and other debt, and corporate equities. Customer receivables generated from margin lending activities are collateralized by customer-owned securities held by the Firm. The Firm monitors required margin levels and established credit terms daily and, pursuant to such guidelines, requires customers to deposit additional collateral, or reduce positions, when necessary. For a further discussion of the Firm’s margin lending activities, see Note 7 to the financial statements in the 2019 Form 10-K. The Firm has additional secured liabilities. For a further discussion of other secured financings, see Note 12. 9. Loans, Lending Commitments and Related Allowance for Credit Losses Loans by Type At March 31, 2020 $ in millions Loans Held for Investment Loans Held for Sale Total Loans Corporate1 $ 61,474 $ 15,525 $ 76,999 Consumer2 31,948 — 31,948 Residential real estate 31,100 14 31,114 Commercial real estate 7,430 1,823 9,253 Total loans, before allowance 131,952 17,362 149,314 Allowance for credit losses (617) — (617) Total loans, net $ 131,335 $ 17,362 $ 148,697 Fixed rate loans, net $ 25,155 Floating or adjustable rate loans, net 123,542 Loans to non-U.S. borrowers, net 24,633 -- 66 of 93 -- Table of Contents Notes to Consolidated Financial Statements (Unaudited) March 2020 Form 10-Q 64 At December 31, 2019 $ in millions Loans Held for Investment Loans Held for Sale Total Loans Corporate1 $ 48,756 $ 10,515 $ 59,271 Consumer2 31,610 — 31,610 Residential real estate 30,184 13 30,197 Commercial real estate 7,859 2,049 9,908 Total loans, before allowance 118,409 12,577 130,986 Allowance for credit losses (349) — (349) Total loans, net $ 118,060 $ 12,577 $ 130,637 Fixed rate loans, net $ 22,716 Floating or adjustable rate loans, net 107,921 Loans to non-U.S. borrowers, net 21,617 1. Institutional Securities business segment Corporate loans include relationship and event-driven loans, secured lending facilities and securities-based lending and other loans. Wealth Management business segment Corporate loans include securities- based and other loans, which are classified as Corporate based on the nature of the borrowing entity or the intended use of the loan proceeds. 2. Wealth Management business segment Consumer loans include securities-based lending and other loans. Loans Held for Investment before Allowance by Origination Year At March 31, 2020 Corporate $ in millions AA-A BBB BB Other NIG Total Revolving Loans $ 3,418 $ 16,474 $ 19,772 $ 8,193 $ 47,857 2020 YTD 122 671 456 23 1,272 2019 631 1,234 1,940 444 4,249 2018 37 2,083 1,096 493 3,709 2017 358 639 500 82 1,579 2016 74 547 505 60 1,186 Prior 641 311 595 75 1,622 Total $ 5,281 $ 21,959 $ 24,864 $ 9,370 $ 61,474 At March 31, 2020 $ in millions Consumer1 Revolving Loans $ 31,362 2020 YTD 62 2019 382 2018 — 2017 16 2016 57 Prior 69 Total $ 31,948 1. Consumer loans primarily comprise securities-based loans, which are subject to collateral maintenance provisions, and at March 31, 2020, these loans are predominantly over-collateralized. For more information on the ACL methodology related to Consumer loans, see Note 2. At March 31, 2020 Residential Real Estate by FICO Scores by LTV Ratio Total $ in millions 680-739 > 80% Revolving Loans $ 103 $ 40 $ 6 $ 149 $ — $ 149 2020 YTD 1,865 369 35 2,143 126 2,269 2019 6,239 1,397 179 7,290 525 7,815 2018 2,699 770 90 3,277 282 3,559 2017 3,248 817 116 3,882 299 4,181 2016 3,924 1,074 152 4,804 346 5,150 Prior 5,659 1,963 355 7,101 876 7,977 Total $ 23,737 $ 6,430 $ 933 $ 28,646 $ 2,454 $ 31,100 At March 31, 2020 Commercial Real Estate $ in millions AA-A BBB BB Other NIG Total Revolving Loans $ 5 $ — $ — $ — $ 5 2020 YTD — — 167 23 190 2019 — 539 2,056 360 2,955 2018 10 723 764 421 1,918 2017 — 217 577 344 1,138 2016 134 100 352 172 758 Prior 10 — 285 171 466 Total $ 159 $ 1,579 $ 4,201 $ 1,491 $ 7,430 YTD–Year to date Past Due Status of Loans Held for Investment before Allowance At March 31, 2020 $ in millions Corporate Consumer Residential Real Estate Commercial Real Estate Current $ 61,466 $ 31,948 $ 30,883 $ 7,430 Past due1 8 — 217 — Total $ 61,474 $ 31,948 $ 31,100 $ 7,430 1. The majority of the amounts are less than 60 days past due as of March 31, 2020. See Note 2 for a description of the ACL calculated under the CECL methodology, including credit quality indicators, used for HFI loans beginning in 2020. Loans Held for Investment before Allowance1 At December 31, 2019 $ in millions Corporate Consumer Residential Real Estate Commercial Real Estate Total Pass $ 47,681 $ 31,605 $ 30,060 $ 7,664 $117,010 Special mention 464 — 28 3 495 Substandard 605 5 96 192 898 Doubtful 6 — — — 6 Total $ 48,756 $ 31,610 $ 30,184 $ 7,859 $118,409 1. There were no loans held for investment considered Loss as of December 31, 2019. -- 67 of 93 -- Table of Contents Notes to Consolidated Financial Statements (Unaudited) 65 March 2020 Form 10-Q Impaired Loans and Lending Commitments before Allowance At December 31, 2019 $ in millions Corporate Consumer Residential Real Estate Commercial Real Estate Total Loans With allowance $ 268 $ — $ — $ 85 $ 353 Without allowance1 32 5 87 — 124 Total impaired loans $ 300 $ 5 $ 87 $ 85 $ 477 UPB 309 5 90 85 489 Lending commitments With allowance $ 4 $ — $ — $ 14 $ 18 Without allowance1 32 — — — 32 Total impaired lending commitments $ 36 $ — $ — $ 14 $ 50 1. No allowance was recorded for these loans and lending commitments as the present value of the expected future cash flows or value of the collateral equaled or exceeded the carrying value. Loans and lending commitments in the previous table were evaluated for a specific allowance. All remaining loans and lending commitments were assessed under the inherent allowance methodology. Impaired Loans before Allowance and Total Allowance by Region At December 31, 2019 $ in millions Americas EMEA Asia Total Impaired loans $ 392 $ 85 $ — $ 477 Total Allowance for credit losses 270 76 3 349 Troubled Debt Restructurings $ in millions At March 31, 2020 At December 31, 2019 Loans, before allowance $ 132 $ 92 Lending commitments 33 32 Allowance for credit losses on Loans and Lending commitments 26 16 Troubled debt restructurings typically include modifications of interest rates, collateral requirements, other loan covenants and payment extensions. As of December 31, 2019, impaired loans and lending commitments classified as held for investment within corporate loans include TDRs. See Note 2 for further information on TDR guidance issued by Congress in the CARES Act as well as by the U.S. banking agencies. For a discussion of the Firm’s ACL methodology under the prior incurred loss model, including credit quality indicators, used for HFI loans as of December 31, 2019, and a further discussion of the Firm's loans, including loan types and categories, see Notes 2 and 8 in the 2019 Form 10-K. Allowance for Credit Losses Rollforward—Loans $ in millions Corporate Consumer Residential Real Estate Commercial Real Estate Total December 31, 2019 $ 241 $ 8 $ 25 $ 75 $ 349 Effect of CECL adoption (31) (6) 21 25 9 Gross charge-offs (32) — — — (32) Provision (release) 215 1 1 75 292 Other — — — (1) (1) March 31, 2020 $ 393 $ 3 $ 47 $ 174 $ 617 $ in millions Corporate Consumer Residential Real Estate Commercial Real Estate Total December 31, 2018 $ 144 $ 7 $ 20 $ 67 $ 238 Provision (release) 26 (1) 2 — 27 Other (6) — — — (6) March 31, 2019 $ 164 $ 6 $ 22 $ 67 $ 259 Inherent $ 150 $ 6 $ 22 $ 67 $ 245 Specific 14 — — — 14 Allowance for Credit Losses Rollforward—Lending Commitments $ in millions Corporate Consumer Residential Real Estate Commercial Real Estate Total December 31, 2019 $ 232 $ 2 $ — $ 7 $ 241 Effect of CECL adoption (53) (1) 3 1 (50) Provision (release) 110 — — 5 115 Other (1) — — (1) (2) March 31, 2020 $ 288 $ 1 $ 3 $ 12 $ 304 $ in millions Corporate Consumer Residential Real Estate Commercial Real Estate Total December 31, 2018 $ 198 $ 2 $ — $ 3 $ 203 Provision (release) 8 — — 1 9 Other — (1) — — (1) March 31, 2019 $ 206 $ 1 $ — $ 4 $ 211 Inherent $ 202 $ 1 $ — $ 4 $ 207 Specific 4 — — — 4 The aggregate allowance for loans and lending commitments increased in the current quarter, principally reflecting a provision for credit losses within the Institutional Securities business segment resulting from the economic impact of COVID-19. This provision was primarily the result of higher actual and expected future downgrades, an increase in funded balances, principally in Corporate relationship and event-driven loans, as well as revisions to our forecasts in light of current and expected future market and macroeconomic conditions. For a further discussion of the Firm’s loans, including loan types and categories, as well as the Firm’s allowance methodology prior to the adoption of CECL, refer to Notes 2 and 8 to the financial statements in the 2019 Form 10-K. See Note 4 for further -- 68 of 93 -- Table of Contents Notes to Consolidated Financial Statements (Unaudited) March 2020 Form 10-Q 66 information regarding Loans and lending commitments held at fair value. See Note 13 for details of current commitments to lend in the future. Employee Loans $ in millions At March 31, 2020 At December 31, 2019 Currently employed by the Firm1 $ 2,867 N/A No longer employed by the Firm2 150 N/A Balance $ 3,017 $ 2,980 Allowance for credit losses3 (180) (61) Balance, net $ 2,837 $ 2,919 Remaining repayment term, weighted average in years 5.0 4.8 1. These loans are predominantly current. 2. These loans are predominantly past due for a period of 90 days or more. 3. The change in Allowance for credit losses includes a $124 million increase due to the adoption of CECL in the first quarter of 2020. Employee loans are granted in conjunction with a program established primarily to recruit certain Wealth Management representatives, are full recourse and generally require periodic repayments, and are due in full upon termination of employment with the Firm. These loans are recorded in Customer and other receivables in the balance sheets. The allowance for credit losses as of March 31, 2020 was calculated under the CECL methodology, while the allowance for credit losses at December 31, 2019 was calculated under the prior incurred loss model. The related provision is recorded in Compensation and benefits expense in the income statements. See Note 2 for a description of the CECL allowance methodology, including credit quality indicators, for employee loans. -- 69 of 93 -- Table of Contents Notes to Consolidated Financial Statements (Unaudited) 67 March 2020 Form 10-Q 10. Other Assets—Equity Method Investments Equity Method Investments $ in millions At March 31, 2020 At December 31, 2019 Investments $ 2,413 $ 2,363 Three Months Ended March 31, $ in millions 2020 2019 Income (loss) $ 29 $ (10) Equity method investments, other than investments in certain fund interests, are summarized above and are included in Other assets in the balance sheets with related income or loss included in Other revenues in the income statements. See “Net Asset Value Measurements—Fund Interests” in Note 4 for the carrying value of certain of the Firm’s fund interests, which are comprised of general and limited partnership interests, as well as any related carried interest. Japanese Securities Joint Venture Three Months Ended March 31, $ in millions 2020 2019 Income (loss) from investment in MUMSS $ 32 $ 3 The Firm and Mitsubishi UFJ Financial Group, Inc. (“MUFG”) formed a joint venture in Japan comprising their respective investment banking and securities businesses by forming two joint venture companies, Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. (“MUMSS”) and Morgan Stanley MUFG Securities Co., Ltd. (“MSMS”) (the “Joint Venture”). The Firm owns a 40% economic interest in the Joint Venture and MUFG owns the other 60%. The Firm’s 40% voting interest in MUMSS is accounted for under the equity method within the Institutional Securities business segment, and is included in the equity method investment balances above. The Firm consolidates MSMS into the Institutional Securities business segment, based on its 51% voting interest. The Firm engages in transactions in the ordinary course of business with MUFG and its affiliates, for example investment banking, financial advisory, sales and trading, derivatives, investment management, lending, securitization and other financial services transactions. Such transactions are on substantially the same terms as those that would be available to unrelated third parties for comparable transactions. 11. Deposits Deposits $ in millions At March 31, 2020 At December 31, 2019 Savings and demand deposits $ 188,504 $ 149,465 Time deposits 46,735 40,891 Total $ 235,239 $ 190,356 Deposits subject to FDIC insurance $ 176,034 $ 149,966 Time deposits that equal or exceed the FDIC insurance limit $ 12 $ 12 Time Deposit Maturities $ in millions At March 31, 2020 2020 $ 16,656 2021 16,836 2022 4,883 2023 4,070 2024 2,788 Thereafter 1,502 Total $ 46,735 12. Borrowings and Other Secured Financings Borrowings $ in millions At March 31, 2020 At December 31, 2019 Original maturities of one year or less $ 2,211 $ 2,567 Original maturities greater than one year Senior $ 181,477 $ 179,519 Subordinated 11,168 10,541 Total $ 192,645 $ 190,060 Total borrowings $ 194,856 $ 192,627 Weighted average stated maturity, in years1 7.6 6.9 1. Only includes borrowings with original maturities greater than one year. -- 70 of 93 -- Table of Contents Notes to Consolidated Financial Statements (Unaudited) March 2020 Form 10-Q 68 Other Secured Financings $ in millions At March 31, 2020 At December 31, 2019 Original maturities: One year or less $ 7,304 $ 7,103 Greater than one year 4,682 6,480 Transfers of assets accounted for as secured financings 1,072 1,115 Total $ 13,058 $ 14,698 Other secured financings include the liabilities related to certain ELNs, transfers of financial assets that are accounted for as financings rather than sales, pledged commodities, consolidated VIEs where the Firm is deemed to be the primary beneficiary and other secured borrowings. These liabilities are generally payable from the cash flows of the related assets accounted for as Trading assets. See Note 14 for further information on other secured financings related to VIEs and securitization activities. For transfers of assets that fail to meet accounting criteria for a sale, the Firm continues to record the assets and recognizes the associated liabilities in the balance sheets. 13. Commitments, Guarantees and Contingencies Commitments Years to Maturity at March 31, 2020 $ in millions Less than 1 1-3 3-5 Over 5 Total Lending: Corporate $ 23,055 $28,998 $41,269 $ 3,174 $ 96,496 Consumer 8,112 23 3 — 8,138 Residential and commercial real estate 163 1,179 49 252 1,643 Forward-starting secured financing receivables 80,666 219 — — 80,885 Central counterparty1 300 — — 12,344 12,644 Underwriting 206 — — — 206 Investment activities 992 226 58 265 1,541 Letters of credit and other financial guarantees 174 2 — 2 178 Total $113,668 $30,647 $41,379 $16,037 $ 201,731 Corporate lending commitments participated to third parties $ 7,226 Forward-starting secured financing receivables settled within three business days $ 71,096 1. Beginning in the first quarter of 2020, commitments to central counterparties are presented separately; these commitments were previously included in Corporate Lending commitments and Forward-starting secured financing receivables depending on the type of agreement. These commitments relate to the Firm's membership in certain clearinghouses and are contingent upon the default of a clearinghouse member or other stress events. Since commitments associated with these instruments may expire unused, the amounts shown do not necessarily reflect the actual future cash funding requirements. For a further description of these commitments, refer to Note 13 to the financial statements in the 2019 Form 10-K. Guarantees Maximum Potential Payout/Notional of Obligations under Guarantee Arrangements Years to Maturity at March 31, 2020 $ in millions Less than 1 1-3 3-5 Over 5 Total Credit derivatives $ 33,900 $ 38,934 $136,167 $ 68,581 $ 277,582 Other credit contracts — — — 107 107 Non-credit derivatives 1,571,566 1,474,498 902,550 769,204 4,717,818 Standby letters of credit and other financial guarantees issued1 1,200 1,006 1,301 3,840 7,347 Market value guarantees 102 35 — — 137 Liquidity facilities 4,047 — — — 4,047 Whole loan sales guarantees — — 2 23,193 23,195 Securitization representations and warranties — — — 68,881 68,881 General partner guarantees 59 137 12 92 300 Client clearing guarantees 17 — — — 17 $ in millions Carrying Amount Asset (Liability) Credit derivatives2 $ (9,855) Other credit contracts (4) Non-credit derivatives2 (146,854) Standby letters of credit and other financial guarantees issued1 111 Market value guarantees — Liquidity facilities 6 Whole loan sales guarantees — Securitization representations and warranties3 (42) General partner guarantees (62) Client clearing guarantees — 1. These amounts include certain issued standby letters of credit participated to third parties, totaling $0.7 billion of notional and collateral/recourse, due to the nature of the Firm’s obligations under these arrangements. As of March 31, 2020, the carrying amount of standby letters of credit and other financial guarantees issued includes an allowance for credit losses of $57 million. 2. The carrying amounts of derivative contracts that meet the accounting definition of a guarantee are shown on a gross basis. For further information on derivatives contracts, see Note 6. 3. Primarily related to residential mortgage securitizations. The Firm has obligations under certain guarantee arrangements, including contracts and indemnification agreements, that contingently require the Firm to make payments to the guaranteed party based on changes in an underlying measure (such as an interest or foreign exchange rate, security or commodity price, an index, or the occurrence or non-occurrence of a specified event) related to an asset, liability or equity security of a guaranteed party. Also included as guarantees are -- 71 of 93 -- Table of Contents Notes to Consolidated Financial Statements (Unaudited) 69 March 2020 Form 10-Q contracts that contingently require the Firm to make payments to the guaranteed party based on another entity’s failure to perform under an agreement, as well as indirect guarantees of the indebtedness of others. Client Clearing Guarantees. In the first quarter of 2020, FICC’s sponsored clearing model was updated such that the Firm could be responsible for liquidation of a sponsored member’s account and guarantees any resulting loss to the FICC in the event the sponsored member fails to fully pay any net liquidation amount due from the sponsored member to the FICC. Accordingly, the Firm’s maximum potential payout amount as of March 31, 2020 reflects the total of the estimated net liquidation amounts for sponsored member accounts. For more information on the nature of the obligations and related business activities for our guarantees, see Note 13 to the financial statements in the 2019 Form 10-K. Other Guarantees and Indemnities In the normal course of business, the Firm provides guarantees and indemnifications in a variety of transactions. These provisions generally are standard contractual terms. Certain of these guarantees and indemnifications related to indemnities, exchange and clearinghouse member guarantees and merger and acquisition guarantees are described in Note 13 to the financial statements in the 2019 Form 10-K. In addition, in the ordinary course of business, the Firm guarantees the debt and/or certain trading obligations (including obligations associated with derivatives, foreign exchange contracts and the settlement of physical commodities) of certain subsidiaries. These guarantees generally are entity or product specific and are required by investors or trading counterparties. The activities of the Firm’s subsidiaries covered by these guarantees (including any related debt or trading obligations) are included in the financial statements. Finance Subsidiary The Parent Company fully and unconditionally guarantees the securities issued by Morgan Stanley Finance LLC, a wholly owned finance subsidiary. Contingencies Legal In addition to the matters described in the following paragraphs, in the normal course of business, the Firm has been named, from time to time, as a defendant in various legal actions, including arbitrations, class actions and other litigation, arising in connection with its activities as a global diversified financial services institution. Certain of the actual or threatened legal actions include claims for substantial compensatory and/or punitive damages or claims for indeterminate amounts of damages. In some cases, the entities that would otherwise be the primary defendants in such cases are bankrupt or are in financial distress. These actions have included, but are not limited to, residential mortgage and credit crisis-related matters. While the Firm has identified below any individual proceedings where the Firm believes a material loss to be reasonably possible and reasonably estimable, there can be no assurance that material losses will not be incurred from claims that have not yet been asserted or are not yet determined to be probable or possible and reasonably estimable losses. The Firm contests liability and/or the amount of damages as appropriate in each pending matter. Where available information indicates that it is probable a liability had been incurred at the date of the financial statements and the Firm can reasonably estimate the amount of that loss, the Firm accrues the estimated loss by a charge to income. In many proceedings and investigations, however, it is inherently difficult to determine whether any loss is probable or even possible or to estimate the amount of any loss. In addition, even where a loss is possible or an exposure to loss exists in excess of the liability already accrued with respect to a previously recognized loss contingency, it is not always possible to reasonably estimate the size of the possible loss or range of loss. For certain legal proceedings and investigations, the Firm cannot reasonably estimate such losses, particularly for proceedings and investigations where the factual record is being developed or contested or where plaintiffs or government entities seek substantial or indeterminate damages, restitution, disgorgement or penalties. Numerous issues may need to be resolved, including through potentially lengthy discovery and determination of important factual matters, determination of issues related to class certification and the calculation of damages or other relief, and by addressing novel or unsettled legal questions relevant to the proceedings or investigations in question, before a loss or additional loss or range of loss or additional range of loss can be reasonably estimated for a proceeding or investigation. For certain other legal proceedings and investigations, the Firm can estimate reasonably possible losses, additional losses, ranges of loss or ranges of additional loss in excess of amounts accrued but does not believe, based on current knowledge and after consultation with counsel, that such losses will have a material adverse effect on the Firm’s financial statements as a whole, other than the matters referred to in the following paragraphs. On July 15, 2010, China Development Industrial Bank (“CDIB”) filed a complaint against the Firm, styled China Development Industrial Bank v. Morgan Stanley & Co. Incorporated et al., which is pending in the Supreme Court of the State of New York, New York County (“Supreme Court of -- 72 of 93 -- Table of Contents Notes to Consolidated Financial Statements (Unaudited) March 2020 Form 10-Q 70 NY”). The complaint relates to a $275 million CDS referencing the super senior portion of the STACK 2006-1 CDO. The complaint asserts claims for common law fraud, fraudulent inducement and fraudulent concealment and alleges that the Firm misrepresented the risks of the STACK 2006-1 CDO to CDIB, and that the Firm knew that the assets backing the CDO were of poor quality when it entered into the CDS with CDIB. The complaint seeks compensatory damages related to the approximately $228 million that CDIB alleges it has already lost under the CDS, rescission of CDIB’s obligation to pay an additional $12 million, punitive damages, equitable relief, fees and costs. On February 28, 2011, the court denied the Firm’s motion to dismiss the complaint. On December 21, 2018, the court denied the Firm’s motion for summary judgment and granted in part the Firm’s motion for sanctions relating to spoliation of evidence. On January 24, 2019, CDIB filed a notice of appeal from the court’s December 21, 2018 order, and on January 25, 2019, the Firm filed a notice of appeal from the same order. On March 7, 2019, the court denied the relief that CDIB sought in a motion to clarify and resettle the portion of the court’s December 21, 2018 order granting spoliation sanctions. On December 5, 2019, the Appellate Division, First Department (“First Department”) heard the parties’ cross appeals. Based on currently available information, the Firm believes it could incur a loss in this action of up to approximately $240 million plus pre- and post-judgment interest, fees and costs. On July 8, 2013, U.S. Bank National Association, in its capacity as trustee, filed a complaint against the Firm styled U.S. Bank National Association, solely in its capacity as Trustee of the Morgan Stanley Mortgage Loan Trust 2007-2AX (MSM 2007-2AX) v. Morgan Stanley Mortgage Capital Holdings LLC, Successor-by-Merger to Morgan Stanley Mortgage Capital Inc. and GreenPoint Mortgage Funding, Inc., pending in the Supreme Court of NY. The complaint asserts claims for breach of contract and alleges, among other things, that the loans in the trust, which had an original principal balance of approximately $650 million, breached various representations and warranties. The complaint seeks, among other relief, specific performance of the loan breach remedy procedures in the transaction documents, unspecified damages and interest. On November 24, 2014, the court granted in part and denied in part the Firm’s motion to dismiss the complaint. On April 4, 2019, the court denied the Firm’s motion to renew its motion to dismiss. Based on currently available information, the Firm believes that it could incur a loss in this action of up to approximately $240 million, the total original unpaid balance of the mortgage loans for which the Firm received repurchase demands that it did not repurchase, plus pre- and post-judgment interest, fees and costs, but plaintiff is seeking to expand the number of loans at issue and the possible range of loss could increase. On September 23, 2014, Financial Guaranty Insurance Company (“FGIC”) filed a complaint against the Firm in the Supreme Court of NY styled Financial Guaranty Insurance Company v. Morgan Stanley ABS Capital I Inc. et al. relating to the Morgan Stanley ABS Capital I Inc. Trust 2007-NC4. The complaint asserts claims for breach of contract and fraudulent inducement and alleges, among other things, that the loans in the trust breached various representations and warranties and defendants made untrue statements and material omissions to induce FGIC to issue a financial guaranty policy on certain classes of certificates that had an original balance of approximately $876 million. The complaint seeks, among other relief, specific performance of the loan breach remedy procedures in the transaction documents, compensatory, consequential and punitive damages, attorneys’ fees and interest. On January 23, 2017, the court denied the Firm’s motion to dismiss the complaint. On September 13, 2018, the First Department affirmed in part and reversed in part the lower court’s order denying the Firm’s motion to dismiss. On December 20, 2018, the First Department denied plaintiff’s motion for leave to appeal its decision to the New York Court of Appeals ("Court of Appeals") or, in the alternative, for re- argument. Based on currently available information, the Firm believes that it could incur a loss in this action of up to approximately $277 million, the total original unpaid balance of the mortgage loans for which the Firm received repurchase demands from a certificate holder and FGIC that the Firm did not repurchase, plus pre- and post- judgment interest, fees and costs, as well as claim payments that FGIC has made and will make in the future. In addition, plaintiff is seeking to expand the number of loans at issue and the possible range of loss could increase. On January 23, 2015, Deutsche Bank National Trust Company, in its capacity as trustee, filed a complaint against the Firm styled Deutsche Bank National Trust Company solely in its capacity as Trustee of the Morgan Stanley ABS Capital I Inc. Trust 2007- NC4 v. Morgan Stanley Mortgage Capital Holdings LLC as Successor-by-Merger to Morgan Stanley Mortgage Capital Inc., and Morgan Stanley ABS Capital I Inc., pending in the Supreme Court of NY. The complaint asserts claims for breach of contract and alleges, among other things, that the loans in the trust, which had an original principal balance of approximately $1.05 billion, breached various representations and warranties. The complaint seeks, among other relief, specific performance of the loan breach remedy procedures in the transaction documents, compensatory, consequential, rescissory, equitable and punitive damages, attorneys’ fees, costs and other related expenses, and interest. On December 11, 2015, the court granted in part and denied in part the Firm’s motion to dismiss the complaint. On October 19, 2018, the court granted the Firm’s motion for leave to amend its answer and to stay the case pending resolution of Deutsche Bank National Trust Company’s appeal to the Court of Appeals in another case, styled Deutsche Bank National Trust Company v. Barclays Bank PLC, regarding the applicable statute of limitations. On January 17, 2019, the First Department reversed the trial court’s order to the extent that it had granted in part the Firm’s motion to dismiss the complaint. On June 4, 2019, the First Department granted the Firm’s motion for leave -- 73 of 93 -- Table of Contents Notes to Consolidated Financial Statements (Unaudited) 71 March 2020 Form 10-Q to appeal to the Court of Appeals. On March 19, 2020, the Firm filed a motion for partial summary judgment. Based on currently available information, the Firm believes that it could incur a loss in this action of up to approximately $277 million, the total original unpaid balance of the mortgage loans for which the Firm received repurchase demands from a certificate holder and a monoline insurer that the Firm did not repurchase, plus pre- and post-judgment interest, fees and costs, but plaintiff is seeking to expand the number of loans at issue and the possible range of loss could increase. Tax In matters styled Case number 15/3637 and Case number 15/4353, the Dutch Tax Authority (“Dutch Authority”) has challenged, in the District Court in Amsterdam, the prior set-off by the Firm of approximately €124 million (approximately $137 million) plus accrued interest of withholding tax credits against the Firm’s corporation tax liabilities for the tax years 2007 to 2013. The Dutch Authority alleges that the Firm was not entitled to receive the withholding tax credits on the basis, inter alia, that a Firm subsidiary did not hold legal title to certain securities subject to withholding tax on the relevant dates. The Dutch Authority has also alleged that the Firm failed to provide certain information to the Dutch Authority and keep adequate books and records. On April 26, 2018, the District Court in Amsterdam issued a decision dismissing the Dutch Authority’s claims. On June 4, 2018, the Dutch Authority filed an appeal before the Court of Appeal in Amsterdam in matters re-styled Case number 18/00318 and Case number 18/00319. On June 26 and July 2, 2019, a hearing of the Dutch Authority’s appeal was held. Based on currently available information, the Firm believes that it could incur a loss in this action of up to approximately €124 million (approximately $137 million) plus accrued interest. 14. Variable Interest Entities and Securitization Activities Consolidated VIE Assets and Liabilities by Type of Activity At March 31, 2020 At December 31, 2019 $ in millions VIE Assets VIE Liabilities VIE Assets VIE Liabilities OSF $ 728 $ 415 $ 696 $ 391 MABS1 368 108 265 4 Other2 934 44 987 66 Total $ 2,030 $ 567 $ 1,948 $ 461 OSF—Other structured financings 1. Amounts include transactions backed by residential mortgage loans, commercial mortgage loans and other types of assets, including consumer or commercial assets and may be in loan or security form. The value of assets is determined based on the fair value of the liabilities and the interests owned by the Firm in such VIEs as the fair values for the liabilities and interests owned are more observable. 2. Other primarily includes operating entities, investment funds and structured transactions. Consolidated VIE Assets and Liabilities by Balance Sheet Caption $ in millions At March 31, 2020 At December 31, 2019 Assets Cash and cash equivalents $ 328 $ 488 Trading assets at fair value 1,234 943 Customer and other receivables 16 18 Intangible assets 107 111 Other assets 345 388 Total $ 2,030 $ 1,948 Liabilities Other secured financings $ 519 $ 422 Other liabilities and accrued expenses 48 39 Total $ 567 $ 461 Noncontrolling interests $ 245 $ 192 Consolidated VIE assets and liabilities are presented in the previous tables after intercompany eliminations. Generally, most assets owned by consolidated VIEs cannot be removed unilaterally by the Firm and are not available to the Firm while the related liabilities issued by consolidated VIEs are non- recourse to the Firm. However, in certain consolidated VIEs, the Firm either has the unilateral right to remove assets or provides additional recourse through derivatives such as total return swaps, guarantees or other forms of involvement. In general, the Firm’s exposure to loss in consolidated VIEs is limited to losses that would be absorbed on the VIE net assets recognized in its financial statements, net of amounts absorbed by third-party variable interest holders. -- 74 of 93 -- Table of Contents Notes to Consolidated Financial Statements (Unaudited) March 2020 Form 10-Q 72 Non-consolidated VIEs At March 31, 2020 $ in millions MABS1 CDO MTOB OSF Other2 VIE assets (UPB) $ 124,211 $ 1,881 $ 6,585 $ 2,263 $ 51,280 Maximum exposure to loss3 Debt and equity interests $ 15,173 $ 254 $ 277 $ 1,086 $ 10,468 Derivative and other contracts — — 4,047 — 3,659 Commitments, guarantees and other 572 — — — 334 Total $ 15,745 $ 254 $ 4,324 $ 1,086 $ 14,461 Carrying value of variable interests—Assets Debt and equity interests $ 15,173 $ 254 $ 277 $ 1,084 $ 10,468 Derivative and other contracts — — 6 — 835 Total $ 15,173 $ 254 $ 283 $ 1,084 $ 11,303 Additional VIE assets owned4 $ 11,024 Carrying value of variable interests—Liabilities Derivative and other contracts $ — $ — $ — $ — $ 272 At December 31, 2019 $ in millions MABS1 CDO MTOB OSF Other2 VIE assets (UPB) $ 125,603 $ 2,976 $ 6,965 $ 2,288 $ 51,305 Maximum exposure to loss3 Debt and equity interests $ 16,314 $ 240 $ — $ 1,009 $ 11,977 Derivative and other contracts — — 4,599 — 2,995 Commitments, guarantees and other 631 — — — 266 Total $ 16,945 $ 240 $ 4,599 $ 1,009 $ 15,238 Carrying value of variable interests–Assets Debt and equity interests $ 16,314 $ 240 $ — $ 1,008 $ 11,977 Derivative and other contracts — — 6 — 388 Total $ 16,314 $ 240 $ 6 $ 1,008 $ 12,365 Additional VIE assets owned4 $ 11,453 Carrying value of variable interests—Liabilities Derivative and other contracts $ — $ — $ — $ — $ 444 MTOB—Municipal tender option bonds 1. Amounts include transactions backed by residential mortgage loans, commercial mortgage loans and other types of assets, including consumer or commercial assets. and may be in loan or security form. 2. Other primarily includes exposures to commercial real estate property and investment funds. 3. Where notional amounts are utilized in quantifying the maximum exposure related to derivatives, such amounts do not reflect changes in fair value recorded by the Firm. 4. Additional VIE assets owned represents the carrying value of total exposure to non- consolidated VIEs for which the maximum exposure to loss is less than specific thresholds, primarily interests issued by securitization SPEs. The Firm’s primary risk exposure is to the most subordinate class of beneficial interest and maximum exposure to loss generally equals the fair value of the assets owned. These assets are primarily included in Trading assets and Investment securities and are measured at fair value (see Note 3). The Firm does not provide additional support in these transactions through contractual facilities, guarantees or similar derivatives. The majority of the VIEs included in the previous tables are sponsored by unrelated parties; examples of the Firm’s involvement with these VIEs include its secondary market- making activities and the securities held in its Investment securities portfolio (see Note 7). The Firm’s maximum exposure to loss is dependent on the nature of the Firm’s variable interest in the VIE and is limited to the notional amounts of certain liquidity facilities and other credit support, total return swaps and written put options, as well as the fair value of certain other derivatives and investments the Firm has made in the VIE. The Firm’s maximum exposure to loss in the previous tables does not include the offsetting benefit of hedges or any reductions associated with the amount of collateral held as part of a transaction with the VIE or any party to the VIE directly against a specific exposure to loss. Liabilities issued by VIEs generally are non-recourse to the Firm. Detail of Mortgage- and Asset-Backed Securitization Assets At March 31, 2020 At December 31, 2019 $ in millions UPB Debt and Equity Interests UPB Debt and Equity Interests Residential mortgages $ 20,460 $ 3,298 $ 30,353 $ 3,993 Commercial mortgages 52,672 3,677 53,892 3,881 U.S. agency collateralized mortgage obligations 45,958 6,257 36,366 6,365 Other consumer or commercial loans 5,121 1,941 4,992 2,075 Total $ 124,211 $ 15,173 $ 125,603 $ 16,314 Transferred Assets with Continuing Involvement1 At March 31, 2020 $ in millions RML CML U.S. Agency CMO CLN and Other3 SPE assets (UPB)4 $ 9,501 $ 79,516 $ 15,480 $ 11,109 Retained interests Investment grade $ 26 $ 780 $ 763 $ — Non-investment grade 13 238 — 87 Total $ 39 $ 1,018 $ 763 $ 87 Interests purchased in the secondary market Investment grade $ — $ 65 $ 78 $ — Non-investment grade 29 68 — — Total $ 29 $ 133 $ 78 $ — Derivative assets $ — $ — $ — $ 830 Derivative liabilities — — — 186 -- 75 of 93 -- Table of Contents Notes to Consolidated Financial Statements (Unaudited) 73 March 2020 Form 10-Q At December 31, 20192 $ in millions RML CML U.S. Agency CMO CLN and Other3 SPE assets (UPB)4 $ 9,850 $ 86,203 $ 19,132 $ 8,410 Retained interests Investment grade $ 29 $ 720 $ 2,376 $ 1 Non-investment grade 17 254 — 92 Total $ 46 $ 974 $ 2,376 $ 93 Interests purchased in the secondary market Investment grade $ 6 $ 197 $ 77 $ — Non-investment grade 75 51 — — Total $ 81 $ 248 $ 77 $ — Derivative assets $ — $ — $ — $ 339 Derivative liabilities — — — 145 Fair Value At March 31, 2020 $ in millions Level 2 Level 3 Total Retained interests Investment grade $ 790 $ — $ 790 Non-investment grade 7 83 90 Total $ 797 $ 83 $ 880 Interests purchased in the secondary market Investment grade $ 141 $ 2 $ 143 Non-investment grade 85 12 97 Total $ 226 $ 14 $ 240 Derivative assets $ 820 $ 10 $ 830 Derivative liabilities 185 1 186 Fair Value at December 31, 2019 $ in millions Level 2 Level 3 Total Retained interests Investment grade $ 2,401 $ 4 $ 2,405 Non-investment grade 6 97 103 Total $ 2,407 $ 101 $ 2,508 Interests purchased in the secondary market Investment grade $ 278 $ 2 $ 280 Non-investment grade 68 58 126 Total $ 346 $ 60 $ 406 Derivative assets $ 337 $ 2 $ 339 Derivative liabilities 144 1 145 RML—Residential mortgage loans CML—Commercial mortgage loans 1. The Transferred Assets with Continuing Involvement tables include transactions with SPEs in which the Firm, acting as principal, transferred financial assets with continuing involvement and received sales treatment. 2. As permitted by applicable guidance, certain transfers of assets where the Firm’s only continuing involvement is a derivative are only reported in the following Assets Sold with Retained Exposure table. 3. Amounts include CLO transactions managed by unrelated third parties. 4. Amounts include assets transferred by unrelated transferors. Transferred assets are carried at fair value prior to securitization, and any changes in fair value are recognized in the income statements. The Firm may act as underwriter of the beneficial interests issued by these securitization vehicles, for which Investment banking revenues are recognized. The Firm may retain interests in the securitized financial assets as one or more tranches of the securitization. These retained interests are generally carried at fair value in the balance sheets with changes in fair value recognized in the income statements. Fair value for these interests is measured using techniques that are consistent with the valuation techniques applied to the Firm’s major categories of assets and liabilities as described in Note 2 in the 2019 Form 10-K and Note 4 herein. Proceeds from New Securitization Transactions and Sales of Loans Three Months Ended March 31, $ in millions 2020 2019 New transactions1 $ 8,471 $ 4,733 Retained interests 4,088 2,887 Sales of corporate loans to CLO SPEs1, 2 66 — 1. Net gains on new transactions and sales of corporate loans to CLO entities at the time of the sale were not material for all periods presented. 2. Sponsored by non-affiliates. The Firm has provided, or otherwise agreed to be responsible for, representations and warranties regarding certain assets transferred in securitization transactions sponsored by the Firm (see Note 13). Assets Sold with Retained Exposure $ in millions At March 31, 2020 At December 31, 2019 Gross cash proceeds from sale of assets1 $ 28,213 $ 38,661 Fair value Assets sold $ 28,068 $ 39,137 Derivative assets recognized in the balance sheets 862 647 Derivative liabilities recognized in the balance sheets 1,004 152 1. The carrying value of assets derecognized at the time of sale approximates gross cash proceeds. The Firm enters into transactions in which it sells securities, primarily equities and contemporaneously enters into bilateral OTC derivatives with the purchasers of the securities, through which it retains exposure to the sold securities. For a discussion of the Firm’s VIEs, the determination and structure of VIEs and securitization activities, see Note 14 to the financial statements in the 2019 Form 10-K. 15. Regulatory Requirements Regulatory Capital Framework and Requirements For a discussion of the Firm’s regulatory capital framework, see Note 15 to the financial statements in the 2019 Form 10-K. The Firm is required to maintain minimum risk-based and leverage-based capital ratios under regulatory capital requirements. A summary of the calculations of regulatory capital and RWA follows. Minimum risk-based capital ratio requirements apply to Common Equity Tier 1 capital, Tier 1 capital and Total capital -- 76 of 93 -- Table of Contents Notes to Consolidated Financial Statements (Unaudited) March 2020 Form 10-Q 74 (which includes Tier 2 capital). Capital standards require certain adjustments to, and deductions from, capital for purposes of determining these ratios. At March 31, 2020 and December 31, 2019, the Firm's ratios for determining regulatory compliance are based on the Advanced Approach and the Standardized Approach rules, respectively. In the current quarter, the U.S. banking agencies have adopted an interim final rule altering, for purposes of the regulatory capital rules, the required adoption time period for CECL. As of March 31, 2020, the risk-based and leverage-based capital amounts and ratios, as well as RWA, adjusted average assets and supplementary leverage exposure are calculated excluding the effect of the adoption of CECL based on our election to defer this effect over a five-year transition period in accordance with the interim final rule. In addition to the minimum risk-based capital ratio requirements, the Firm is subject to the following Common Equity Tier 1 buffers: • A greater than 2.5% capital conservation buffer; • The G-SIB capital surcharge, currently at 3%; and • Up to a 2.5% CCyB, currently set by U.S. banking agencies at zero. The Firm’s Regulatory Capital and Capital Ratios At March 31, 2020 $ in millions Required Ratio1 Amount Ratio Risk-based capital Common Equity Tier 1 capital 10.0% $ 65,195 15.2% Tier 1 capital 11.5% 73,896 17.3% Total capital 13.5% 83,847 19.6% Total RWA 427,782 Leverage-based capital Tier 1 leverage 4.0% $ 73,896 8.1% Adjusted average assets2 910,499 SLR 5.0% 73,896 6.2% Supplementary leverage exposure3 1,185,734 At December 31, 2019 $ in millions Required Ratio1 Amount Ratio Risk-based capital Common Equity Tier 1 capital 10.0% $ 64,751 16.4% Tier 1 capital 11.5% 73,443 18.6% Total capital 13.5% 82,708 21.0% Total RWA 394,177 Leverage-based capital Tier 1 leverage 4.0% $ 73,443 8.3% Adjusted average assets2 889,195 SLR 5.0% 73,443 6.4% Supplementary leverage exposure3 1,155,177 1. Required ratios are inclusive of any buffers applicable as of the date presented. Failure to maintain the buffers would result in restrictions on the Firm’s ability to make capital distributions, including the payment of dividends and the repurchase of stock, and to pay discretionary bonuses to executive officers. 2. Adjusted average assets represents the denominator of the Tier 1 leverage ratio and is composed of the average daily balance of consolidated on- balance sheet assets for the quarters ending on the respective balance sheet dates, reduced by disallowed goodwill, intangible assets, investments in covered funds, defined benefit pension plan assets, after- tax gain on sale from assets sold into securitizations, investments in the Firm's own capital instruments, certain defined tax assets and other capital deductions. 3. Supplementary leverage exposure is the sum of Adjusted average assets used in the Tier 1 leverage ratio and other adjustments, primarily: (i) for derivatives, potential future exposure and the effective notional principal amount of sold credit protection offset by qualifying purchased credit protection; (ii) the counterparty credit risk for repo-style transactions; and (iii) the credit equivalent amount for off-balance sheet exposures. U.S. Bank Subsidiaries’ Regulatory Capital and Capital Ratios The OCC establishes capital requirements for the Firm’s U.S. Bank Subsidiaries and evaluates their compliance with such capital requirements. Regulatory capital requirements for the U.S. Bank Subsidiaries are calculated in a similar manner to the Firm’s regulatory capital requirements, although G-SIB capital surcharge requirements do not apply to the U.S. Bank Subsidiaries. The OCC’s regulatory capital framework includes Prompt Corrective Action (“PCA”) standards, including “well- capitalized” PCA standards that are based on specified regulatory capital ratio minimums. For the Firm to remain an FHC, the U.S. Bank Subsidiaries must remain well-capitalized in accordance with the OCC’s PCA standards. In addition, failure by the U.S. Bank Subsidiaries to meet minimum capital requirements may result in certain mandatory and discretionary actions by regulators that, if undertaken, could have a direct material effect on the U.S. Bank Subsidiaries’ and the Firm’s financial statements. At March 31, 2020 and December 31, 2019, the U.S. Bank Subsidiaries’ risk-based capital ratios are based on the Standardized Approach rules. At March 31, 2020, the risk-based -- 77 of 93 -- Table of Contents Notes to Consolidated Financial Statements (Unaudited) 75 March 2020 Form 10-Q and leverage-based capital amounts and ratios are calculated excluding the effect of the adoption of CECL based on our election to defer this effect over a five-year transition period. MSBNA’s Regulatory Capital At March 31, 2020 $ in millions Well-Capitalized Requirement Required Ratio1 Amount Ratio Risk-based capital Common Equity Tier 1 capital 6.5% 7.0% $ 16,839 18.2% Tier 1 capital 8.0% 8.5% 16,839 18.2% Total capital 10.0% 10.5% 17,349 18.7% Leverage-based capital Tier 1 leverage 5.0% 4.0% $ 16,839 11.2% SLR 6.0% 3.0% 16,839 8.8% At December 31, 2019 $ in millions Well-Capitalized Requirement Required Ratio1 Amount Ratio Risk-based capital Common Equity Tier 1 capital 6.5% 7.0% $ 15,919 18.5% Tier 1 capital 8.0% 8.5% 15,919 18.5% Total capital 10.0% 10.5% 16,282 18.9% Leverage-based capital Tier 1 leverage 5.0% 4.0% $ 15,919 11.3% SLR 6.0% 3.0% 15,919 8.7% MSPBNA’s Regulatory Capital At March 31, 2020 $ in millions Well-Capitalized Requirement Required Ratio1 Amount Ratio Risk-based capital Common Equity Tier 1 capital 6.5% 7.0% $ 8,487 22.9% Tier 1 capital 8.0% 8.5% 8,487 22.9% Total capital 10.0% 10.5% 8,556 23.0% Leverage-based capital Tier 1 leverage 5.0% 4.0% $ 8,487 9.7% SLR 6.0% 3.0% 8,487 9.3% At December 31, 2019 $ in millions Well-Capitalized Requirement Required Ratio1 Amount Ratio Risk-based capital Common Equity Tier 1 capital 6.5% 7.0% $ 7,962 24.8% Tier 1 capital 8.0% 8.5% 7,962 24.8% Total capital 10.0% 10.5% 8,016 25.0% Leverage-based capital Tier 1 leverage 5.0% 4.0% $ 7,962 9.9% SLR 6.0% 3.0% 7,962 9.4% 1. Required ratios are inclusive of any buffers applicable as of the date presented. Failure to maintain the buffers would result in restrictions on the U.S. Bank Subsidiaries' ability to make capital distributions, including the payment of dividends. U.S. Broker-Dealer Regulatory Capital Requirements MS&Co. Regulatory Capital $ in millions At March 31, 2020 At December 31, 2019 Net capital $ 10,887 $ 13,708 Excess net capital 6,620 10,686 MS&Co. is a registered U.S. broker-dealer and registered futures commission merchant and, accordingly, is subject to the minimum net capital requirements of the SEC and the CFTC. MS&Co. has consistently operated with capital in excess of its regulatory capital requirements. As an Alternative Net Capital broker-dealer, and in accordance with Securities Exchange Act of 1934 (“Exchange Act”) Rule 15c3-1, Appendix E, MS&Co. is subject to minimum net capital and tentative net capital requirements. In addition, MS&Co. must notify the SEC if its tentative net capital falls below certain levels. At March 31, 2020 and December 31, 2019, MS&Co. has exceeded its net capital requirement and has tentative net capital in excess of the minimum and notification requirements. MSSB Regulatory Capital $ in millions At March 31, 2020 At December 31, 2019 Net capital $ 2,924 $ 3,387 Excess net capital 2,774 3,238 MSSB is a registered U.S. broker-dealer and introducing broker for the futures business and, accordingly, is subject to the minimum net capital requirements of the SEC. MSSB has consistently operated with capital in excess of its regulatory capital requirements. Other Regulated Subsidiaries MSIP, a London-based broker-dealer subsidiary, is subject to the capital requirements of the PRA, and MSMS, a Tokyo-based broker-dealer subsidiary, is subject to the capital requirements of the Financial Services Agency. MSIP and MSMS have consistently operated with capital in excess of their respective regulatory capital requirements. Certain other U.S. and non-U.S. subsidiaries of the Firm are subject to various securities, commodities and banking regulations, and capital adequacy requirements promulgated by the regulatory and exchange authorities of the countries in which they operate. These subsidiaries have consistently operated with capital in excess of their local capital adequacy requirements. -- 78 of 93 -- Table of Contents Notes to Consolidated Financial Statements (Unaudited) March 2020 Form 10-Q 76 16. Total Equity Share Repurchases Three Months Ended March 31, $ in millions 2020 2019 Repurchases of common stock under the Firm's Share Repurchase Program $ 1,347 $ 1,180 The Firm’s 2019 Capital Plan (“Capital Plan”) includes the share repurchase of up to $6.0 billion of outstanding common stock for the period beginning July 1, 2019 through June 30, 2020. Additionally, the Capital Plan includes quarterly common stock dividends of up to $0.35 per share, beginning with the common stock dividend announced on July 18, 2019. On March 15, 2020, the Financial Services Forum announced that each of its eight member banks, including the Firm, had voluntarily suspended their share repurchase programs. For information about the Firm's 2019 Capital Plan, see Note 16 to the financial statements in the 2019 Form 10-K. A portion of common stock repurchases was conducted under a sales plan with MUFG, whereby MUFG sold shares of the Firm’s common stock to the Firm, as part of the Firm’s Share Repurchase Program. The sales plan is only intended to maintain MUFG’s ownership percentage below 24.9% in order to comply with MUFG’s passivity commitments to the Board of Governors of the Federal Reserve System and has no impact on the strategic alliance between MUFG and the Firm, including the joint ventures in Japan. Common Stock Dividends per Share Three Months Ended March 31, 2020 2019 Dividends declared per common share $ 0.35 $ 0.30 Common Shares Outstanding for Basic and Diluted EPS Three Months Ended March 31, in millions 2020 2019 Weighted average common shares outstanding, basic 1,555 1,658 Effect of dilutive Stock options, RSUs and PSUs 18 19 Weighted average common shares outstanding and common stock equivalents, diluted 1,573 1,677 Weighted average antidilutive common stock equivalents (excluded from the computation of diluted EPS) 12 6 Preferred Stock Shares Outstanding Carrying Value $ in millions, except per share data At March 31, 2020 Liquidation Preference per Share At March 31, 2020 At December 31, 2019 Series A 44,000 $ 25,000 $ 1,100 $ 1,100 C1 519,882 1,000 408 408 E 34,500 25,000 862 862 F 34,000 25,000 850 850 H 52,000 25,000 1,300 1,300 I 40,000 25,000 1,000 1,000 J 60,000 25,000 1,500 1,500 K 40,000 25,000 1,000 1,000 L 20,000 25,000 500 500 Total $ 8,520 $ 8,520 Shares authorized 30,000,000 1. Series C is composed of the issuance of 1,160,791 shares of Series C Preferred Stock to MUFG for an aggregate purchase price of $911 million, less the redemption of 640,909 shares of Series C Preferred Stock of $503 million, which were converted to common shares of approximately $705 million in 2009. For a description of Series A through Series L preferred stock issuances, see Note 16 to the financial statements in the 2019 Form 10-K. The preferred stock has a preference over the common stock upon liquidation. The Firm’s preferred stock qualifies as and is included in Tier 1 capital in accordance with regulatory capital requirements (see Note 15). Preferred Stock Dividends $ in millions, except per share data Three Months Ended March 31, 2020 Three Months Ended March 31, 2019 Per Share1 Total Per Share1 Total Series A $ 253 $ 11 $ 250 $ 11 C 25 13 25 13 E 445 15 445 15 F 430 14 430 15 G2 — — 414 8 H3 344 18 — — I 398 16 398 16 J4 — — — — K 366 15 366 15 L 305 6 — — Total $ 108 $ 93 1. Dividends on all series are payable quarterly, unless otherwise noted. 2. Series G preferred stock was redeemed during the first quarter of 2020. For further information, see Note 16 to the 2019 Form 10-K. 3. Series H was payable semiannually until July 15, 2019, and is now payable quarterly. 4. Series J is payable semiannually until July 15, 2020, and then quarterly thereafter. -- 79 of 93 -- Table of Contents Notes to Consolidated Financial Statements (Unaudited) 77 March 2020 Form 10-Q Accumulated Other Comprehensive Income (Loss)1 $ in millions CTA AFS Securities Pension, Postretirement and Other DVA Total December 31, 2019 $ (897) $ 207 $ (644) $ (1,454) $ (2,788) OCI during the period (141) 1,325 25 3,674 4,883 March 31, 2020 $ (1,038) $ 1,532 $ (619) $ 2,220 $ 2,095 December 31, 2018 $ (889) $ (930) $ (578) $ 105 $ (2,292) OCI during the period (12) 429 1 (599) (181) March 31, 2019 $ (901) $ (501) $ (577) $ (494) $ (2,473) CTA—Cumulative foreign currency translation adjustments 1. Amounts are net of tax and noncontrolling interests. Components of Period Changes in OCI Three Months Ended March 31, 2020 $ in millions Pre-tax Gain (Loss) Income Tax Benefit (Provision) After-tax Gain (Loss) Non- controlling Interests Net CTA OCI activity $ (20) $ (112) $ (132) $ 9 $ (141) Reclassified to earnings — — — — — Net OCI $ (20) $ (112) $ (132) $ 9 $ (141) Change in net unrealized gains (losses) on AFS securities OCI activity $ 1,773 $ (416) $ 1,357 $ — $1,357 Reclassified to earnings (41) 9 (32) — (32) Net OCI $ 1,732 $ (407) $ 1,325 $ — $1,325 Pension, postretirement and other OCI activity $ 25 $ (4) $ 21 $ — $ 21 Reclassified to earnings 5 (1) 4 — 4 Net OCI $ 30 $ (5) $ 25 $ — $ 25 Change in net DVA OCI activity $ 5,015 $ (1,216) $ 3,799 $ 129 $3,670 Reclassified to earnings 5 (1) 4 — 4 Net OCI $ 5,020 $ (1,217) $ 3,803 $ 129 $3,674 Three Months Ended March 31, 2019 $ in millions Pre-tax Gain (Loss) Income Tax Benefit (Provision) After-tax Gain (Loss) Non- controlling Interests Net CTA OCI activity $ (4) $ (18) $ (22) $ (10) $ (12) Reclassified to earnings — — — — — Net OCI $ (4) $ (18) $ (22) $ (10) $ (12) Change in net unrealized gains (losses) on AFS securities OCI activity $ 570 $ (133) $ 437 $ — $ 437 Reclassified to earnings (10) 2 (8) — (8) Net OCI $ 560 $ (131) $ 429 $ — $ 429 Pension, postretirement and other OCI activity $ — $ (1) $ (1) $ — $ (1) Reclassified to earnings 3 (1) 2 — 2 Net OCI $ 3 $ (2) $ 1 $ — $ 1 Change in net DVA OCI activity $ (824) $ 201 $ (623) $ (21) $ (602) Reclassified to earnings 4 (1) 3 — 3 Net OCI $ (820) $ 200 $ (620) $ (21) $ (599) Cumulative Adjustments to Beginning Retained Earnings Related to the Adoption of Accounting Updates Three Months Ended $ in millions March 31, 2020 Financial Instruments—Credit Losses $ (100) Three Months Ended $ in millions March 31, 2019 Leases $ 63 -- 80 of 93 -- Table of Contents Notes to Consolidated Financial Statements (Unaudited) March 2020 Form 10-Q 78 17. Interest Income and Interest Expense Three Months Ended March 31, $ in millions 2020 2019 Interest income Investment securities $ 445 $ 475 Loans 1,154 1,195 Securities purchased under agreements to resell and Securities borrowed1 398 947 Trading assets, net of Trading liabilities 749 713 Customer receivables and Other2 757 960 Total interest income $ 3,503 $ 4,290 Interest expense Deposits $ 406 $ 462 Borrowings 997 1,380 Securities sold under agreements to repurchase and Securities loaned3 509 600 Customer payables and Other4 235 834 Total interest expense $ 2,147 $ 3,276 Net interest $ 1,356 $ 1,014 1. Includes fees paid on Securities borrowed. 2. Includes interest from Cash and cash equivalents. 3. Includes fees received on Securities loaned. 4. Includes fees received from prime brokerage customers for stock loan transactions entered into to cover customers’ short positions. Interest income and Interest expense are classified in the income statements based on the nature of the instrument and related market conventions. When included as a component of the instrument’s fair value, interest is included within Trading revenues or Investments revenues. Otherwise, it is included within Interest income or Interest expense.k 18. Income Taxes The Firm is under continuous examination by the IRS and other tax authorities in certain countries, such as Japan and the U.K., and in states and localities in which it has significant business operations, such as New York. The Firm believes that the resolution of these tax examinations will not have a material effect on the annual financial statements, although a resolution could have a material impact in the income statements and on the effective tax rate for any period in which such resolutions occur. The Firm has established a liability for unrecognized tax benefits, and associated interest, if applicable (“tax liabilities”), that it believes is adequate in relation to the potential for additional assessments. Once established, the Firm adjusts such tax liabilities only when new information is available or when an event occurs necessitating a change. It is reasonably possible that significant changes in the balance of unrecognized tax benefits may occur within the next 12 months. At this time, however, it is not possible to reasonably estimate the expected change to the total amount of unrecognized tax benefits and the impact on the Firm’s effective tax rate over the next 12 months. See Note 13 regarding the Dutch Tax Authority’s challenge, in the District Court in Amsterdam (matters styled Case number 15/3637 and Case number 15/4353), of the Firm’s entitlement to certain withholding tax credits, which may impact the balance of unrecognized tax benefits. Net Discrete Tax Provisions/(Benefits) Three Months Ended March 31, $ in millions 2020 2019 Recurring1 $ (99) $ (107) Intermittent (31) (101) 1. Recurring discrete tax items are related to conversion of employee share-based awards. The current quarter includes intermittent net discrete tax benefits associated with the remeasurement of prior years’ tax liabilities. The prior year quarter includes intermittent net discrete tax benefits primarily associated with remeasurement of reserves and related interest as a result of new information pertaining to the resolution of multi-jurisdiction tax examinations. 19. Segment, Geographic and Revenue Information Selected Financial Information by Business Segment Three Months Ended March 31, 2020 $ in millions IS WM IM I/E Total Investment banking $ 1,144 $ 158 $ — $ (31) $ 1,271 Trading 3,416 (347) (37) 24 3,056 Investments (25) — 63 — 38 Commissions and fees1 874 588 — (102) 1,360 Asset management1 113 2,680 665 (41) 3,417 Other (1,079) 62 7 (1) (1,011) Total non-interest revenues 4,443 3,141 698 (151) 8,131 Interest income 2,423 1,193 8 (121) 3,503 Interest expense 1,961 297 14 (125) 2,147 Net interest 462 896 (6) 4 1,356 Net revenues $ 4,905 $ 4,037 $ 692 $ (147) $ 9,487 Income before provision for income taxes $ 950 $ 1,055 $ 143 $ (2) $ 2,146 Provision for income taxes 151 191 25 (1) 366 Net income 799 864 118 (1) 1,780 Net income applicable to noncontrolling interests 42 — 40 — 82 Net income applicable to Morgan Stanley $ 757 $ 864 $ 78 $ (1) $ 1,698 -- 81 of 93 -- Table of Contents Notes to Consolidated Financial Statements (Unaudited) 79 March 2020 Form 10-Q Three Months Ended March 31, 2019 $ in millions IS WM IM I/E Total Investment banking $ 1,151 $ 109 $ — $ (18) $ 1,242 Trading 3,130 302 (3) 12 3,441 Investments 81 1 191 — 273 Commissions and fees1 621 406 — (61) 966 Asset management1 107 2,361 617 (36) 3,049 Other 222 80 3 (4) 301 Total non-interest revenues 5,312 3,259 808 (107) 9,272 Interest income 3,056 1,413 4 (183) 4,290 Interest expense 3,172 283 8 (187) 3,276 Net interest (116) 1,130 (4) 4 1,014 Net revenues $ 5,196 $ 4,389 $ 804 $ (103) $10,286 Income before provision for income taxes $ 1,595 $ 1,188 $ 174 $ (2) $ 2,955 Provision for income taxes 190 264 33 — 487 Net income 1,405 924 141 (2) 2,468 Net income applicable to noncontrolling interests 34 — 5 — 39 Net income applicable to Morgan Stanley $ 1,371 $ 924 $ 136 $ (2) $ 2,429 I/E–Intersegment Eliminations 1. Substantially all revenues are from contracts with customers. For a discussion about the Firm’s business segments, see Note 21 to the financial statements in the 2019 Form 10-K. Detail of Investment Banking Revenues Three Months Ended March 31, $ in millions 2020 2019 Institutional Securities Advisory $ 362 $ 406 Institutional Securities Underwriting 782 745 Firm Investment banking revenues from contracts with customers 89% 85% Trading Revenues by Product Type Three Months Ended March 31, $ in millions 2020 2019 Interest rate $ 1,074 $ 785 Foreign exchange 338 241 Equity security and index1 1,072 1,451 Commodity and other 266 422 Credit 306 542 Total $ 3,056 $ 3,441 1. Dividend income is included within equity security and index contracts. The previous table summarizes realized and unrealized gains and losses, from derivative and non-derivative financial instruments, included in Trading revenues in the income statements. The Firm generally utilizes financial instruments across a variety of product types in connection with its market- making and related risk management strategies. The trading revenues presented in the table are not representative of the manner in which the Firm manages its business activities and are prepared in a manner similar to the presentation of trading revenues for regulatory reporting purposes. Investment Management Investments Revenues—Net Cumulative Unrealized Carried Interest $ in millions At March 31, 2020 At December 31, 2019 Net cumulative unrealized performance-based fees at risk of reversing $ 714 $ 774 The Firm’s portion of net cumulative performance-based fees in the form of unrealized carried interest (for which the Firm is not obligated to pay compensation) are at risk of reversing when the return in certain funds fall below specified performance targets. See Note 13 for information regarding general partner guarantees, which include potential obligations to return performance fee distributions previously received. Investment Management Asset Management Revenues— Reduction of Fees Due to Fee Waivers Three Months Ended March 31, $ in millions 2020 2019 Fee waivers $ 11 $ 11 The Firm waives a portion of its fees in the Investment Management business segment from certain registered money market funds that comply with the requirements of Rule 2a-7 of the Investment Company Act of 1940. Certain Other Fee Waivers Separately, the Firm’s employees, including its senior officers, may participate on the same terms and conditions as other investors in certain funds that the Firm sponsors primarily for client investment, and the Firm may waive or lower applicable fees and charges for its employees. Net Revenues by Region Three Months Ended March 31, $ in millions 2020 2019 Americas $ 6,646 $ 7,321 EMEA 1,148 1,702 Asia 1,693 1,263 Total $ 9,487 $ 10,286 For a discussion about the Firm’s geographic net revenues, see Note 21 to the financial statements in the 2019 Form 10-K. -- 82 of 93 -- Table of Contents Notes to Consolidated Financial Statements (Unaudited) March 2020 Form 10-Q 80 Revenue Recognized from Prior Services Three Months Ended March 31, $ in millions 2020 2019 Non-interest revenues $ 614 $ 671 The previous table includes revenue from contracts with customers recognized where some or all services were performed in prior periods and is primarily composed of investment banking advisory fees and distribution fees. Receivables from Contracts with Customers $ in millions At March 31, 2020 At December 31, 2019 Customer and other receivables $ 2,199 $ 2,916 Receivables from contracts with customers, which are included within Customer and other receivables in the balance sheets, arise when the Firm has both recorded revenues and has the right per the contract to bill the customer. Assets by Business Segment $ in millions At March 31, 2020 At December 31, 2019 Institutional Securities $ 707,489 $ 691,201 Wealth Management 233,824 197,682 Investment Management 6,482 6,546 Total1 $ 947,795 $ 895,429 1. Parent assets have been fully allocated to the business segments. -- 83 of 93 -- Table of Contents Financial Data Supplement (Unaudited) 81 March 2020 Form 10-Q Average Balances and Interest Rates and Net Interest Income Three Months Ended March 31, 2020 2019 $ in millions Average Daily Balance Interest Annualized Average Rate Average Daily Balance Interest Annualized Average Rate Interest earning assets Investment securities1 $ 110,277 $ 445 1.6% $ 94,906 $ 475 2.0% Loans1 134,441 1,154 3.5 116,698 1,195 4.2 Securities purchased under agreements to resell and Securities borrowed2: U.S. 121,106 378 1.3 141,806 934 2.7 Non-U.S. 56,865 20 0.1 77,256 13 0.1 Trading assets, net of Trading liabilities3: U.S. 78,771 626 3.2 74,152 631 3.5 Non-U.S. 22,903 123 2.2 11,861 82 2.8 Customer receivables and Other4: U.S. 68,772 555 3.2 63,649 697 4.4 Non-U.S. 60,787 202 1.3 55,142 263 1.9 Total $ 653,922 $ 3,503 2.2% $635,470 $ 4,290 2.7% Interest bearing liabilities Deposits1 $ 199,574 $ 406 0.8% $181,017 $ 462 1.0% Borrowings1, 5 192,061 997 2.1 189,181 1,380 3.0 Securities sold under agreements to repurchase and Securities loaned6: U.S. 31,461 328 4.2 26,615 450 6.9 Non-U.S. 29,682 181 2.5 32,350 150 1.9 Customer payables and Other7: U.S. 128,744 109 0.3 117,932 554 1.9 Non-U.S. 63,914 126 0.8 65,498 280 1.7 Total $ 645,436 $ 2,147 1.3% $612,593 $ 3,276 2.2% Net interest income and net interest rate spread $ 1,356 0.9% $ 1,014 0.5% 1. Amounts include primarily U.S. balances. 2. Includes fees paid on Securities borrowed. 3. Excludes non-interest earning assets and non-interest bearing liabilities, such as equity securities. 4. Includes Cash and cash equivalents. 5. Includes borrowings carried at fair value, whose interest expense is considered part of fair value and therefore is recorded within Trading revenues. 6. Includes fees received on Securities loaned. The annualized average rate was calculated using (a) interest expense incurred on all securities sold under agreements to repurchase and securities loaned transactions, whether or not such transactions were reported in the balance sheets and (b) net average on-balance sheet balances, which exclude certain securities-for-securities transactions. 7. Includes fees received from prime brokerage customers for stock loan transactions entered into to cover customers’ short positions. -- 84 of 93 -- Table of Contents Glossary of Common Terms and Acronyms March 2020 Form 10-Q 82 2019 Form 10-K Annual report on Form 10-K for year ended December 31, 2019 filed with the SEC ABS Asset-backed securities AFS Available-for-sale AML Anti-money laundering AOCI Accumulated other comprehensive income (loss) AUM Assets under management or supervision Balance sheets Consolidated balance sheets BEAT Base erosion and anti-abuse tax BHC Bank holding company bps Basis points; one basis point equals 1/100th of 1% Cash flow statements Consolidated cash flow statements CCAR Comprehensive Capital Analysis and Review CCyB Countercyclical capital buffer CDO Collateralized debt obligation(s), including Collateralized loan obligation(s) CDS Credit default swaps CECL Current Expected Credit Losses, as calculated under the Financial Instruments—Credit Losses accounting update CFTC U.S. Commodity Futures Trading Commission CLN Credit-linked note(s) CLO Collateralized loan obligation(s) CMBS Commercial mortgage-backed securities CMO Collateralized mortgage obligation(s) CVA Credit valuation adjustment DVA Debt valuation adjustment EBITDA Earnings before interest, taxes, depreciation and amortization ELN Equity-linked note(s) EMEA Europe, Middle East and Africa EPS Earnings per common share E.U. European Union FDIC Federal Deposit Insurance Corporation FFELP Federal Family Education Loan Program FFIEC Federal Financial Institutions Examination Council FHC Financial Holding Company FICC Fixed Income Clearing Corporation FICO Fair Isaac Corporation Financial statements Consolidated financial statements FVA Funding valuation adjustment GILTI Global Intangible Low-Taxed Income G-SIB Global systemically important banks HELOC Home Equity Line of Credit HQLA High-quality liquid assets HTM Held-to-maturity I/E Intersegment eliminations IHC Intermediate holding company IM Investment Management Income statements Consolidated income statements IRS Internal Revenue Service IS Institutional Securities LCR Liquidity coverage ratio, as adopted by the U.S. banking agencies LIBOR London Interbank Offered Rate M&A Merger, acquisition and restructuring transaction MSBNA Morgan Stanley Bank, N.A. MS&Co. Morgan Stanley & Co. LLC MSIP Morgan Stanley & Co. International plc -- 85 of 93 -- Table of Contents Glossary of Common Terms and Acronyms 83 March 2020 Form 10-Q MSMS Morgan Stanley MUFG Securities Co., Ltd. MSPBNA Morgan Stanley Private Bank, National Association MSSB Morgan Stanley Smith Barney LLC MUFG Mitsubishi UFJ Financial Group, Inc. MUMSS Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. MWh Megawatt hour N/A Not Applicable NAV Net asset value N/M Not Meaningful Non-GAAP Non-generally accepted accounting principles NSFR Net stable funding ratio, as proposed by the U.S. banking agencies OCC Office of the Comptroller of the Currency OCI Other comprehensive income (loss) OIS Overnight index swap OTC Over-the-counter OTTI Other-than-temporary impairment PRA Prudential Regulation Authority PSU Performance-based stock unit RMBS Residential mortgage-backed securities ROE Return on average common equity ROTCE Return on average tangible common equity ROU Right-of-use RSU Restricted stock unit RWA Risk-weighted assets SEC U.S. Securities and Exchange Commission SLR Supplementary leverage ratio SOFR Secured Overnight Financing Rate S&P Standard & Poor’s SPE Special purpose entity SPOE Single point of entry TDR Troubled debt restructuring TLAC Total loss-absorbing capacity U.K. United Kingdom UPB Unpaid principal balance U.S. United States of America U.S. GAAP Accounting principles generally accepted in the United States of America VaR Value-at-Risk VIE Variable interest entity WACC Implied weighted average cost of capital WM Wealth Management -- 86 of 93 -- Table of Contents March 2020 Form 10-Q 84 Other Information None. Legal Proceedings The following development has occurred since previously reporting certain matters in the Firm’s 2019 Form 10-K. See also the disclosures set forth under “Legal Proceedings” in the 2019 Form 10-K. Residential Mortgage and Credit Crisis Related Matter On March 19, 2020, the Firm filed a motion for partial summary judgment in Deutsche Bank National Trust Company solely in its capacity as Trustee of the Morgan Stanley ABS Capital I Inc. Trust 2007- NC4 v. Morgan Stanley Mortgage Capital Holdings LLC as Successor-by-Merger to Morgan Stanley Mortgage Capital Inc., and Morgan Stanley ABS Capital I Inc. Unregistered Sales of Equity Securities and Use of Proceeds Issuer Purchases of Equity Securities Three Months Ended March 31, 2020 $ in millions, except per share data Total Number of Shares Purchased1 Average Price Paid Per Share Total Shares Purchased as Part of Share Repurchase Program2,3 Dollar Value of Remaining Authorized Repurchase January 11,966,543 $ 55.82 4,860,960 $ 2,733 February 7,624,176 $ 52.63 7,135,908 $ 2,354 March 17,552,911 $ 40.65 17,278,471 $ 1,653 Total 37,143,630 $ 48.00 29,275,339 1. Includes 7,868,291 shares acquired by the Firm in satisfaction of the tax withholding obligations on stock-based awards granted under the Firm’s stock-based compensation plans during the three months ended March 31, 2020. 2. Share purchases under publicly announced programs are made pursuant to open- market purchases, Rule 10b5-1 plans or privately negotiated transactions (including with employee benefit plans) as market conditions warrant and at prices the Firm deems appropriate and may be suspended at any time. On April 18, 2018, the Firm entered into a sales plan with Mitsubishi UFJ Financial Group, Inc. (“MUFG”). See Note 16 to the financial statements for further information on the sales plan. 3. The Firm’s Board of Directors has authorized the repurchase of the Firm’s outstanding stock under a share repurchase program (the “Share Repurchase Program”). The Share Repurchase Program is a program for capital management purposes that considers, among other things, business segment capital needs, as well as equity- based compensation and benefit plan requirements. The Share Repurchase Program has no set expiration or termination date. Share repurchases by the Firm are subject to regulatory non- objection. On June 27, 2019, the Federal Reserve published summary results of CCAR and and the Firm received a non- objection to its 2019 Capital Plan. The Firm’s 2019 Capital Plan includes a share repurchase of up to $6.0 billion of its outstanding common stock during the period beginning July 1, 2019 through June 30, 2020. On March 15, 2020, the Financial Services Forum announced that each of its eight member banks, including the Firm, had voluntarily suspended their share repurchase programs. For further information, see “Liquidity and Capital Resources—Regulatory Requirements—Capital Plans and Stress Tests.” Controls and Procedures Under the supervision and with the participation of the Firm’s management, including the Chief Executive Officer and Chief Financial Officer, the Firm conducted an evaluation of the effectiveness of the Firm’s disclosure controls and procedures (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)). Based on this evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Firm's disclosure controls and procedures were effective as of the end of the period covered by this report. No change in the Firm’s internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) occurred during the period covered by this report that materially affected, or is reasonably likely to materially affect, the Firm’s internal control over financial reporting. Exhibits Exhibit Index Exhibit No. Description 15 Letter of awareness from Deloitte & Touche LLP, dated May 5, 2020, concerning unaudited interim financial information. 31.1 Rule 13a-14(a) Certification of Chief Executive Officer. 31.2 Rule 13a-14(a) Certification of Chief Financial Officer. 32.1 Section 1350 Certification of Chief Executive Officer. 32.2 Section 1350 Certification of Chief Financial Officer. 101 Interactive Data Files pursuant to Rule 405 of Regulation S-T formatted in Inline eXtensible Business Reporting Language (“Inline XBRL”). 104 Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101). -- 87 of 93 -- Table of Contents S-1 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. MORGAN STANLEY (Registrant) By: /s/ JONATHAN PRUZAN Jonathan Pruzan Executive Vice President and Chief Financial Officer By: /s/ PAUL C. WIRTH Paul C. Wirth Deputy Chief Financial Officer Date: May 5, 2020 -- 88 of 93 -- EXHIBIT 15 To the Board of Directors and Shareholders of Morgan Stanley: We have reviewed, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the unaudited condensed consolidated interim financial statements of Morgan Stanley and subsidiaries (the “Firm”) for the three- month periods ended March 31, 2020 and 2019, as indicated in our report dated May 5, 2020; because we did not perform an audit, we expressed no opinion on that information. We are aware that our report referred to above, which is included in your Quarterly Report on Form 10-Q for the quarter ended March 31, 2020, is incorporated by reference in the following Registration Statements of the Firm: Filed on Form S-3: Filed on Form S-8: Registration Statement No. 33-57202 Registration Statement No. 33-63024 Registration Statement No. 33-60734 Registration Statement No. 33-63026 Registration Statement No. 33-89748 Registration Statement No. 33-78038 Registration Statement No. 33-92172 Registration Statement No. 33-79516 Registration Statement No. 333-07947 Registration Statement No. 33-82240 Registration Statement No. 333-27881 Registration Statement No. 33-82242 Registration Statement No. 333-27893 Registration Statement No. 33-82244 Registration Statement No. 333-27919 Registration Statement No. 333-04212 Registration Statement No. 333-46403 Registration Statement No. 333-28141 Registration Statement No. 333-46935 Registration Statement No. 333-28263 Registration Statement No. 333-76111 Registration Statement No. 333-62869 Registration Statement No. 333-75289 Registration Statement No. 333-78081 Registration Statement No. 333-34392 Registration Statement No. 333-95303 Registration Statement No. 333-47576 Registration Statement No. 333-55972 Registration Statement No. 333-83616 Registration Statement No. 333-85148 Registration Statement No. 333-106789 Registration Statement No. 333-85150 Registration Statement No. 333-117752 Registration Statement No. 333-108223 Registration Statement No. 333-129243 Registration Statement No. 333-142874 Registration Statement No. 333-131266 Registration Statement No. 333-146954 Registration Statement No. 333-155622 Registration Statement No. 333-159503 Registration Statement No. 333-156423 Registration Statement No. 333-159504 Registration Statement No. 333-178081 Registration Statement No. 333-159505 Registration Statement No. 333-200365 Registration Statement No. 333-168278 Registration Statement No. 333-200365-12 Registration Statement No. 333-172634 Registration Statement No. 333-221595 Registration Statement No. 333-177454 Registration Statement No. 333-221595-01 Registration Statement No. 333-183595 Registration Statement No. 333-188649 Filed on Form S-4: Registration Statement No. 333-192448 Registration Statement No. 333-25003 Registration Statement No. 333-204504 Registration Statement No. 333-237743 Registration Statement No. 333-211723 Registration Statement No. 333-218377 Registration Statement No. 333-231913 We also are aware that the aforementioned report, pursuant to Rule 436(c) under the Securities Act of 1933, is not considered a part of the Registration Statements prepared or certified by an accountant or a report prepared or certified by an accountant within the meaning of Sections 7 and 11 of that Act. /s/ Deloitte & Touche LLP New York, New York May 5, 2020 -- 89 of 93 -- EXHIBIT 31.1 Certification I, James P. Gorman, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Morgan Stanley; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and 5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. Date: May 5, 2020 /s/ JAMES P. GORMAN James P. Gorman Chairman of the Board and Chief Executive Officer -- 90 of 93 -- EXHIBIT 31.2 Certification I, Jonathan Pruzan, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Morgan Stanley; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and 5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. Date: May 5, 2020 /s/ JONATHAN PRUZAN Jonathan Pruzan Executive Vice President and Chief Financial Officer -- 91 of 93 -- EXHIBIT 32.1 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Quarterly Report of Morgan Stanley (the “Firm”) on Form 10-Q for the quarter ended March 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, James P. Gorman, Chairman of the Board and Chief Executive Officer of the Firm, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that: 1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Firm. /s/ JAMES P. GORMAN James P. Gorman Chairman of the Board and Chief Executive Officer Date: May 5, 2020 -- 92 of 93 -- EXHIBIT 32.2 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Quarterly Report of Morgan Stanley (the “Firm”) on Form 10-Q for the quarter ended March 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jonathan Pruzan, Executive Vice President and Chief Financial Officer of the Firm, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that: 1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Firm. /s/ JONATHAN PRUZAN Jonathan Pruzan Executive Vice President and Chief Financial Officer Date: May 5, 2020 -- 93 of 93 --